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ABSTRACT

Nucleic acids play important roles in living systems by storing and transferring
genetic information and directing protein synthesis. Recently, it was found that nucleic
acids can catalyze chemical and biochemical reactions similar to protein enzymes. In
addition, they can also serve as drug targets for the treatment of deadly diseases such
as AIDS and cancers. As a result, the 3D structure study of nucleic acids and proteinnucleic acids complexes by X-ray crystallography has become one of the most active
research areas.
However, the two intrinsic bottlenecks of macromolecule X-ray crystallography,
including crystallization and phase determination, have significantly limited its
application in study and discovery of the new structures and folds, as well as in
exploration of the biological mechanisms. So far, the selenium derivatization (Se-Met) of

proteins and multiple anomalous dispersion (MAD) or single anomalous dispersion
(SAD) technology have revolutionized the protein crystallography field by providing a
rational solution to solve the phase determination problem. Similarly, it’s important and
urgent to develop a corresponding methodology for nucleic acid X-ray crystallography.
The work presented here includes two general research directions: the seleniumderivatized nucleic acids (SeNA) and the tellurium-derivatized nucleic acids (TeNA):
1) The SeNA strategy by site-specifically replacing oxygen with selenium at the 2’
and 4 positions of thymidine and uridine has been developed. We found that the
selenium derivatization at both sites are relatively stable and doesn’t cause significant
structure perturbations by comparing with their corresponding native counterparts. In
addition to the phase determination, the 2’-Se modification can also facilitate crystal
growth of many oligonucleotides. Moreover, we have observed colorful DNAs and RNAs
with the 4-Se modification for the first time.
2) The TeNA strategy by covalently incorporating tellurium functionalities into
different positions of nucleic acids, particularly at the 2’ and 5 position of thymidine, has
been developed. We have demonstrated the compatibility of the tellurium modification
and solid-phase synthesis, as well as the potential application of the tellurium
modifications in anti-viral drug synthesis and DNA-damage investigation.

INDEX WORDS: Selenium, Tellurium, Nucleic acids, DNA, RNA, 3D-structure, X-ray
crystallography, Anti-virus drug, DNA-damage
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1.

INTRODUCTION

1.1 Nucleic acids and macromolecule X-ray crystallography
Nucleic acids play important roles in cells by storing and transferring genetic
information and directing the protein synthesis, as well as catalytic functions. (1) (2) (3)
Nucleic acid research helps to better understand diseases and identify novel drug
targets for development of therapeutics and the treatment of some deadly world-wide
epidemic diseases, such as AIDS and cancers. Instead of the traditional attacking of
aberrant proteins, modulating specific gene expressions of diseases and cancers can
lead to better treatment. (4) More importantly, nucleic acids themselves can be used as
therapeutics by serving as potential antisense, antigene, aptamer, ribozyme and siRNA
agents. (5) Research activities in this area require further development of new nucleic
acid analogs with improved properties.
3D structural investigations at the atomic level can normally provide useful
guidance for functional studies. X-ray crystallography, NMR, electron microscopy and
atomic force microscopy are the major methodologies used for macromolecular 3D
structure studies. (6) Among them, X-ray crystallography continues to be the major and
the most powerful investigation tools in nucleic acid research, which allows us to better
understand biological processes at the atomic level, including mechanisms of replication
initiation, transcription and translation regulation, DNA-drug complexes, catalytic RNAs,
riboswitch function, and nucleic acid-protein interactions. It has also provided
fundamental insights into hydration, stereoelectronic effects and conformational
preorganization. (7) The nucleic acid research has provided guiding principles for the
optimal design of small molecular drugs and the nucleic acid-based therapeutics.

2

Especially in the past few decades, development in instrumentation, including area
detectors, advanced computers, graphical display units and synchrotron radiation, has
greatly contributed to the success of X-ray crystallography, which provides obvious
advantages over other methodologies.(8)
Although powerful it is, there are still two major challenges in the field of X-ray
crystallography. One is crystallization to get high quality of macromolecular crystals, for
which, there are no rational approaches so far except the regular trial-and-error screen
strategy, because there are so many factors can affect the crystal growth, such as
temperature, concentration, buffer conditions and even the noise. The other one is
called phase problem, which actually is a more serious bottleneck and has largely
slowed down the structure determination of new macromolecules. This problem was
induced by the fact that the precise phase angle is not detectable from the diffraction
pattern of macromolecules. (9) (10) But phase information is needed to calculate the 3D
electron densities of macromolecules structure through Fourier transformation after
collecting diffraction data.
Most of the traditional ways to solve this phase problem were based on the
existence of an endogenous heavy atom (such as selenomethionine residues in the
proteins) or the incorporation of other heavy atoms which would occupying enough sites
or space in the molecule to give a clear signal. (11) Actually, all the nowadays popular
used methods including multiple and single isomorphous replacement (MIR, SIR),
multiple and single isomorphous replacement with anomalous scattering (MIRAS,
SIRAS) and multi- and single-wavelength anomalous dispersion (MAD, SAD) require
heavy atoms derivatization. (12) So far, besides the powerful “magic seven” derivatives,
a useful heavy atom databank has already been founded for protein crystallography. (13)
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Comparing with protein phasing, there are fewer strategies for nucleic acids phasing.
Most of the heavy atoms soaking and co-crystallization, which usually very powerful for
protein crystallography, have been proved to be not very successful in nucleic acid case,
probably due to the lack of the large solvent channels in nucleic acid structure, which
allows diffusion of metal ions into crystals in most of proteins, as well as the limitation of
specific binding sites for ions in nucleic acid. In addition, these bindings could also
cause the backbone cleavage of nucleic acids.
People used to believed that halogenated strategy (bromination and iodination) in
combination with multi- or single-wavelength anomalous dispersion (MAD or SAD,
respectively) are the most convenient and powerful method for the determination of
nucleic acid new structures which avoid the requirement of at least three isomorphous
crystals to use MIR methodology (multiple isomorphous replacement). (14) However,
since the chemical incorporation of halogen atoms is primarily limited to the 5-position of
pyrimidine nucleosides due to their stability, this lack of multiple choice of positions
greatly limited derivatization freedom to avoid base-stacking disruptions, other structural
perturbations, and possible crystallization problems. Moreover, in the majority of cases,
halogen derivatives cannot be crystallized under native conditions and the derivative
crystals sometimes do not diffract as well as the native ones. In addition, recent reports
have indicated that the light sensitivity of halogen derivatives can lead to their
decomposition after long-time exposure to even moderate X-ray dose. (15) Therefore,
it’s very necessary to develop an alternative and more powerful method for the
crystallography structure studies of nucleic acids, this method could also be applied to
determine the structure of protein-nucleic acids complexes and some more complicated
biomacromolecule systems.

4

1.2 SeNA: A powerful tool to get the nucleic acids structure
1.2.1 Brief introduction of selenium in chemistry and biochemistry
Selenium (Se), following oxygen and sulfur, is an element located in VIA group of
periodic table. Although it was discovered early in 1817 by Jons Jakob Berzeliu, (16)
owing to the toxic nature of Se (found in the Se-accumulating plants), the early research
interest in this area was generally low. Between the 1930s and mid 1950s, the animal
nutritionists and chemists were curious to know the structures and functions of the Se
compounds present in those Se-containing plants. (17) However, these studies were not
successful and failed to identify any Se compounds, probably due to their instability
under the isolation conditions. Since the discoveries of the presence of Se in proteins
and key roles that Se played in a number of physiological processes in mid 1950s, there
has been a growing interest in Se-related research. (18) (19)
Although it is toxic in large doses, (exceeding the tolerable upper intake level of
400 micrograms per day lead to selenosis), selenium is nowadays regarded an
essential trace micronutrient element. (20) In plants, it occurs as a bystander mineral,
sometimes in toxic proportions in forage (some plants may accumulate selenium as a
defense against being eaten by animals, but other plants such as locoweed require
selenium, and their growth indicates the presence of selenium in soil). (21) It is a
component of the unusual amino acids selenocysteine and selenomethionine. In
humans, selenium functions as cofactor for reduction of antioxidant enzymes such as
glutathione peroxidases and certain forms of thioredoxin reductase found in animals and
some plants (this enzyme occurs in all living organisms, but not all forms of it in plants
require selenium). (22) (23) (24) Selenium also plays a role in the functioning of the
thyroid gland by participating as a cofactor for three known thyroid hormone deiodinases.
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The further health effects such as cancer, HIV, tuberculosis and diabetes related
selenium functions are still under controversial, detailed research are still to be carried
out to draw the conclusions. (25) Usually, the daily dietary selenium comes from nuts,
cereals, meat, fish and eggs.
As oxygen (atomic radius, 0.73 Å) and sulfur (1.02 Å), selenium (1.16 Å) was
also found in several tRNAs besides its presence in proteins due to their close chemical
and electronic properties. Se in natural tRNAs is present in naturally occurring 2selenouridine and 5-[(methylami-no)methyl]-2-selenouridine (mnm5se2U). (26) The Seatoms at C(2) of the modified uridines are introduced by 2-selenouridine synthase via
displacement of the S-atoms in the corresponding 2-thiouridine nucleotides of the
tRNAs, and selenophosphate is used as the Se donor. (27) (28) Selenium provides both
RNA and protein with many unique biochemical and biological functions, and properties.
There are ca. 23 known Se-containing proteins in mammals. (29) In most of these
enzymes, Se is present in the form of selenocysteine residue. Selenocysteine (Sec, an
analog of cysteine, Cys), referred to as the 21st amino acid, exists naturally in all
kingdoms of life. (30) Also owing to its large size and chemical and electronic properties,
Se was found in mnm5se2U at the anticodon wobble positions of several bacterial
tRNAs, (31) including tRNALys, tRNAGlu, and tRNAGln. The 2-seleno functionality on
this modified nucleotide most likely improves the translation accuracy and efficiency.
These observations in vivo suggest that the presence of Se can provide natural RNA
with many useful and unique properties to better function and survival. As
themechanism of the Se modification in tRNAs remains a mystery, understanding of the
Se presence and function in protein can provide useful information for studying the Se
derivatization and function in RNA. The Se-atom in Sec gives quite different properties
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from O and S. (32) (33) The most obvious difference is the lower pKa value of the Sec
SeH group (pKa 5.2) compared to the Cys SH (pKa 8.5), and its higher reduction
potential. (34) (35) Thus, Sec is a much stronger nucleophile and better reductant than
cysteine at physiological pH. These differences are the fundamental reasons why the
Sec participation in selenoproteins, particularly in the redox proteins, can largely
enhance the redox reaction rates, even up to 1000-fold. (36) (37) Obviously, Se plays an
important role at the redox centers of several important redox enzymes in both
eukaryotes and prokaryotes. (38) Compared to the extensive studies on the Sederivatized natural proteins, the study and progress on the Se-derivatized naturally
occurring RNAs are rather limited due to the Se-RNA availability and the research
challenges. The exciting research and progress in protein study, however, have
stimulated the research on syntheses and studies of Se-derivatized naturally occurring
and unnatural nucleic acids.

1.2.2 Selenium derivatized protein in X-ray crystallography
Another important property of selenium is that it can serve as a good anomalous
scattering center in X-ray diffraction with a special K edge of 0.9795 Ǻ, 12.6578 keV.
The anomalous scattering is a phenomenon that was led by the resonance between
beams of X-ray waves and electronic transitions from bound atomic orbitals. (39) This
effect can be exploited in X-ray crystallographic studies on biological macromolecules
by making diffraction measurements at selected wavelengths associated with a
particular resonant transition. (40) (41) With this manner, the problem of determining the
three dimensional structure of thousands of atoms is reduced to that of initially solving
for a few anomalous scattering centers that can then be used as a reference for
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developing the entire structure. Also based on that, MAD (multiple wavelength
anomalous dispersion) was especially applied to provide a definitive experimental
solution for the phase problem. This MAD experiment can be thought of as in situ
isomorphous replacements (as MIR) in which physics rather than chemistry are used to
effect the change in scattering strength at the site. But unlike MIR, a series of changes
in common at a single constellation of sites suffices in general for definitive phase
determination because of the phase shifts that accompany the anomalous scattering.
(42) The MAD method has potential advantages for accuracy in phase evaluation in that
isomorphism is perfect, relative scattering strength and phase power increase with
scattering angle, diffraction data can be measured from a single crystal and
algebraically exact analysis is possible. To better apply this method, the most important
task is finding proper heavy elements as resonance centers. (43)
In principle, an accessible spectral range for MAD experiments can be considered
to the window from ~0.3 to ~3.0 Å in wavelength (4 to 40 keV in energy). Obviously, the
dominant lighter atoms (H, C, N and 0) in macromolecules are inappreciable at this
range, and although sulfur anomalous scattering has been used for protein phasing in
special cases, its resonance energy is ordinarily inaccessible for MAD experiments.
Either intrinsic metal centers (e.g. Fe or Zn) or introduced heavy atoms (e.g. Hg,Au or
Gd) are suitable and they can produce dramatic effects. However, metalloproteins or
chemical derivatives are not always at hand. (44) Fortunately, systematic biological
incorporation of selenomethionine in place of methionine residues in proteins offers the
possibility of generality. Cowie and Cohen (1957) showed that a strain of E. coli made
auxotrophic for methionine could grow for 100 generations in selenomethionine,
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suggesting that all proteins needed to sustain life in this organism can function well
when fully substituted with selenomethionine. (45)
Early experiment results of MAD phasing of seleno achieved by Hendrickson et.al.,
including selenolanthionine (1985) and selenobiotinyl streptavidin (1989) (46) have
demonstrated that selenium is very effective and successful as a center for MAD
phasing. In 1990, the ribonuclease H structure was also successfully determined by this
selenomethionyl MAD analysis, (47) after that, this selenium derivatization has greatly
revolutionized the protein X-ray crystallography field. It is estimated that about two thirds
of all new crystal structures of proteins are now determined by this strategy. (48)

1.2.3 Selenium derivatized nucleic acids in X-ray crystallography
Since selenium is such an attractive and powerful functionality for X-ray
crystallography in combining with MAD, and also because of the above stated special
difficulties of nucleic acid crystallography structure determination (lack of metal binding
sites, backbone cleavage etc.), naturally, we decided to introduce selenium into nucleic
acids and our group has developed and pioneered this exciting area since year of 1998.
Selenium functionalities were successfully introduced into different locations of nucleic
acids through chemically and enzymatically synthetic method by atom-specific
replacement of oxygen with selenium. Here we defined the selenium modified nucleic
acids as SeNA.
This selenium derivatization strategy has great potential in structural and
functional studies of nucleic acids. So far, our results suggested that this derivatization
can become a better alternative to the conventional Br derivatization in terms of stability
during the exposure of crystal sample in X-ray, (49) and comparing the limited sites of
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bromine modification, the selenium strategy has more site-options since there are so
many oxygen atoms available in nucleic acids. In addition, based on a rudimentary
calculation on X-ray phasing power of a selenium scatter, one selenium atom can
enable phase determination for DNA or RNA up to 30 nucleotides. (50) Since selenium
and oxygen are in the same family VIA in periodic table, it’s possible that this selenium
derivatization doesn’t cause significant structure perturbation when replacing oxygen
atoms in nucleic acids. Actually, this novel derivatization methodology has been utilized
by several laboratories to study the X-ray crystal structures of DNA and RNA molecules,
such as ribozymes, HOMO-DNA and riboswitches. (51) (52) To further facilitate this
strategy, enzymatic method has also been developed to prepare selenium-derivatized
nucleic acids via DNA polymerization and RNA transcription. (53) The next two sections
will briefly summarize the recently achievement and development of SeNA synthesis
and applications.

1.3 Chemical synthesis of SeNA

1.3.1 Selenium modification at 5’-position
As proof of principle, the methyl selenide functionality was introduced into the 5’position of all the A, C, G, T, and U residues. (54) This synthesis was achieved by
activating of 5’-hydroxyl groups of 2a with good leaving groups such as Br, Ms and Ts,
followed by a SN2 substitution of selenide reagents in presence of a phase-transfer
catalyst. After being transferred to the according phosphoramidites, all these Secontaining building blocks 2b and 2c (in figure 1.1) were successfully incorporated into
DNA oligonucleotides through standard solid phase synthesis. It’s been proved that the
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selenium function was very stable when treated with mild iodine solution in the
methylated form (2c), while compound 2b could easily be oxidized into diselenide form.
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It’s also worthy pointing out that Stec et al synthesized a selenium modified TT
dimer by replacing the 5’ bridging oxygen with selenium in 1994 (Scheme 1.1). (14) The
purpose of this work was to test the inhibition of this kind of compounds to nucleases
and find some anti-virus applications as antisense drugs. As a result, they observed
certain cytotoxicity of these selenium compounds instead of anti-virus activity, which
however, could still provide a useful tools for molecular and cell biological applications.
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Scheme 1.1: synthesis of 5’-Se-modified TT dimer.

1.3.2 Selenium modification at 2’-position
The successful demonstration of the stability of selenium functionality and its
compatibility with solid phase phosphoramidite chemistry promoted us to investigate the
further possible positions in nucleic acid for selenium introduction. Then, the synthesis
of phosphoramidite and oligonucleotides containing selenium at the 2’-α-position of
uridine were achieved by using the 3’,5’-protected-2,2’-anhydrous uridine as
intermediate (Scheme 1.2). (55) In this work, the crystal structural of a selenium
modified DNA decamer 5’-GCGTAU2’-SeMeACGC-3’ was also investigated at high
resolution (1.3 Ǻ, comparing 1.8 Ǻ of the native sample without Se). The diffraction data
was successfully phased on the basis of selenium anomalous signal. Figure 1.2 showed
the absorption of selenium atom in X-ray fluorescence spectrum and in this experiment,
three sets of data were collected for MAD: the inflection point (edge), the absorption
maximum (peak) and ca.460 eV above the peak wavelength (remote). This structural
data showed the 2’-methylseleno group was directed into the minor groove and this
modification can remain the native C3’-endo conformation, which was consist with Aform DNA and RNA molecules. It is also worthy to point out that the data collected at the
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peak wavelength is sufficient for SAD phasing when high-resolution diffraction data are
collected. The Fourier electron density maps were computed (figure 1.3) based on the
refinement of the two selenium positions.
O
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Scheme 1.2: Synthesis of 2’-methylseleno containing uridine phosphoramidite and its
incorporation into oligonucleotides.

Figure 1.2: X-ray fluorescence spectrum of the decamer crystal. The theoretical value
for the Se K edge is 12.6578 keV (0.9795 Å).
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Figure 1.3: Fourier electron density maps for the final structure of the decamer DNA
duplex calculated at 1.3 Å resolution with MAD phases. [d(GCGTA)USed(ACGC)]2, DNA
atoms are colored green, cyan, red and orange for carbon, nitrogen, oxygen and
phosphorus, respectively, and the two selenium atoms per asymmetric unit are
highlighted in pink.

Then, a modified synthetic route was developed to introduce selenium functionality
into the 2’ position for both uridine and cytidine as showed in Scheme 1.3. (56) A new
coupling reagent 5-(benzylmerapto)-1H-tetrazole was used to make RNAs including a
number of biologically and structurally important sequences with different secondary
structures. This reagent could make the coupling yields of the modified nucleosides as
high as over 99%. Moreover, the thermaldenaturization and crystallization of a selenium
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containing self-complementary octomer GU(2’-SeMe)GTACAC were also studied
comparing the native one. As a result, the two derivatized USeMe residues have been
proved to have no significant effect on duplex stability of this A-form DNA. In addition,
this oligonucleotide could be easily crystallized in many more screen conditions than
native and bromine modified one, although their morphologies seemed the same
(Figure 1.4, scaled by 5 fold). The high resolution structure of this sequence containing
selenium derivatization was determined via MAD and SAD with a resolution of 1.28 Ǻ.
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CH2Cl2; (e) synthesis of oligonucleotides on solid phase; (f) Ms-Cl, TEA, THF; (g)
toluene/ tetrahexylammonium hydrogen sulfate, Na2CO3 (satd); (h) (Bu)4N+ F-, THF; (i)
TMS-Im, then Ac2O, TEA and DMAP in THF; (j) TMS-Im, then POCl3-triazole-TEA in
CH3CN; (k) NH4OH.

Scheme 1.3: Improved synthesis of 2’-methylseleno containing uridine and cystidine
phosphoramidite and their incorporation into oligonucleotides.

a

b

c

Figure 1.4: Photos of crystals of the native and Se-derivatized octamers. (a) Native-Oct.;
(b) Se-Oct.; (c) Se/Br-Oct. Sizes of the crystals are ranged from 0.1x0.1 to 0.4x0.4 mm.

Based on the key intermediate of 2’-methylselenouridine, a 5’-silyl-2’-ACE
chemistry was successfully applied for the synthesis of longer RNAs, (57) which usually
was achieved by chemical synthesis of short fragments and enzymatic ligation to longer
sequences (This part will be also mentioned in the following section). In this synthesis,
the benzhydry group was introduced into the 5’ of phosphoramidte replacing trityl group
(Scheme 1.4) and several DNAs have been examed as model systems for the
compatibility with the conditions used in the 5’-sily-2’-ACE chemistry.
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A NMR study of the DNA duplex 5’-ATGGAGCTC-3’& 3’-TACCUSeCGAG was
carried to get more insight into the base pairs, which also tested the possible application
of selenium label in NMR spectrum assignment and even functional studies. From the
partial spectra showed in figure 1.5, it’s clear that the chemical shift of hydrogen in the
A:USe pair was obvious upfield-moved comparing the native counterpart (9D-5 Vs 9A-5),
which could be further applied to the complicated NMR assignment and more structure
determination.

12345 6789
5'-A T G G A G C T C-3’
3’-T A C C USe C G A G–5’
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Figure 1.5: NMR study of Se-DNA, the complementary strand, and Se-derivatized DNA
duplex at 283 K. (A) unmodified heteroduplex as a control; (B) 5’-GAGCUSeCCAT-3’
single strand; (C) 5’-ATGGAGCTC-3’ single strand; (D) modified heteroduplex.

All the synthesis stated above used 2,2’-anhydrous nucleosides as intermediates,
which was preferred by pyrimidines while not working for purine bases. Therefore, to
achieve that, a new strategy was developed by Micura and co-workers: a good leaving
group such as Tf (trifluoromethanesulfonyl) was usually introduced into the 2’-β-position,
followed by the substitution (SN2) by selenium. This method has been already proved by
the successful synthesis of 2’-methylseleno adenosine (Scheme 1.5) (58) and the
following guanosine (Scheme 1.6). (59) So far, all the four 2’-SeMe containing RNA
building blocks A C G U phosphoramidites are achieved and actually, they are most
stable and convenient to use practically. It’s claimed in their work that DTT is necessary
to use for reduction of selenium atoms due to the long exposure to the mild iodine

18

solution (Figure 1.6). In addition, the crystallization of two Se-RNAs (12mer:
CGSeCGAAUUAGCG and 16mer: GCAGSeAGUUAAAUCUGC) was investigated.
Similarly, they observed that there are boarder numbers of buffer conditions than their
native counterparts, although the appearance of some thin needle-shaped and
microsized crystals was also included. Importantly, a large number of Se-RNAs were
found to be crystallized in new unique conditions totally different with the native ones.
After that, the structure of the Se-16mer was studied comparing with native one. The
superimposition vision of was showed in Figure 1.7a and the electron density map of
the region around Se-modified residue G4 was showed in 1.7e. It’s worthy to mention
that the two local G(syn):A(anti) mispairs in the Se-sample were held differently with
native one and the electron density of this mispair is slightly worse than the base pairs
closer to the RNA tips (Figure 1.7b), which was a sign of the structure “breathing”.
Furthermore, the crystal contact model in the lattices revealed that the RNA
helices are packed in the head-to-tail fashion with a few side-to-side. Comparing the
figure 1.7c and 1.7d, it was found that the side-to-side interaction model was shifted in
the Se-crystal structure, which didn’t involve another attached helix structure. Another
rather noticeable difference was the orientation of G4 and G20, which faced the
opposite strand of the neighboring helix in native RNA, while in Se-RNA faced against
that. Moreover, from the structure data showed in 11f, which presented that three
selenium atoms could form a equilateral triangle in the center of the packing interactions
and therefore placing this nine nucleotides into close proximity, the authors assumed
that was also a possible reason that this selenium modification could drive the crystal
growth.

19
NHAc
N
N
DMTO
(IPr)3SiO

NHAc

N

N

N

N

O
O

DMTO
OR
NC

O

1: R=H
2: R=SO2CF3

P
N

O

SeCH3

Phosphoramidite

NHAc

RO
O

DMTO
(IPr)3SiO

N

O

3: R=H
4: R=SO2CF3

N

O

CH3COO-K+, (iPr)2NEt
N

N

NHAc
N

N

N

N
NaBH4
CH3SeSeCH3/ THF

DMTO
(IPr)3SiO

N
N

O
O

SeCH3

5: R=CH2OSi(iPr)3
6: R=H

1M TBAF

Scheme 1.5: Synthesis of the 2’-Se-methyladenosine phosphoramidite 7.

20

Figure 1.6: Redox behavior of Redox behavior of RNA 12mer. CGSeCGAAUUAGCG. (a)
Chemical structures of reduced and oxidized selenium-modified RNA and (b) their
HPLC traces and (c) their LC-ESI-MS spectra.
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Figure 1.7: Crystal structure of the 2’-methylseleno-modified RNA duplex. (rGCAGSeA
GUUAAAUCUGC)2 (a) its superimposition (green) with the native structure (red). (b)
electron density map of G(syn):A+(anti) mispair, hydrogen bond was showed in dash
line. (c) and (d) crystal packing of the native and selenium modified sample. (e) electron
density map for the Se-G4. (f) Packing contacts between three Se-modified RNAs
involving 2’-methylseleno groups (red spheres for Se atoms and sticks for methyl
groups).
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Recently, several 2’-slenium modified residues were applied into the structure
study of Diels-Alder ribozyme, a unique 49-nucleotide ribozyme, which could accelerate
the Diels-Alder cyclization reactions with high enentioselectivity. The well solved
structures in both unbound and bound states with reaction product have provided more
detail insight into its catalytic pocket, the substrate recognition, binding and catalytic
mechanism of steroselective carbon-carbon bond formation. (52)

1.3.3 Selenium modification at 4’-position

The replacement of the sugar ring (4’-) oxygen of nucleosides and nucleic acids
by sulfur has been the subject of numerous studies, especially the application to the
modification of aptamers and siRNA, as well as gene regulation. (60) The 4’-S-DNA can
be amplified by PCR and can direct transcription in mammalian cells. In case of 2’-FANA, the sulfur substitution can cause a conformational switch which leads to
interesting properties. The synthesis of the corresponding selenium counterparts has
been one of the most challenging projects and will also have interesting biological
properties besides the structural applications, including seeking new nucleoside based
anti-virus templates and building blocks for antisense oligonucleotides synthesis.
The first 4’-Selenouridine was synthesized by Matsuda et.al (61) via the
stereoselective seleno-Pummerer reaction between a protected selenoxide 7 (Scheme
1.7) and a persilylated uracil, which could also be transferred to 4’-Selenocytidine
derivative 11 through the activation and aminolation of position 4. The coupling
constants (J1’,2’=8.6 Hz and J3’,4’=1.7 Hz ) showed a conformational preference for the S
type (2’-endo) conformer.
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Similar synthetic strategy was also applied by Jeong et al. to synthesize 4’Selenouridine and cytidine. (62) Their key intermediate 4’-selenoxide 8, which was
synthesized from D-gulonic-γ-lactone instead of D-ribose, as showed in scheme 1.8. In
this work, the X-ray crystal structure of this 4’-Se-uridine was obtained and the following
conformational study by coupling constants and NOE were also carried on, which
further indicated that the replacement of the ribose ring oxygen by selenium causes a
conformational change from a C3’-endo to a C2’-endo pucker in the solution state.
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The following work by Pinto et.al(63) further applied the Pummerer rearrangement
of a selenoxide as the key step to build not only pyrimidines U, T, C, but also the purine
nucleosides with high β-stereoselectivity, as shown in scheme 1.9. This breakthrough
could provide a useful way to finish the synthesis of all the 4’-Selenium containing
nucleosides building blocks.
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Since it has been proved that these 4’-selenonucleosides adopt a southern, DNAlike conformations, it’s very interesting to further explore this conformational preference
in their oligonucleotides forms. With all the building blocks in hand, Pinto and Damha
et.al carried out the biophysical characterization of oligonucleotides containing this 4’Selenium functionalities. (64) In this work, the 5-mehtyl-4’-Se-Uridine (4’-Se-rT) was
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converted into the according phosphoramidite and several DNAs and RNAs containing
this residue were synthesized through solid phase synthesis, although the coupling yield
is low (10-40%). Their thermal denaturalization and CD-studies indicated that this 4’-SerT insertion in an oligonucleotide behaved more like RNA in terms of both thermal
binding affinity and hairpin structure affection, instead of the DNA-like conformation
preference in its nucleoside form, although it also caused less base stacking. The
further crystallography studies are underway.

1.3.4 Selenium modification at phosphate backbone

Although powerful the above stated 2’-methylseleno and 4’-oxygen replacement
by selenium derivatization strategies are, these modifications could greatly induce the
sugar pucker into 3’-endo form, which was different with the duplex conformation in
solution. Therefore, this strategy has much better application for A-form DNAs and usual
RNAs. To further develop the advantage that selenium could replace all kinds of oxygen
atoms in nucleic acid, Egli and his co-workers have successfully applied the strategy of
PSe-DNAs into this field and proved its feasibility. (65) PSe-DNAs are backbone
modified nucleic acid analogues where one of the nonbridging oxygen atoms of the
phosphate group is replaced by a selenium atom (Figure 1.8). This analog was
developed initially for antisense purpose (66) and it was found to have diminished
binding and antisense activity relative to the parent phosphodiester oligomers and DNA
phosphorothioates (PS-DNA), as well as more cytotoxicity. But these biological
properties didn’t affect its application in X-ray crystallography, since it has been proved
to be stable for several months under crystallization conditions.
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The synthesis of this PSe-DNAs could be achieved by the modification of the
oxidation step in the process of standard solid phase oligonucleotides synthesis, using
potassium selenocyanate (KSeCN) in acetonitrile/triethylamine as oxidizing reagent
instead of iodine solution. The selenium introduction was quantitative when the
modification positions are located close to the 5’-end of target sequences, and the
produced diastereomeric mixtures of PSe-DNA could be separated very well either by
reversed-phase, SAX, or anion-exchange HPLC. However, more part of selenium will
be oxidized when moving the modified position more inside, which was confirmed by
MALDI TOF MS-Spec, presumably due to a reaction of the oxidation reagent. Moreover,
earlier stability study about this derivatization concluded that the half-life of selenium
was about one month and there was 10% lost in a week. But for crystallography
purpose, some loss of selenium was still acceptable, the remained of which was still
powerful enough to generate the anomalous signals.
Using this modification, the crystallization of a Z-form DNA d(CpSeGCGCG)2 was
studied by one of the diastereomers. The diffraction quality crystals usually appeared in
one week, and as expected, the presence of two selenium atoms in one asymmetric
unit (because it’s complementary sequence) resulted in a very strong anomalous signal.
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As usual, the fraction data were collected at three wavelengths (inflection point, peak
and reference). Figure 1.9 and 1.10 showed the calculated Fourier electron density
maps and the comparison of selenium structure and native one respectively, which
showed that these two geometries are very similar, although actually the PSe duplex is
rotated a little bit. From the structure data, it’s also clear that both selenium atoms are
attaching to water molecules by hydrogen bonds.

Figure 1.9: Fourier electron density map of the PSe-DNA duplex.

Figure 1.10: Superimposition of the PSe Z-DNA and native one ZDF001. Selenium
atoms were represented by blue balls.
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This successful prelude study of PSe-DNA encouraged them to further apply this
strategy

into

the

structure

study

of

a

homo-DNA [dd(CGAATTCG)]2,

the

oligonucleotides with the standard 2’-deoxyribofuranose replaced by the 2’,3’dideoxyglucopyranose, as showed in figure 1.11, (67) which could be used to answer
the question: Why nature uses exclusively pentoses as the building blocks for the
nucleic acids, but never hexoses? By the later 1990, they have collected several
preliminary data for this sequence, but the structure remained not resolved due to the
phase problem; all the attempts either using molecular replacement (MR), multiple
isomorphous replacement (MIR) or multiwavelength anomalous dispersion (MAD)
methods had failed. In this work, one of the PSe-isomer was used and the final crystal
structure was determined in high resolution (figure 1.12), moreover, more detail insights
regarding the role of backbone-base inclination and interstrand stacking in pairing
selectivity were also investigated based on the structural data. This also represented the
first example of an unknown structure to be solved using selenium derivatization
strategy.
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Figure 1.12: Structure and electron density of PSe-homo-DNA. (a) Structure of
phosphoroselenoate homo-DNA. (b) Electron density of PSe-homo-DNA home-DNA
[dd(CGAATTCG)]2, superimposed on the final structure. Selenium atoms are shown as
yellow spheres.

Besides the selenocyanate type of reagent, there were actually several other
alternative selenium transfer reagents developed for the synthesis of PSe-nucleoside,
such as SePPh3, BTSe (Stawinski's benzothioselenol-3-one), and the organometallic
reagent (iPrC5H4)2TiSe5. Similar as KSeCN, the working mechanism of introducing
selenium was still based on the modified oxidation step of solid phase synthesis. (68)
It’s worthy to mention that in the work of (iPrC5H4)2TiSe5, a metal binding study was
carried out for the sequence of d(GGAATGTCSeTGTCG) using
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P NMR. As showed in

figure 1.13, two set of metal titrations were compared, as a result, 5 equivalents of Cd2+
could cause an obvious 4.0 ppm upfield shift of PSe signal, while there was no
significant shift even 20 eqiv of Mg2+ was added to the sample, which indicates that the
phosphoroselenoate could preferentially bind Cd2+ rather than Mg2+ ions and this
selectivity could be very useful for the future study.
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Figure 1.13:

31

P NMR spectra of the Se-modified 13mer DNA. (GGAATGTCSeTGTCG).

The plot on the right shows a shift of the phosphoroselenoate signals upon addition of
Cd2+ ions (304 MHz), whereas the plot on the left shows no shift of the signals upon
addition of Mg2+ ions (202 MHz).

Recently, another new selenium transfer reagent Se-Cyanoethylphthalimide was
developed for the further high efficient synthesis of oligonucleotide phosphoroselenoate
(Scheme 1.10). (69) Inspired by the similar sulfur protection group, the selenium atom in
this work was protected by a cyanoethyl group and a phthalimide function, which could
prevent the selenium oxidation in early stages, and be removed during the base
treatment of clued nucleic acids oligonucleotides before purifications. As an example, a
selenium containing dimer was synthesized, as well as the deprotection, purification and
characterization.
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Although powerful they are, the serious drawback of abovementioned reagents is
the lose of stereoselective control of Rp Vs Sp for the phosphorus center, which usually
can’t be achieved using enzymatic methods. Since most of the biomolecules the
oligonucleotides interact with are chiral and exist in single stereochemical forms, each
diasteromer of a P-chiral oligonucleotide may interact with them in a slightly different
way. Therefore, in the anti-sense application point of view, it’s necessary to take the
stereoselectivity into consideration to assure their most favorable biological activity,
although it has been proved that both Sp and Rp diastereomers of TTPαSe could be
accepted by DNA polymerase. To address this issue, Stec et.al (70) has developed an
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oxathiaphospholane based novel approach which originally designed for the
stereodefined phosphorothioate oligonucleotides. (71) As showed in scheme 1.11, the
diastereomerically pure seleno-oxathiaphospholane monomer intermediate 2 was
obtained in satisfactory yield, which could be inserted into any other part of
oligonucleotides.
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The other part of backbone modification in triphosphate with selenium will be
discussed in the section of enzymatic synthesis of SeNA.
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1.3.5 Selenium modification in nucleobases
Very recently, we achieved the incorporation of selenium functions into the 4position on the thymidine base for Se base pair and crystal structure studies. (72) (The
project will be detailed descripted in Chapter 6). Since the replacement of oxygen with
sulfur on nucleobases has been proved to be able to enhance the DNA duplex base
paring selectivity, replication efficiency and fidelity, thus providing much more insights on
the DNA duplex at the atomic level, (73) (74) (75) we assumed that besides facilitating
the phase problem in X-ray crystallography, selenium could also be used as a molecular
probe to track more insight information to the duplex structures. In the sulfur
derivatization work, it was found that the 2-thio thymidine causes the slight stabilization
of the T-A paring and DNA duplex, while the 4-thio thymidine causes the slight
destabilization of them. So, it’s interesting to check what the effect of selenium, actually,
it’s the first time that selenium base pairs in nucleic acids are studied, although the
synthesis of Se containing nucleobase and nucleoside was finished several decades
ago. (76) The incorporation of this modified residue into real nucleic acids is still
challenging. Furthermore, some specific pyrimidines in natural tRNAs have been
derivatized by Se on the nucleobased and this Se function has been barely understood,
although it was suggested that the Se substitution might be involved in the tRNA
anticodon. (77) So, this work could also offer a powerful tool to do the functionality study.
The synthesis of target phosporamidite and oligonucleotide is showed in scheme
1.12. The position 4 was activated by a triazoyl group, followed by the substitution of
selenium functionality, which was generated by the reduction of di(2-cyanoethyl)
diselenide with NaBH4, to generate the key intermediate 3. Then the according
phosphoramidte building block was made and incorporated into oligonucleotides.
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solid phase synthesis.

After proving the compatibility of this derivatization with solid phase synthesis, we
have synthesized several oligonucleiotides and the thermal stability experiments was
carried out using a duplex system of 5’-ATGGTSeGCTC-3’ & 3’-TACCACGAG-5’ as
example. As a result, the Tm results showed the Se containing duplex (Tm=38.6)
worked very well comparing the native one (Tm=39.2). The following crystallography
study also proved that there is no obvious global structural perturbation observed
comparing the native structure (Figure 1.14A), although the modified base has shifted a
little bit, which indicated that the DNA is flexible and has the ability to accommodate the
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bigger atom such as selenium (Figure 1.14B). In addition, the density map of base pair
clearly showed (Figure 1.14C) that the thymidine 4-selenium atom forms a hydrogen
bond (Se…H-N) with the adenosine 6-amino group in DNA duplex. In this work, a 2’SeMe-uridine was used to facilitate the crystal growth. This trick could also have
potential application to some other new sequences not easy to be crystallized. The
following more detailed functional research about this base modified nucleic acid, as
well as the elucidation of this kind of modification in tRNAs, are still ongoing. It’s also
worthy to point out that this selenium modification in the base could generate yellow
colored DNA, which could provide a useful probe for nucleic acids researches.

Figure 1.14: The global and local structures of the 4-Se-T DNA (5’-GdUSeGTSeACAC-3’).
(A) superimposition of modified (2NSK, in cyan) over native (1DNS, in pink). (B)
Comparison of Se (green) and native (Cyan) local T4 structures. (C) Electron density of
T4-A5 Se base pair.

Following this work and continuing our investigation of nucleic acid base pairing
and stacking via atom-specific mutagenesis and crystallography, we have also
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synthesized for the first time the 6-Se-deoxyguanosine phosphoramidite and its
containing oligonucleotides, scheme 1.13. (78) Despite the synthesis of the 2’-deoxy-6selenoguanosine and its derivatives several decades ago, (79) (76) as well as the
successful incorporation of 6-S-derivative into nucleic acids, (80) the synthesis of
nucleic acids containing the Se-guanine remained a challenge. Similarly, the synthesis
of the key 6-Se-G intermediate was achieved by the selective activation of guanosine 6position by TIBS group (2,4,6-triisopropylbenzene-1-sulfonyl), followed by the selenium
substitution. Again, the corresponding phosphoramidite was proved to be compatible
well with the solid phase synthesis and several DNA oligonucleotides containing this
functionality were successfully synthesized, purified and characterized. Similar as 4-SeT work, all these kinds of DNAs are found to be yellow colored with a new UV
absorption at 360 nm, from which the extinction coefficient was determined at both 260
and 360 nm ( ε 360G as 2.3 x 104 M-1cm-1 and ε 260G as 5.3 x 103 M-1cm-1).
Se

Se

Moreover, we crystallized a ternary complex of the Se-G-DNA, RNA and RNase H,
and determined its X-ray crystal structure. This is the first structure determination of a
protein-nucleic acid complex on the basis of Se-derivatized nucleic acids and MAD
phasing. It was revealed by this work (as shown in figure 1.15) that the global nucleic
acid structures of the native and Se-modified duplexes are very similar; and the SeG
and C can also form a base pair similar to the native G-C pair by selenium mediation of
hydrogen bond (Se…H-N). The GC base pair could accommodate the large selenium
atom by shifting approximately 0.3 Å, which also explained the decrease of Tm by this
kind of modification (including sulfur). It’s worthy pointing out that this novel trial provide
an alternative and easier tool to solve the structure of a protein-nucleic acid complex via
Se-nucleic acids instead of Se-Met methodology. Besides the structural application, this
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yellow Se-G DNAs may also have great potentials in construction of colored DNA
nanoscale devices and structures as well as in nucleic acid diagnosis.
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Figure 1.15: The superimposed global and local structures of the 6-Se-G-modified
(2R7Y) and native (2G8U) DNA/RNA duplexes. (5'-ATGTCG-p-3'/5'-UCGACA-3') of the
nucleic acid-protein complex. The balls represent selenium atoms in the Se-derivatized
DNA (5'-AT-SeG-TC-SeG-p-3'). (A) The structure of the Se-DNA sequence (2R7Y, in
yellow) is superimposed over the corresponding native (2G8U, in grey); (B) The
structure of the RNA sequence (2R7Y, in green) is superimposed over the
corresponding native (2G8U, in grey); (C) The Se-G3/C5 base pair (2R7Y) with the
experimental electron density shows three hydrogen bonds (exo-6-Se/exo-4-NH2, 1NH/N3, and exo-2-NH2/exo-2-O) with bond lengths in 3.48, 3.16 and 2.59 Å,
respectively.
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1.4 Enzymatic synthesis of SeNA
The chemical methods to obtain selenium derivatized nucleic acids at all different
positions were based on the Se modified phosphoramidites synthesis and automatic or
semiautomatic solid phase synthesis, which was very suited to short oligonucleotides,
while not powerful for the preparation of longer ones. To achieve that, a nucleoside
triphosphate analogue containing selenium functionalities at different positions could be
synthesized and incorporated into DNAs and RNAs enzymatically.
As trial, the α-nonbridging selenium (α-Se-TTP) was synthesized in our lab, as
showed in figure 1.16. (56) Since polymerases can conduct the polymerization reaction
steroselectively, the enzymatic approach will generate diastereomerically pure PSenucleic acids, which provided another advantage over chemical counterpart. So, it’s not
necessary to separate the diastereomers.
A designed primer (21nt) and template (55nt) (figure 1.17A) were used in this
demo-system and it’s clearly showed from a time-course experiment (figure 1.17B) that
the full-length DNAs were obtained from all primer extension reactions including those
with both diastereomers of PSe in quantitative yield. It was also found that this two
diastereomers could be recognized equally by the Klenow fragment of DNA polymerase
I and even as well as the native TTP. To further confirm that the formation of DNAs were
not due to the oxidation, a exonuclease digestion experiments was carried out using
Exonuclease III since it has been reported that the modification of the nucleotide
backbone could prevent this process. From the result of figure 1.17C, an obvious
resistance was observed comparing the native TTP, which indicated the real selenium
incorporation. Moreover, the different digestion resistance patterns of the two
diastereomers were observed from the gel data, which probably due to the different
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binding modes of nuclease at the initial and the stationary phases. As expected, when
the selenium modified DNAs were oxidized to normal TTP, no resistance was observed.
This successful demonstration of the principle and the fact that large-scale
preparation could be achieved using a larger volume and higher concentration of
primer/template have paved the way to enzymatic synthesis of long DNAs and RNAs
with selenium derivatizations on the backbones without further separation of the
resulting diastereomers. To further widen its application, we developed the PSe-RNAs
by in vitro transcriptions using T7 RNA polymerase and α-Se-ATP as selenium building
block in the same primer/template system (Figure 1.18). (81) Surprisingly, one of the
PSe-diastereomers (we define it as ATPαSe I) was found to be even more efficient than
native ATP, while the other one was not the right substrate. There was no full-length
product formed when using ATPαSe II and actually, more data showed that this nonworking ATPαSe was neither a substrate nor an inhibitor (Figure 1.18b). Therefore, it’s
not necessary to separate the mixture in this transcript experiment.
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Figure 1.17: Enzymatic incorporation of backbone selenium into DNAs. (A) Primer and
template sequences. (B) Time-course primer extension using R-Se-TTP I and II (Sp and
Rp) on 19% polyacrylamide gel. (C) Exonuclease III digestion after primer extension.
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Figure 1.18: Enzymatic incorporation of ATPaSe into RNA by T7 RNA polymerase. a)
The DNA sequences of the top strand and template. b) Gel electrophoresis analysis of
the transcription mixture after 1 h of incubation at 37.8C.

Again, to further confirm the real incorporation of selenium, the RNA transcript
products were subjected to the digestion with snake venom phosphodiesterase I, which
is an exonuclease that degrades both DNA and RNA in 3’ to 5’ direction. The result
(figure 1.19) indicated that the formed phosphoroselenoate RNA can indeed resist the
enzymatic digestion, which was four to five times slower than that of the corresponding
native one.

Figure 1.19: Time-course enzymatic digestion of phosphoroselenoate RNA with snake
venom phosphodiesterase I. (a) gel electrophoresis autoradiography; (b) the digestion
Vs time plot.
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Figure 1.20: NTPaSe structures.

Then, all the four selenium modified RNA nucleoside triphosphate building blocks
(Adenosine, Cytidine, Guanosine and Uridine triphosphats, figure 1.20) were
synthesized and were incorporated into a desired hammerhead ribozyme as a model
system to test the in vitro transcriptional incorporation and properties of these selenium
containing-residues in a relatively larger biological system. (82) As showed in figure
1.21b, the results were consistent with our previous experiments, NTPαSe I was a good
substrate as the native NTP, while interestingly, the NTPαSe II was neither a substrate
nor an inhibitor for the enzyme, which indicated that it is not necessary to isolate this
pair of mixture for enzymatic incorporation. The following time-course experiment using
NTPαSe I was carried out to compare their incorporation efficiency as substrates with
the natural NTPs. It’s found that the transcription yields are at the same levels as that of
natural ones (figure 1.21c).
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Figure 1.21: Enzymatic incorporation of selenium functionality into hammerhead
ribozyme. (A) Secondary structure of the hammerhead ribozymes; the underlined
sequences are highly conserved. (B) Transcription with native NTP, ATPRSe I and II,
CTPRSe I and II, GTPRSe I and II, and UTPRSe I and II. (C) Time-course experiment
of the transcription with native NTP, ATPRSe I, CTPRSe I, GTPRSe I, and UTPRSe I.

To study the activities of these Se-hammerhead ribozymes, the catalysis efficiency
was carried out using a kinased 33nt RNA substrate in presence of metal ions such as
Mg2+, as showed in figure 1.22. Interestingly, the hammerhead ribozymes transcribed
with UTPαSe I and CTPαSe I have the same level of efficiency as the native one, while
the GTPαSe transcribed was only 30% of native activity, and for the ATPαSe one, there
was only a trace amount product, although it could be rescued by nearly 200-fold when
Mg2+ was replaced by Mn2+ (Figure 1.22c). The reason behind this was maybe because
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the 5’-phosphate oxygen atoms could be involved in the catalysis process, which then
provided a possible method to investigate more detail insight for the catalytic
mechanism of ribozymes.

Figure 1.22: Catalysis and analysis of the modified and native hammerhead ribozymes.
(A) Time-course ribozyme digestion of the RNA substrate. (B) Plot of the catalytic
experimental results, relative to the activity of the native ribozyme. (C) Time-course
Mn2+ rescue experiment of the ribozymes transcribed with ATPαSe and ATP.

Inspired by the previous results that the replacement of thymidine 4-oxygen with
selenium didn’t affect the DNA duplex stability and the hydrogen bond between A and T,
very recently, we also synthesized a base selenium modified TTP and tried to
incorporate it into DNA by DNA polymerase (Scheme 1.14). (83) As a result, this base
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Se-triphosphate is proved a good substrate for DNA polymerases. Using a short DNA
template (T1), SeTTP was incorporated into a short DNA primer (Figure 1.23A) and
confirmed by MS analysis (Figure 1.23B). Using a longer DNA template, our timecourse experiment (Figure 1.24A) has shown that SeTTP polymerization efficiency is at
the same level of native TTP (Figure 1.24B). Both Klenow and Klenow exo- can
incorporate SeTTP with high efficiency.
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Besides the direct incorporation of modified residues by enzymes, there is another
way to make relative large selenium modified nucleic acids, using a comprehensive
enzymatic ligation to fuse two or more Se-containing fragments together. As the starting
work of this strategy, Micura’s lab has successfully achieved the selenium derivatization
for a rat spliceosomal U6 snRNA stem-loop motif using T4 RNA ligase, (84) which
possesses the ability to join the 3’-hydroxy and the 5’-phosphate termini of individual
ribonucleic acid strands. In this work, 2’-SeMe-U and C were used as selenium building
blocks and four potential sites were investigated for the ligation yield as indicate by
arrows in figure 1.25a. Finally, some criteria were founded about the “donors (providing
the 5’-phosphate terminus)” and “accepters”, based on which position 4 was selected
with optimal sites of selenium derivatization compared (figure 1.24b).

Figure 1.25: Target stem-loop motif of rat spliceosomal U6 snRNA (a) and the
conception of the ligation experiments with T4 RNA ligase in position 4 (b).
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Although the target RNA was only about 30 nucleotides in length, their
experimental results have showed that selenium-modified RNAs are stable throughout
enzymatic ligation conditions and have approved the potential application in making
longer nucleotides containing one or multiple selenium modified residues. Later on, (58)
they further selected the aptamer domain of the adenine deaminase (add) adenineriboswitch as candidate and synthesized the relevant selenium modified sequences
based on single-stranded ligation via T4 RNA ligase and on splinted ligation via T4 DNA
ligase respectively. As showed in figure 1.26, they considered two potential ligation sites
for the 71 nt RNA as indicated by arrows based on the standards they founded
previously.

Figure 1.26: Enzymatic ligation of Se-modified RNA. (a) adenine riboswitch (add) target
sequence and potential sites S1 and S2 for ligation with T4 RNA ligase and T4 DNA
ligase, respectively. (b) T4 RNA ligations of 31 nt donor (5’-phosphate) and 40 nt
acceptor (3’-OH) strands (for 3-10 Se-labels); (c) T4 DNA ligations of 31 nt donor and 40
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nt acceptor strands with a 15 nt 2’-O-methyl RNA splint (for 3-10 Se-labels); (d) T4 RNA
ligations of 48 nt donor and 23 nt acceptor strands (for 6-7 Se-labels).

1.5 Tellurium derivatized nucleic acids (TeNA)
Comparing the other chalcogen elements oxygen, sulfur and selenium which play
unique roles in the functional groups of living systems, tellurium seems much quiet. So
far, no similar structural and biological functions have yet been discovered in the case of
the heavier tellurium. The underlying reasons can be sought in its more metallic
properties which are expressed by a distinct weakening of covalent bonds with
hydrogen and carbon atoms when compared with sulfur and selenium, but no further
conclusive information about tellurium in living systems is available due to the lack of
proper model. (85)
The first successful attempts to incorporate tellurium into proteins were made with
Te-resistant fungi grown in the presence of tellurite on a sulfur-free medium, and the
results were supportive for a biosynthesis of tellurium-containing amino acids. (86) More
recently, telluromethionine (TeM) was found to replace Met residues in dihydrofolate
reductase in high percentage (40%) using a methionine-auxotrophic E. coli strain and
supplying synthetic telluromethionine to the medium. (87) Optimization of the selective
pressure incorporation method finally allowed for quantitative TeM bioincorporation into
a series of proteins, and the related X-ray crystallographic analysis confirmed the
stability of tellurium function and the isomorphous character of these protein variants.
(88) Comparing selenium, tellurium atom is not a good anomalous center for MAD
application, however, the electron density of the tellurium atom is sufficient to generate
clear signals in the isomorphous and anomalous difference Patterson maps at the
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commonly used CuKα wavelength, which makes the synchrotron facility is not
necessary to collect X-ray diffraction data of the Te-derivatized protein crystals. (89)
Unfortunately, the facile oxidation of telluromethionine was also found to present a
serious drawback for the use of this methionine analogue for bioexpression of heavy
atom variants of proteins, as well as the further application in protein structure
determination, since oxidized forms were difficult to refold from inclusion bodies or to
crystallize. (90) In particular, surface-located and, in a more pronounced manner,
solvent-exposed TeM residues were found to oxidize readily and thus to generate
electron densities of difficult assignment and local non-isomorphism. In terms of
structure stability in solution, the per-telluromethionine-variant of annexin V was less
stable than the related wild-type protein and the selenomethionine-variant. (91)
However, the success of introducing selenium into nucleic acids and the great
developing of tellurium chemistry has inspired us to further explore the potential
application of tellurium functionality in nucleic acid structure determination through X-ray
crystallography or even cryo-EM by covalent incorporation of organic telluride into
nucleic acid. Only if the isomorphism is confirmed as proof of principle, the limitation of
tellurium oxidation wouldn’t cause drawback for nucleic acids since there are much less
refolding issues comparing proteins.

1.6 The objectives and contributions of this dissertation
The objectives of this research are to further develop more SeNA and TeNA building
blocks as powerful tools for much wider and convenient applications nucleic acids
structure determination, as well as explore other functions of selenium and tellurium in
nucleic acids. This research focuses on four key objectives:
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A. Synthesizing the 2’-SeMe-thymidine building block
The selenium modified ribothymidine at 2’-position was obtained especially for
some tRNA structure and function study. Meanwhile, this work have completed the set
of 2’-Se-modification building blocks for all natural residues of nucleic acids, making the
2’-selenium labels more available. In addition, we also found that this 2’-modification
strategy could greatly facilitate the crystal growth for many oligonucleotides sequences
comparing their native counterparts.

B.

Investigating base modified SeNA at 4 position of thymidine
This is the first trial of SeNA produce on the base. To our surprise, besides the

structural application, this base SeNA could generate yellow DNAs with a special UVabsorption. The following structure and hydrogen bonding studies confirmed the
isomorphism of this derivatization and provide a powerful tool for hydrogen bonding,
base stacking studies.

C. Proof of TeNA principle by 2’-Te modified DNA
In this work, the tellurium function was incorporated into the 2’-position of the ribose
in several DNA oligonucleotides for the first time. Although this derivatization showed
some structure perturbation in terms of DNA duplex stability probably due to the
modification location is in the minor groove, and no crystal could be growing in this work,
it still could provide a potential tool to investigate the DNA backbone cleavage and base
elimination damage caused by heavy atoms such as Te. In addition, a novel additionelimination reaction based method was developed for making d4T analogs, a FDA
proved anti-HIV drug.
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D. Proof of TeNA principle by 5-Te modified DNA
Due to the structure perturbation caused by the 2’-Te modification, we also carried
out the derivatization of tellurium at 5 position of nucleobase since it locates in the DNA
major groove where provide more space for the accommodation of bigger atoms. In this
work, a crystal structure of first Te-DNA was resolved in high resolution and the structure
isomorphism of Te-structure at this position was also confirmed.
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2.

METHODS AND MATERIALS

This chapter summarizes some common used materials, methods and
instruments through all this dissertation research, the detailed, special and additional
method information will be provided in each chapter.

2.1

Synthesis of Se and Te modified nucleosides
Most solvents and reagents were purchased from Sigma, Fluka, or Aldrich and

used without purification unless mentioned otherwise. The dimethyl ditelluride reagent
was purchased from Organometallic Inc. Triethylamine (TEA) was dried over KOH (s)
and distilled under argon. When necessary, solid reagents were dried under high
vacuum. Reactions with compounds sensitive to air or moisture were performed under
argon.

Solvent

mixtures

are

indicated

as

volume/volume

ratios.

Thin

layer

chromatography (TLC) was run on Merck 60 F254 plates (0.25 mm thick; Rf values in
the text are for the title products), and visualized under UV-light or by a Ce-Mo staining
solution (phosphomolybdate, 25 g; Ce(SO4)2•4H2O, 10 g; H2SO4, 60 mL, conc.; H2O, 940
mL) with heating. Preparative TLC was performed using Merck 60 F254 pre-coated
plates (1000 mesh, 2 mm thick). Flash chromatography was performed using Fluka silica
gel 60 (mesh size 0.040-0.063 mm) using a silica gel:crude compound weight ratio of ca.
30:1. 1H,

13

C and

31

P-NMR spectra were recorded using Bruker-300 or 400 (300 or 400

MHz). All chemical shifts (δ) are in ppm relative to tetramethylsilane and all coupling
constants (J) are in Hz. High resolution mass spectrum (HRMS) analysis was performed
at Georgia State University Mass-Spec center and Scripps Center for Mass
Spectrometry, California.
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2.2

Synthesis of phosphoramidites containing Se and Te
The common two phosphoramidite reagents: 2-cyanoethyl N,N-diisopropylchloro-

phosphoramidite and 2-cyanoethyl N,N,N,N-tetraisopropylphosphorodiamidite were
purchased from Chemgen. Inc., the 5-(benzylthio)-1H-tetrazole (5-BMT) is used as
catalyst when the later one was used. The equivalence of phosphoramidite reagent is
usually from 1.5 to 2.5 by monitoring the reactions. The access reagent could be
removed by pentane or hexane precipitation. Usually, a flash neutral alumina column is
needed to removed the organic salts which otherwise could affect the following solid
phase synthesis.

2.3

Design and synthesis of oligonucleotides sequences containing Se and Te

2.3.1

PDB and NDB database
Most of the sequences applied for crystallography structure studies are referred

from the protein and nucleic acids data base (PDB and NBD), as initial models to study
the structure derivatization isomorphism. Their web address is: http://www.pdb.org/ and
http://ndbserver.rutgers.edu/. The positions of modified residues are randomly selected
and usually cover 5’, middle and 3’ regions of a sequence.

2.3.2

Solid phase synthesis
Both native and the modified oligonucleotides are synthesized through solid

phase synthesis in the ABI392 DNA/RNA Synthesizer (Figure 2.1). The samples are
usually synthesized in a 1.0 μmol scale, in several cases it could be 0.2 and 10 μmol.
The general solid phase synthesis procedure is showed in figure 2.2.
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Figure 2.1: ABI 392 Solid Phase Synthesizer.
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This procedure is performed from 3’ to 5’ of a sequence on control pore glass
(CPG-500 or 1000) immobilized with the appropriate nucleoside through a succinate
linker. All the reagents are purchased from Glen Research. In DNA works, regular DNA
phosphoramidites (dA-CE, dG-CE, Ac-dC-CE, and dT-CE, 0.1 M in acetonitrile) are
used for most of synthesis, when base selenium modification is involved, the ultra-mild
phosphoramidites (Pac-dA-CE, Ac-dC-CE and iPr-Pac-dG-CE, also 0.1 M in acetonitrile)
are used which provide a mild basic deprotection (0.05 M K2CO3 in methanol instead of
ammonium hydroxide). In RNA works, 2’-TOM protected phosphoramidites are used for
most of synthesis, when base selenium modification is involved, the ultra-mild 2’TBDMS protected phosphoramidits are used (the concentration of both types of reagent
is 0.1M in acetonitrile). Coupling steps are carried out using a 5-(benzylmercapto)-1Htetrazole (5-BMT) solution (0.25 M) as activator in acetonitrile with 25 seconds coupling
time. A 10% of THF solution of acetic anhydride, along with 16% MeIm in THF serves as
capping reagents. 3% trichloroacetic acid in methylene chloride and 0.02 m iodine in
THF/pyridine/H2O are used as detritylation and oxidation reagents respectively in the
last two steps. In this work, all the oligonucleotides were prepared with DMTr-on form,
which means the last trityl group is reserved for the following purification purpose.

2.4

Oligonucleotides purification and characterization
After synthesis, the DNA oligonucleotides are cleaved from the solid support

and fully deprotected by aqueous ammonia (conc.) treatment for 14 hr at 55°C. For the
ultramild synthesized sample associated with base Se modification in this work, the
cleavage step is finished by using 0.05 M K2CO3 in methanol for 8 hours at room
temperature. Similarly, the 2’-O-TOM protected RNA oligonucleotides were deprotected
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following recommendations from Glen Research with minor modifications. Briefly, 1 mL
of a methylamine solution [prepared by mixing 40% aqueous methylamine with 33%
ethanolic methylamine (Fluka) in a 1:1 ration] was added to an eppendorf tube
containing the RNA resin (1 μmol), followed by incubation for 6 hr at 35°C or overnight
at room temperature. The supernatant was evenly transferred into two sterile 1.5 mLeppendorf tubes. After these tubes were chilled at -20°C for 10 min, the solvents were
completely evaporated on speed vacuum. Each portion was treated with 25 equivalents
of tetrabutylammonium fluoride [0.25 mL (for 0.5 μmol RNA 20mer), 1.0 M in THF, Fluka]
and incubated for 6 hr at 35°C. Following evaporation of THF on speed vacuum, the two
portions were combined in 1.0 mL of 1.0 M Tris-HCl buffer (RNase-free, pH 7.5),
incubated with shaking overnight at 25°C, and filtrated through a 0.2 μm pore-sized filter.
The 5’-DMTr deprotection of both DNA and RNA oligonucleotides was performed in a
2% trichloroacetic acid solution (from 10% w/w, 0.9 M in water) for 1.5 min, followed by
neutralization to pH 7.0 with a freshly made aqueous solution of triethylamine (1.1 M)
and petroleum ether extraction to remove DMTr-OH.

2.4.1

High Performance Liquid Chromatography (HPLC)
The DNA and RNA oligonucleotides were analyzed and purified by reverse

phase high performance liquid chromatography (RP-HPLC) both DMTr-on and DMTr-off.
Purification was carried out using a 21.2x250 mm Zorbax, RX-C8 column at a flow rate
of 6 mL/min. Buffer A consisted of 20 mM triethylammonium acetate (TEAAc, pH 7.1,
RNase-free water), while buffer B containing 50% aqueous acetonitrile in buffer A.
Similarly, analysis was performed on a Zorbax SB-C18 column (4.6x250 mm) at a flow
of 1.0 mL/min using the same buffer system. The DMTr-on oligonucleotides were
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eluded with up to 100% buffer B in 20 min in a linear gradient, while the DMTr-off
oligonucleotides were eluted with up to 70% of buffer B in a linear gradient in the same
period of time. The collected fractions were lyophilized; the purified compounds were redissolved in RNase-free water. The pH was adjusted to 7.0 after the final purification of
the Se-oligonucleotides without the DMTr group.

2.4.2

Mass spectrometry
The ESI-MS was performed using a Waters Micromass Q-TOF micro instrument.

The data were acquired in both positive and negative ion modes by syringe pump
infusion of the sample solutions at a flow rate of 7 µL/min. The MALDI mass
spectrometry analysis was performed on an Applied Biosystems 4800 plus MALDI
TOF/TOF analyzer mass spectrometer (Framingham, MA). This instrument is equipped
with a Diode-pumped Nd:YAG laser at 355-nm. The mass spectra were acquired as an
average of 3 shots with a same laser intensity attenuator setting (4002 arbitrary unit) for
all samples. All spectra were recorded on a biomass spectrometer in linear-negative
mode with delayed extraction. 3-hydroxypicolinic acid (3-HPA)/diammonium citrate (9:1)
in water was used as the matrix. A 10:1 matrix:sample mixture was prepared, applied to
the sample plate as 1 μL drops, and allowed to air dry before the analysis. 25 kV were
applied as the acceleration voltage. A mass range of 1000–10000 was scanned. Each
spectrum was summed from multiple spectra at different spots. Proteins, such as insulin,
thioredoxin, and apomyoglobin, were used as external standards. This work was
performed by Dr. Siming Wang, Dr. Lupei Du and Yanyi Chen at Mass Spectrometry
Center of Georgia State University. In addition, the Scrippts center of mass spectrometry
can also provide similar service.
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2.5

Nucleic acids stability and thermaldenaturization (Tm) studies
Solutions of the duplex DNAs (2 μM) were prepared by dissolving the DNAs and

RNAs in a buffer containing NaCl (50 mM), sodium phosphate (10 mM, pH 7.2), EDTA
(0.1 mM) and MgCl2 (10 mM) . The solutions were then heated to 95 °C for 2 min,
cooled slowly to room temperature, and stored at 4 °C overnight before measurement.
Prior to thermal denaturation, helium was bubbled through the samples. Denaturation
curves were acquired at 260 nm by heating and cooling between 5 to 80 °C for four
times in a rate of 0.5 °C/min using Cary-300 UV-Visible Spectrometer equipped with a
Peltier Temperature Controller. The data were analyzed in accordance with the
convention of Puglisi and Tinoco. (92)

2.6

Circular dichroism spectroscopy
The CD spectra of samples were recorded in a Jasco-810 spectropolarimeter at

25 ºC. The DNA spectrum were measured in a 1-mm pathlength cell with a UVabsorption at around 0.5. After subtracting the spectrum of blank solvent, all sample
spectra were obtained as the average of at least five scans from 200 to 500 nm with a
scan rate of 100 nm/min.

2.7

Crystallization of modified and non-modified nucleic acids
The most popular used hanging drop vapor diffusion technique is applied for

the crystallization of all the oligonucleotides in this work. And all the experiments are
carried out in greased VDX 24-well plate. The principle of vapor diffusion is showed in
figure 2.3. A drop composed of a mixture of sample and reagent is placed in vapor
equilibration with a liquid reservoir of reagent. Typically the drop contains a lower
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reagent concentration than the reservoir. To achieve equilibrium, water vapor leaves the
drop and eventually ends up in the reservoir. As water leaves the drop, the sample
undergoes an increase in relative supersaturation and crystallization out of the solution.
Equilibration is reached when the reagent concentration in the drop is approximately the
same as that in the reservoir.
In this work, the purified oligonucleotides (1 mM) were heated to 70°C for 2
minute, and cooled slowly to room temperature before hanging drop crystal setting.
Both native buffer (from the original literatures) and Nucleic Acid Mini Screen Kit
(Hampton Research) were applied to screen the crystallization conditions at different
temperatures.

Figure 2.3: Hanging drop vapor diffusion for crystallization.

2.8

Crystal growth monitor
All the crystal growth was monitored by Olympus BX-60 optical microscope

equipped with Olympus U-CMAD3-3.3 MPX digital camera, which is used to take the
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crystal pictures in high resolution. The software Rincon from Imagingplanet, Inc. was
applied to measure and calculate the crystal parameters.

2.9

Crystal data collection and structure determination
All the diffraction data were collected in beamline X-12B and X-12C of NSLS

(National Synchrotron Light Source) in Brookhaven National Laboratory. The obtained
crystals were mounted through Magnetic Crystal Cap with different sizes of pins on the
top. 30% glycerol, PEG 400, 35% MPD, perfluoropolyether, Paratone-N or the mixture
of mother liquid with certain amount of MPD were normally used and screened as
cryoprotectants before the crystals were freezing in liquid nitrogen. The data collection
was taken under the liquid nitrogen stream at 99°K either by automounter system or
physically on-site. Usually, a number of crystals were scanned to find the one with
strong anomalous scattering at the K-edge absorption of selenium. The distance of the
detector to the crystals was adjusted depending of the diffraction, usually set to 150 mm.
The wavelengths of 0.9795 Å was chosen for selenium SAD phasing, while 0.9792 Å,
0.9795 Å and 0.9400 Å were chosen for selenium MAD phasing collection. The crystals
were exposed for 10 or 15 seconds per image with an oscillation angle of one degree,
and a total of 180~360 images were taken for each data set based on different space
groups. All the data were processed using HKL2000 and DENZO/SCALEPACK. (93)
The crystal structure of this Se and Te modified oligonucleotides were solved by
molecular replacement, followed by the refinement of selenium and tellurium atom
positions in CNS. (94) The refinement protocol includes simulated annealing, positional
refinement, restrained B-factor refinement, and bulk solvent correction. Besides the
stereo-chemical topology and geometrical restrain parameters of DNA/RNA,(95) the
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topologies and parameters for modified dU with selenium and tellurium were
constructed and applied. After several cycles of refinement and the model rebuilding, a
number of highly ordered waters were added. Finally, the occupancies of Se and Te
were refined.

Cross-validation with a 5-10% test set was monitored during the

refinement. (96) The σA-weighted maps of the (2m|Fo| - D|Fc|) and the difference
(m|Fo| - D|Fc|) maps were computed and used throughout the model building. (97)
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3.

SYNTHESIS AND STRUCTURE STUDY OF THE 2’-SeMe-THYMIDINE
CONTAINING OLIGONUCLEOTIDES

(This work has been published on Organic Letters, 2007, 9 (5): 749-752, Jiansheng Jiang, Jozef Salon
and Zhen Huang are listed as co-authors.)

3.1

Introduction
As stated in the introduction part, SeNA is built by chemical replacement of

oxygen atoms in nucleic acids with selenium. Therefore, there are multiple positions
available in different residues. Besides the criteria of structure isomorphism, synthetic
accessibility and stability are the most important factors need to be firstly considered to
design the right applicable SeNA molecules. The previous results from our and other
research groups have confirmed the advantage of selenium modification at 2’ position of
nucleoribose, which actually, this is also one of the very early starting points of this
young research area. The methylated selenium function is stable enough to tolerate not
only the normal solid phase synthesis including strong acid and base treatment, but also
the long time high energy X-ray exposure, more important, although locating in the
minor groove of DNA, this group doesn’t cause significant global and local structure
perturbations. Because of that, all this series of 2’-SeMe modified A, G, C, U building
blocks have already been developed recently and especially, the 2’-Se-uridine-CE is
now commercially available from Glen research as a novel phosphoramidite. The easily
accessibility and stability make this 2’-SeMe derivatization widely used in the
determination of some more complicated nucleic acids structures, especially in the RNA
research area, since this is more like a RNA analog.
Considering that ribothymidine is also a common modification in maturized tRNAs,
(98) it’s worthy developing the synthesis of this 2’-SeMe modified thymidine as an

66

analog for both thymidine and ribothymidine in DNA and RNA researches. (99) (100) It
can also serve as the supplementary building blocks to complete this 2’-Se modification
family. In this chapter, the first synthesis of 2’-SeMe-thymidine phosphoramidite and its
containing DNA and RNA oligonucleotides are described, as well as a crystallography
structure study based on this derivatization.

3.2 Results and discussion
3.2.1 Synthesis of 2’-SeMe-thymidine and the phosphoramidite
As showed in scheme 3.1, the synthesis of the 2’-methylseleno-ribothymidine
derivative (4) started from the glycosylation of the protected D-ribose (1) with thymine
under the Vorburggen conditions. Due to the 2’-neiboring group effect, this glycosylation
generated exclusively the protected β-ribothymidine derivative, followed by the NaOMe
treatment to give fully-deprotected ribothymidine (2) in 88% yield over two steps. After
the cyclization of 2 in DMF, the 2,2’-anhydrothymidine was selectively protected with
DMTr group at the 5’-position to give 3 in 87% yield in two steps. Unlike the synthesis of
the 2’-methylseleno-uridine, we initially encountered problems of low yield and long
reaction time in the introduction of the selenium functionality into anhydroribothymidine
3. We attempted to increase the reaction yield by using different reducing reagents,
such as LiAlH4 and DIBAH to form the methyl selenide nucleophile via the reduction of
dimethyl diselenide. Unfortunately, we always observed the reduction of the nucleobase,
which leaded to lower yields. This problem was later overcome by using a weaker
reducing reagent (NaBH4) at a higher temperature (50 ºC) in pure EtOH, which gave
high yield in three hours. Finally, the 2’-Se-ribothymidine (4) was converted to the
corresponding phosphoramidite (5) in 90% yield, in dry CH2Cl2 using 2-cyanoethyl
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N,N,N,N-tetraisopropyl phosphoramidite and 5-benzylmercapto-tetrazole (5-BMP, as
catalyst). The detailed synthesis steps and the characterization of each intermediate are
listed in the following.
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Scheme 3.1: Synthesis of 5’-DMTr-2’-MeSe-thymidine phosphoramidite (5) and
oligonucleotides containing this Se derivatization (6).

5-Methyluridine or ribothymidine (2)
Thymine (3.80 g, 30.23 mmol) and 1-O-acetyl-2,3,5-tri-O-benzoylribose (12.7 g, 25.4
mmol) were suspended in dry acetonitrile (350 mL), followed by adding trimethylsilyl
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chloride (3.2 mL, 25.9 mmol), hexamethyldisilazane (5.3 mL, 25.4 mmol), and tin
chloride (2.97 mL, 25.4 mmol), then the suspension was heated to reflux for 1.5 h. The
solution was concentrated in vacuum (approximately 20 mL) and dissolved in methylene
chloride (100 mL). The organic solution was washed with water (20 mL), saturated
sodium bicarbonate (2 X 20 mL), and brine (20 mL) , dried over MgSO4 and
concentrated to give 2',3',5'-tri-O-benzoyl-5-methyluridine as a white solid (14.36 g). 1HNMR (400 MHz, CDCl3) δ:1.61 (s, 3H, 5-CH3), 4.72-4.78 (m, 1H, H-2’), 4.68 and 4.92
(2x dd, J1 =2.4 Hz, J2 = 12 Hz, 2H, H-5’), 5.78 (t, J =6.0 Hz, 1H, H-3’), 4.92-4.97 (m, 1H,
H-4’), 6.43 (d, J =6.2 Hz, 1H, H-1’), 7.18-8.14 (m, 16H, aromatic H and H-6). The white
solid (14.36 g, 25.2 mmol), without further purification, was dissolved in methanol (350
mL). Sodium methoxide (8.16 g, 151.2 mmol) was then added, and the reaction mixture
was stirred at room temperature overnight. The solution was neutralized with Dowex 50
X 8-4200 ion-exchange resin (approximately 5 g, monitored by wet pH paper),
concentrated, and dissolved in water (100 mL), which then be lyophilized after
extracting with ethyl ether (2 X 150 mL). The lyophilized sample was recrystallized from
absolute ethanol to give compound 2 as a white solid (5.76 g, 88% in two steps). 1HNMR (400 MHz, D2O) δ:1.78 (s, 3H, 5-CH3), 3.72 and 3.83 (2 X dd, J1 =4.0 Hz, J2 =
12.8 Hz, 2H, H-5’), 4.02 (m, 1H, H-4’), 4.15 (t, J =2.6 Hz, 1H, H-3’), 4.25 (t, J =2.5 Hz,
1H, H-2’), 5.82 (d, J =6.0 Hz, 1H, H-1’), 7.60 (s, 1H, H-6). 1H-NMR spectrum is identical
to the literature (18).
2,2’-Anhydro[1-(β-D-arabinofuranosyl)-5-methyluridine]
Diphenylcarbonate (7.0 g, 0.033 mol) and sodium bicarbonate (0.16 g, 1.8 mmol) were
added to the DMF (25 mL) solution of 5-methyluridine (5.6 g, 0.022 mol). The mixture
was heated to reflux, and carbon dioxide was generated. After 1.5 hour, the darkened
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solution was concentrated to approximately 4 mL under reduced pressure. The black
residue was poured into diethylether (200 mL) under vigorous stirring, and a brown gum
product was formed. The ether was decanted and the residue was dissolved in a
minimum amount of methanol. The crude product was precipitated again with fresh
ether (150 mL) to yield a stiff light brown gum. The ether was decanted and the gum
was dried under high vacuum over night to give a solid that was easily crushed to give a
light tan powder (4.4 g, 85% crude yield). The material could be used directly in the
following step without further purification. 1H-NMR (400 MHz, d-DMSO) δ: 1.79 (s, 3H,
5-CH3), 3.12-3.25 (m, 2H, H-5’), 4.05-4.11 (m, 1H, H-4’), 4.35-4.41 (m, 1H, H-3’), 5.19
(d, J = 5.6 Hz, 1H, H-2’), 6.29 (d, J =6.2 Hz, 1H, H-1’), 7.76 (s, 1H, H-6). 1H-NMR
spectrum is identical to the literature (19).
2,2’-Anhydro-1-[2’-deoxy-5’-O-(4,4-dimethoxytrityl)-β-D-arabinofuranosyl-5-ethyluridine]:
The starting material, 2,2’-anhydro[1-(β-D-arabinofuranosyl)-5-methyluridine] (4.0 g nonpurified after the cyclization step), was co-evaporated with dry pyridine (3 X 5 mL) and
then dissolved in dry pyridine (25 mL). A first half of dimethoxytrityl chloride (2.36 g, 6.95
mmol) was added and the solution was stirred at room temperature for one hour. Then a
second half of dimethoxytrityl chloride was added and the reaction was completed after
stirred for additional one hour, followed by quenching with methanol (4 mL). The
solution was evaporated and co-evaporated with CH3CN (2 X 5 mL). The residue was
then dissolved in CHCl3 (40 mL) and the solution was washed with saturated sodium
bicarbonateand (2 X 15 mL) and saturated sodium chloride (2 X 15 mL). The organic
phase was dried over Na2SO4 (s) and evaporated after the filtration of the drying agent.
The obtained crude product (6.9 g) was purified on a silica gel column equilibrated with
methylene chloride, and the pure product was eluted with a methanol/CH2Cl2 gradient
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(methanol in CH2Cl2, 0-3%). The fractions containing the product were combined,
evaporated and dried on high vacuum overnight to yield the pure product (3, 7.80 g) in
87% yield (calculated from ribothymidine). 1H-NMR (400 MHz, CDCl3) δ: 1.92 (s, 3H, 5CH3), 2.94-3.09 (m, 2H, H-5’), 3.79 (s, 6H, 2x CH3O), 4.36-4.42 (m, 1H, H-4’), 4.494.51 (m, 1H, H-3’), 5.26 (dd, J1 =1.4 Hz, J2 = 5.8 Hz, 1H, H-2’), 6.15 (d, J =6.0 Hz, 1H,
H-1’), 6.76-6.80 (m, 4H, aromatic), 7.17 -7.35 (m, 10H, H-6 and 9 aromatic protons).
13

C-NMR (CDCl3) δ: 55.23 (OCH3), 63.01 (C-5’), 75.63 (C-3’), 86.23 (Ar-C) 87.41 (C-4’),

89.09 (C-2’), 90.40 (C-1’) , 118.75 (C-5), 113.21, 126.95, 127.90, 129.84, 135.45,
144.37, 158.50, 159.27 (Ar-C), 131.22 (C-6), 159.27 (C-2), 172.86 (C-4). HRMS (ESITOF): molecular formula, C31H30N2O7; [M+H]+:543.2051 (calc.543.2053).
2’-methylseleno-5’-O-(4,4’-dimethoxytrityl)-5-methyluridine (4)
NaBH4 (0.56 g, 14.72 mmol) was placed in a 50 ml round ask and suspended in dry
THF (15 mL) under vigorous stirring. Dimethyl diselenide (CH3SeSeCH3, 1.47 ml, 14.72
mmol) was slowly injected in an ice-water bath under dry argon. Anhydrous ethanol (2
ml) was added dropwisely until gas bubbles started in the yellow mixture. The reaction
mixture turned white or light yellow after 30 min, then a solution of 3 (4.0 g, 7.36 mmol)
in THF (8 ml) was injected into the flask. The ice-water bath was removed after the
addition, and the reaction was heated at 50 ºC and monitored by TLC (5% CH3OH in
CH2Cl2, product Rf = 0.47). The reaction was completed in 3 h, and the solvent was
removed under reduced pressure. The residue was dissolved in methylene dichloride
(20 mL) and the solution was washed with NaCl solution (sat., 3 X 10 mL). The organic
layer was dried over anhydrous MgSO4, followed by the filtration and solvent
evaporation. The residue was then purified on a silica gel column (equilibrated with
CH2Cl2) and the column was eluted with a methanol/methylene chloride gradient
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(CH3OH in CH2Cl2, 0-3%) to afford the pure foamy product (4, 4.24 g) in 82 % yield. 1HNMR (400 MHz, CDCl3) δ: 1.45 (s, 3H, 5-CH3), 2.12 (s, 3H, CH3Se), 2.82-2.87 (m, 1H,
OH), 3.39-3.60 (dd, J1 =2.0 Hz, J2 = 10.6Hz, 2H, H-5’), 3.62-3.66 (dd, J1 =5.2 Hz, J2 =
8.8 Hz , 1H, H-2’), 3.82 (s, 6H, CH3O), 4.23-4.25 (m, 1H, H-4’), 4.38-4.40 (dd, J1 =2.0
Hz, J2 = 5.2 Hz, 1H, H-3’), 6.26 (d, J = 8.8 Hz, 1H, H-5), 6.81-6.88 (m, 4H, aromatic),
7.25-7.43 (m, 9H, aromatic), 7.62 (d, J = 1.2 Hz, 1H, H-6), 8.62 (br, 1H, NH).

13

C-NMR

(CDCl3) δ: 4.69 (SeCH3), 11.69 (5-CH3), 50.17 (C-2’), 55.30 (OCH3), 63.78 (C-5’), 72.28
(C-3’), 84.52 (C-4’), 87.08 (C-1’), 87.25 (Ar-C), 111.79 (C-5), 113.33, 127.31, 128.14,
130.11, 135.12 (Ar-C), 135.19 (C-6), 144.18 (Ar-C), 150.46 (C-2), 158.82 ( Ar-C), 163.49
(C-4). HRMS (ESI-TOF): molecular formula, C32H34N2O7Se; [M-H]-: 637.1446
(calc.637.1453).
3’-O-(2-cyanoethyl-N,N-diisopropylphosphoramidite)-2’-methylseleno-5’-O(4,4’-dimethoxytrityl)-5-methyluridine (5)
The starting material 4 (2.4 g , 3.76 mmol) and the catalyst 5-Benzylthio-1H-Tetrazole
(0.06 g, 0.3 mmol) were placed in a 100 ml round flask and dried on high vacuum over
night. Dry CH2Cl2 (45 ml) was added followed by adding 2-cyanoethyl N,N,N,Ntetraisopropyl

phosphane

(1.36

g,

4.5

mmol)

and

a

few

drops

of

N,N-

diisopropylethylamine. The reaction mixture was stirred at 0°C under dry argon for 30
min, followed by stirring for 2 h at room temperature until most of the starting material
was converted. The reaction mixture was then quenched with NaHCO3 (10 ml, sat.) by
stirring for 15 min, and extracted with CH2Cl2 (3 X 10 ml). The combined organic layer
was washed with NaCl (3 X 10 ml, sat.) and dried over anhydrous MgSO4 for 15 min,
followed by the filtration and solvent evaporation. The crude product was re-dissolved in
CH2Cl2 (3 ml), and precipitated in petroleum ether (200 ml) under vigorous stirring,
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generating white powder. The petroleum ether solution was then decanted carefully. The
crude product was dissolved in CH2Cl2 and loaded on a column packed with aluminum
oxide (activated, neutral, 150 mesh, 58 Å) and equilibrated with CH2Cl2. The column
was then eluded with a gradient solution from CH2Cl2 to 30% of EtOAc in CH2Cl2
containing 1% triethylamine. The product fractions were collected based on the UV light
and evaporated under the reduced pressure. The purified compound was re-dissolved
in 3 ml of CH2Cl2, followed by the precipitation again in petroleum ether (200 mL, as
indicated above) to yield a white foamy product 5 as the diastereomer mixture (2.6 g) in
83 % yield. The compound was dried on the high vacuum for over night before being
used in solid phase synthesis. 1H-NMR (400 MHz, CDCl3) δ: 0.89-1.42 (m, 24H, 8xCH3ipr), 1.40 (2x s, 6H, 2x 5-CH3), 2.10 (2x s, 6H, 2x CH3Se), 2.42 and 2.69 (2x t, J =7.8
Hz, 4H, 2x CH2-CN), 3.48-3.72 (m, 12H, 4x CH-ipr, CH2-CH2-CN, 2x H-2’, 2x 2H-5’),
3.82 (s, 12H, 4x CH3O), 3.90-4.05 (m, 2H, CH2-CH2-CN), 4.22 and 4.31 (2x m, 2H, 2x
H-4’), 4.58-4.72 (m, 2H, 2x H-3’), 6.39 and 6.42 (d and d, J =8.6 Hz, 2H, 2x H-1’), 6.796.92 (m, 8H, aromatic protrons), 7.20-7.45 (m, 18H, aromatic protons), 7.59 and 7.62
(2x s, 2H, H-6), 8.18-8.31 (br, 2H, 2x NH).13C-NMR (CDCl3) δ: 4.57 and 4.71 (SeCH3),
11.53 and 11.59 (5-CH3), 20.11, 20.18, 20.46, 20.53, 22.50, 24.38, 24.45, 24.58, 24.66,
24.77,24.85, 43.23, 43.30, 43.35, 43.42, 46.36, 46.43, 47.38, 47.43, 50.36 (C-2’, CH2CH2-CN and C-ipr), 55.31 (OCH3), 63.28, 63.33 (C-5’), 74.91 and 75.09 (C-3’), 84.97
(C-4’), 87.29 (Ar-C), 89.38 and 89.25 (C-1’), 111.69 (C-5), 113.46, 117.29, 126.99,
127.81, 128.54, 130.21, 130.42, 135.22, 135.40 (Ar-C), 135.44 (C-6), 144.10 (Ar-C),
150.37 (C-2), 158.85 ( Ar-C), 163.34 (C-4). HRMS (ESI-TOF): molecular formula,
C41H51N4O8PSe; [M+H]+:839.2675 (calc.839.2682).
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3.2.2 Incorporation of Se-functionality into oligunucleotides
Similar to solid-phase oligonucleotide synthesis using the non-modified thymidine
and 2’-SeMe-uridine phosphoramidites, this novel 2’-Se-ribothymidine phosphoramidite
was incorporated into several DNA oligonucleotides under the standard conditions (here
we still use 0.10 M as the original concentration for all the phosphoramidite building
blocks, although as low as 0.05 M concentrations are still working) in the presence of 5BMP as the coupling catalyst. This Se-phosphoramidite could also be incorporated into
RNAs under the same conditions, using a longer coupling time (usually 10 to 12 mins
instead of 25s for DNA). As we reported previously, the 2’-selenium functionality was
very stable under the mild I2 treatment (20 mM, 20 seconds) for the phosphite oxidation
to the according phosphate at each cycle. The synthesized oligonucleotides were
cleaved off the solid support (CPG: control pored glass) and fully deprotected with
concentrated ammonia at 55 ºC overnight, followed by the reversed-phase HPLC
purification twice: DMTr-on and DMTr-off purification. A typical HPLC analysis profile of
the Se-DNAs with the DMTr groups on is shown in Figure 3.1A. The HPLC analysis
indicated that the Se-modified and non-modified phosphoramidites have the same
incorporation efficiency and that the total formation of the short abortive oligonucleotides
is less than 5%, which revealed a high coupling yield per synthetic cycle (higher than
99%), including the Se-T phosphoramidite incorporation. A representative reverse phase
HPLC purification profile of the DMTr-off Se-DNAs is shown in Figure 3.1B, which used
to further approve the purity of oligonucleotides. All of the purified Se-oligonucleotides
were also confirmed by MALDI-TOF MS analysis. A typical MS spectrum of the SeDNAs is shown in Figure 3.2, and all MALDI-MS data are collected in Table 3.1.
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Figure 3.1: Reversed-phase HPLC analysis and purification of the Se-DNAs. (A)
the

HPLC

analysis

profile

of

the

crude

DMTr-on

Se-DNA (5’-DMTr-

GTSeGTACAC-3’) after cleavage from the solid support and deprotection. The
HPLC analysis was performed on a Zorbax SB-C18 column (4.6 x 250 mm) with
a linear gradient from buffer A (20 mM triethylammonium acetate, pH 7.1) to 70%
buffer B (50% acetonitrile, 20 mM triethyl ammonium acetate, pH 7.1) in 20
minutes; the Se-DNA retention time was 20.6 min. (B) the HPLC purification
profile of the DMTr-off Se-DNA (5’-GTSeGTACAC-3’). The sample was eluted on
a Zorbax SB-C18 column (21 x 250 mm; flow rate: 6 mL/min) with the same
gradient and buffers; its retention time is 14.8 min.
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Figure 3.2: MALDI-TOF MS analysis of the DMTr-off Se-DNA (ATGGTSeGCTC).
Molecular formula: C89H114N32O54P8Se; FW: 2822.8; found [M+H]+: 2823; calculated
[M+H]+: 2823.8.

Table 3.1: MALDI-TOF analysis of 2’-SeMe containing DNA and RNA oligonucleotides.
Se-Sequences

Formula

MS (Calcd.) [M+H]+

DNA-1: GTSeGTACAC

C79H101N30O46P7Se

2503 (2503.5)

DNA-2: ATGGTSeGCTC

C89H114N32O54P8Se

2823 (2823.8)

DNA-3: GGATSeGGGCG

C91H112N42O51P8Se

2938 (2937.9)

DNA-4: GCGTSeATACGC

C98H125N38O58P9Se

3122 (3122.0)

RNA-1: GGTSeAUUGCGGUACC

C135H169N52O97P13Se

4555(4554.7)

RNA-2: UGAGCTSeUCGGCUC

C124H157N45O91P12Se

4186(4185.5)

RNA-3: CUGUGTSeUCGAUCCACAG C162H204N60O118P16Se

5455 (5455.2)
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3.2.3 Thermal denaturalization study
To compare the thermostability of the Se-oligonucleotides with their native ones,
the UV melting experiment was carried out. The samples (2 mM DNA or RNA duplexes
or hairpin loop), dissolved in the buffer of 50 mM NaCl, 10 mM NaH2PO4-Na2HPO4 (pH
6.5), 0.1 mM EDTA, and 10 mM MgCl2, were heated to 85 °C and allowed to cool to
room temperature slowly. The oligonucleotide samples were then stored at 5 °C for
several hours before the UV melting measurements were carried out. The typical curves
and all the melting temperatures are presented in Figure 3.3 and Table 3.2 respectively.

(A)

(B)

Figure 3.3: Melting curves of native and Se-9mer DNA duplex. (A) Native DNA duplex
5’-ATGGTGCTC-3’ & 3’-TACCACGAG-5’ (Tm= 42.6 ± 1.4 ºC). (B) Se-DNA Duplex 5’ATGGTSeGCTC-3’ & 3’-TACCACGAG-5’ (Tm= 42.9 ± 1.1 ºC)
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Table 3.2: UV Melting Temperatures of the 2’-Se-RNAs and DNAs.

From these data, it could be concluded that there were no significant differences
between the melting temperatures of the 2-Se-oligonucleotide duplexes and the native
ones, which indicates a very minor changes of DNA duplex stability comparing the
native counterparts, in terms of both DNA and RNA cases. In addition, from the fact that
the Se-modified and native tRNA TΨC loops have almost the same melting
temperatures, we could draw preliminary conclusion that this selenium derivatization
could be potentially applied as a powerful tool to investigate the mechanism of TΨC
loops containing tRNAs, since it’s still very hard due to the lack of structure information.
As the UV melting study cannot provide detailed information on the structure change,
NMR and crystallography will be needed for further structure characterizations.
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3.2.4 CD-measurement of 2’-SeMe-T modified G-quardruplex
To further explore the potential application of this 2’-Se-thymidine building block,
collaborating with Dr. Xiang Zhou’s group in Wuhan University, China, we modified the
different bridge thymidine residues in human telomeric G-quardruplex sequence 5’(TTAGGG)4-3’ with this functionality and carried out the crystallography studies of these
sequences in presence of porphyrin type small compound which could induce the
formation of G-quartet structure. (101) Figure 3.4 shows the typical MALDI-TOF
spectrum of 2’-SeMe modified 24mer, and figure 3.5 shows the preliminary CD results
without and with porphyrin compound, which indicate the similar property as native ones.
The further crystallization part of this project is still on going.

Figure 3.4: MALDI-TOF mass-spectrum of selenium modified huamn telomeric Gquardruplex

sequence.

5’-TTAGGGT(2’-SeMe)TAGGGTTAGGGTTAGGG-3’,

C241H299N96O146P23Se, Calculated mass: 7667.9, Observed: 7668.
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Figure 3.5: CD-spectrum of Se-Huamn telomeric G-quardruplex sequence with different
equivalence of porphyrin compound. The peaks at 295 and 295 nm indicate the
formation of anti-parallel structure G-quartet.

3.2.5 Crystallization and structure studies
With pure oligonucleotides on hand, we carried out the crystallography studies for
this modification work. As a result, we found that the Se-DNA (GTSeGTACAC, selfcomplementary) crystallized in 2-3 weeks in the native buffer, where the native DNA
(GTGTACAC) crystallized over 2 months. However, when the Nucleic Acid Mini Screen
kit (Hampton Research, with 24 diversified crystallization buffers) was screened, to our
pleasant surprise, we found that the Se-DNA crystallized overnight in all the 24 buffer
conditions overnight. In contrast, the native DNA did not crystallize at all over many
weeks in these Hampton buffers. It was also reported that the two RNAs (12-mer and
16-mer) containing the 2-Se-guanosines crystallized, respectively, in 17 and 33 buffers,
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whereas their corresponding native RNAs crystallized in 15 and 24 buffers, individually.
Though the crystallization conditions of these Se-RNAs expanded slightly, it appears
that these two Se-RNAs, which crystallized mostly as thin needle crystals, behaved
similarly to many Se-Met-derivatized proteins that required the fine tuning of their native
crystallization conditions. By contrast, the majority of these Se-DNA crystals grown
under the new buffers was larger than the native DNA crystals grown under the native
buffer conditions, and these Se-DNA crystals also diffracted well. Our results reveal that
the 2-Se derivatization of thymidine facilitated the crystal packing and growth and
appeared to help expand the crystallization conditions.
Finally, the structure of the Se-DNA crystal, grown under the buffer No.7 (the
detailed composition of the screen buffers is listed in the appendix 1) was determined at
1.40 Å resolution via the Se SAD phasing and refinement. The data collection
parameters, phasing and refinement statistics are listed in table 3.3. It’s clearly
observed that this oligonucleotide displays a 2’-exo sugar pucker, which is consistant
with the A form DNA and RNA molecules. And the selenium function locates in the minor
groove of this duplex. When the 2’-Se-T DNA was superimposed with naitve counterpart
(they have the same space group), it was found that no virtually structure perturbations
was observed (single strand, double strand and local residue comparison in Figure 3.6A,
C and D), which indicates that this Se derivatization does not alter the native structure
significantly. In addition, figure 3.6B clearly showed the electron density map of
selenium functionality (Se were represented by red balls), this 100% occupancy also
showed the stability of this SeMe group in X-ray exposure. Furthermore, comparing the
resolution of native DNA (2.0 Å), this higher structure resolution allows observation of
ordered 43 water molecules and other structure features.
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Figure 3.6: Various functionalities modified DNA crystal structures. (A) Superimposed
structure comparison of the native DNA (GTGTACAC, 1DNS in green) and the Sederivatized DNA (GTSeGTACAC, 2HC7 in cyan). (B) The structure model and the
electron density map of 2’-Se-ribothymidine residue in the structure. (C) Superimposed
duplex structure of native and selenium DNA. (D) Superimposed local residues.
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Table 3.3: X-ray data collection, phasing and refinement statistics for 2HC7. Two data
sets were collected: the data collected at selenium K-edge (0.9793 Å) was used for SAD
phasing, and the data collected at 1.100 Å was used for the refinement.
Data Collection
Resolution range, Å
(last shell)
Unique reflections
Completeness, %
Rmerge ,%
<I/σ(I)>
Redundancy
R-Cullis
Phasing power
Figure of merit

λ= 0.9793 Å
40.0-1.50 (1.551.50)
3786 (349)
99.7 (99.7)
6.4 (29.7)
13.5 (4.3)
13.3 (13.6)
0.352
4.053
0.421

Refinement
Resolution range, Å (last
shell)
Number of reflections
Rwork , %
Rfree , %
Number of atoms
Nucleic Acid (single)
Heavy atom
Water
R.m.s. deviations
Bond length, Å
Bond angle,
Average B-factors, Å2
All atoms
Wilson plot
Overall anisotropic Bvalues
B11/B22/B33
Bulk solvent correction
Solvent density, e/Å3
B-factors, Å2
Coordinates error (c.-v.),
5Å
Esd. from Luzzatt plot, Å
Esd. from SIGMAA, Å

λ= 1.100 Å
40.0 - 1.40 (1.45
- 1.40)
4577 (492)
98.8 (92.3)
3.6 (34.3)
13.1 (2.1)
12.7 (10.0)

18.72 - 1.40
(1.49 - 1.40)
4252 (492)
17.0 (22.1)
18.7 (24.4)
162
1 (Se)
43
0.015
1.9
18.5
16.1
-0.86/-0.86/1.71
0.34
45.1
0.15
0.08
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3.3 Conclusion of this chapter
In

conclusion,

we

have

successfully

synthesized

the

2’-SeMe-thymidine

phosphoramidite as an analogue of both thymidine and ribothymidine phosphoramidites
for the solid phase oligonucleotide synthesis. Subsequently, we have incorporated it into
DNAs and RNAs with over 99% coupling yield. Our thermal denaturing study of the Semodified DNAs and RNAs also reveals that this Se derivatization did not significantly
change the stability of the structures of the DNA and RNA duplexes and the tRNA TΨC
loop. Furthermore, our X-ray crystal structure study with a Se-modified DNA octamer
(GTSeGTACAC) shows that the Se-derivatized DNA structure (1.40 Å resolution) is
virtually identical to the native structure (2.0 Å resolution) with the same space group.
More importantly, we observed that this Se modification dramatically expanded the
crystallization conditions of the Se-DNA and largely facilitated crystal growth while
retaining the high diffraction quality. In addition to DNA investigations, this 2’-SeMethymidine can also serve as a ribothymidine analogue for the structure and function
studies of tRNAs and rRNAs. As the Se derivatization can facilitate the phase
determination and crystallization, it will significantly impact the structure and function
studies of nucleic acids and their protein complexes using X-ray crystallography. In
addition, we are in the process of further investigating the mechanism of the crystal
growth facilitated by this Se derivatization.
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4 ADVANTAGES OF SELENIUM OVER BROMINE STRATEGY: STRUCTURE
COMPARISON OF THE 2’-SE AND 5-BR DERIVATIZED NUCLEIC ACIDS
(This work has been published on Nucleic Acids Research, 2007, 35 (2): 477-485, Jiansheng Jiang,
Nicolas Carrasco and Zhen Huang are listed as co-authors.)

4.1 Introduction
With the increasing requirement to obtain detailed insight into the structure-function
relationships of DNA-drug complexes, functional RNAs (such as catalytic RNAs and
snoRNAs), and RNA-protein and DNA-protein interactions, X-ray crystallography
application in this field has been much popular and important, accordingly, the
improvement of this technology itself especially solving the phase problem in nucleic
acids, which actually has been the limiting factor that largely slowed down the structural
determination of new structures, has become more and more important and urgent. As
stated in the introduction part, the conventional approaches for DNA and RNA
derivatization for phase information, such as heavy-atom soaking and co-crystallization,
have proved to be much more difficult for nucleic acids than for proteins, probably
because nucleic acids often lack specific binding sites for metal ions. As a result, the
halogen such as bromine (K edge, 0.920 Å) derivatization is used as the conventional
method to derivatize DNAs via 5-bromo-deoxyuridine (thymidine analog) and RNAs via
5-bromo-uridine in Multiwavelength Anomalous Dispersion (MAD) phasing. The
derivatives containing the bromine derivatization are relatively stable because of
formation of vinyl halides. However, it is difficult to introduce bromine to other positions
because of the chemical nature of the halogen. For instance, as bromide is a good
leaving group, bromine placed on the ribose 2’-position can be displaced by the
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pyrimidine exo-2-oxygen, the purine 3-nitrogen, or the near-by nucleotide phosphate
groups. Though the 8-bromo-purine nucleosides can been easily prepared, (102) the 8Br-substituted purine bases tend to adopt a syn-conformation, (103) which greatly
perturbs local structure. Therefore, in the conventional halogen derivatization, the
halogens are primarily limited to the 5-position of uracil (sometimes cytosine), which
places the halogen in the major groove. As the major groove of A-form dsDNA or dsRNA
is narrow and deep, the halogen derivatization may perturb these structures. The
halogen derivatization can also cause base-stacking disruption, hydration pattern
change, and other structural perturbations. Probably that’s also the reason that the
halogen derivatized nucleic acid usually are hard to be crystallized. In addition, halogen
derivatives, such as the bromine derivatives, are light sensitive, and long-time exposure
to X-ray or UV sources may cause decomposition. (104) These factors could have
caused a lot of trouble to solve the nucleic acid structures in many cases.
The revolutionized success of selenomethionine derivatization method in protein
X-ray crystallography was also applied in nucleic acid. Indirect derivatization method of
RNA using selenomethionine-labeled U1A for phase and structure determination was
also successfully demonstrated though it is labor-intensive. More important, the direct
derivatization of DNAs and RNAs with selenium has been demonstrated by our
preliminary results. So far, this novel derivatization methodology has been utilized in Xray crystal structure studies of RNA and DNA molecules by several laboratories,
including structure analysis and determination of ribozymes and riboswitches. As the
synthesis and purification of SeNAs are much easier than those of proteins, nucleic
acid-protein complexes may also be derivatized by SeNAs instead of their protein
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counterparts. Therefore, this atom-specific derivatization appears to have great potential
in structural and functional studies of nucleic acids and their protein complexes.
It has been stated in the previous chapter that the 2’-Se is proved to be the most
completed and stable type of Se-derivatization so far, in order to further investigate this
SeNA strategy, we carried out the systematic structural comparison between the Se and
the conventional Br derivation using the model DNA (5'-GTGTACAC-3'). It is worth to
mention that the Se derivatization is placed on the sugar ring and located in the minor
groove of the duplex, while the Br derivatization occurs to the base and is located in the
major groove. In addition, the crystal growth facilitation by this 2’-Se derivatization was
further demonstrated in this work.

4.2 Results and discussion
4.2.1 Preparation of DNA crystals containing Se and Br
For the simplicity and cost of synthesis, 2’-SeMe-dU instead of 2’-SeMe-dT is
used to replace T2 in the self-complementary DNA (GTGTACAC, Figure 4.1A). In order
to directly compare with the conventional Br derivatization strategy, we also synthesized
this DNA model with the Br derivatization at the T4 position (Figure 4.1B), in the
presence and absence of the Se derivatization at the T2 position, the building block of
5-Br-2’-deoxyuridine phosphoramidite is commercial available from ChemGens, Inc.
The native DNA (5'-GTGTACAC-3'), the Se-DNA (5'-GdUSeGTACAC-3'), the Br-DNA
(5'-GTGdUBrACAC-3'),

and

the

Se-Br-DNA

(5'-GdUSeGdUBrAC-A-C-3')

were

synthesized on solid phase DNA synthesizer following the standard procedures and
purified by HPLC. The purified oligonucleotides were analyzed by MS and HPLC to
confirm their accuracy and purity.
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Figure 4.1: Structures of the 2’-Se modification and 5-Br modification of DNA.

4.2.2 Crystal parameters comparison of native, Se and Br derivatized DNAs
Though the Se-DNA crystallized in the native buffer, (105) crystallization
conditions were still screened using the Nucleic Acid Mini Screen kit (Hampton
Research) (Appendix). l μL of the oligonucleotide solutions (1 mM) was typically used in
each of these screens with hanging drop at 25°C. In the cases of the Se-DNA and the
Se-Br-DNA, their crystals with diffraction quality were identified in many identical buffer
conditions (typical crystal pictures are showed in figure 4.2). Crystals of the Se-DNA (5'GdUSeGTA-CAC-3'), grown in buffer #7 of the kit (10% v/v MPD, 40 mM sodium
cacodylate pH 6.0, 12 mM spermine tetra-HCI, 80 mM potassium chloride and 20 mM
magnessium chloride), were identified to give the highest diffraction resolution, while
crystals of the Se-Br-DNA (5'-GdUSeG-dUBrACAC-3'), grown in buffer #9 (10% v/v
MPD, 40 mM sodium cacodylate pH 6.0, 12 mM spermine tetra-HCI, 80 mM sodium
chloride, 12 mM potassium chloride, and 20 mM magnessium chloride), gave highest
resolution. The Br-DNA crystal was grown under the native conditions (33,34, 40% v/v
MPD, 4 mM spermine and 8 mM magnessium chloride). The best Br-DNA crystal was
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obtained after a week under the lower temperature (15°C). The size of these crystals
generating good diffraction is approximately 0.1x0.1x0.1 mm. The Se-DNA and Br-DNA
data were collected at beam line X12C, and the Se-Br-DNA data sets were collected at
X25, X29 and X12 in NSLS of Brookhaven National Laboratory. A number of crystals
were scanned to find the one with strong anomalous scattering at the K-edge absorption
of selenium and/or bromine. The distance of the detector to the crystals was set to 90
mm. The chosen wavelengths for selenium and bromine MAD are listed in Table 4.1 &
4.2. The crystals were exposed for 10 or 15 seconds per image after one degree
rotation, and a total of 180 images were taken for each data set. The additional
reference data sets were collected at 1.10 Å wavelength and were used for the final
structure

refinement.

All

data

were

processed

using

HKL2000

and

DENZO/SCALEPACK. The positions of the selenium and bromine atoms were identified
by the heavy atom search scripts provided by CNS. Following the refinement of the
selenium and bromine positions, the experimental phases were calculated and
extended using the MAD or SAD procedures in CNS. The initial phased maps were then
improved by the solvent flattening and density modification procedure. The model of
single strand of DNA was manually built into the electron density map using O, and then
the refinement was carried out. The refinement protocol includes simulated annealing,
positional refinement, restrained B-factor refinement, and bulk solvent correction. The
stereo-chemical topology and geometrical restrain parameters of DNA/RNA have been
applied. The topologies and parameters for modified dU with selenium (UMS) and dU
with bromine (BRU) were constructed and applied. After several cycles of refinement
and the model rebuilding, a number of highly ordered waters were added. Final, the
occupancies of selenium and bromine were refined. Cross-validation with a 5-10% test
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set was monitored during the refinement. The σA-weighted maps of the (2m|Fo| - D|Fc|)
and the difference (m|Fo| - D|Fc|) density maps were computed and used throughout
the model building.

a

b

c

Figure 4.2: Photos of crystals of the native and derivatized octamers. (a) Native-Oct.;
(b) Se-Oct.; (c) Se/Br-Oct. Sizes of the crystals ranged from 0.1x0.1 to 0.4x0.4 mm.

4.2.3 Crystallization facilitation by Se-derivatization
We performed the crystallization screening to study the crystallizability of these
modified oligonucleotides, as a result, we found that the SeMe functionality containing
DNA could formed quality crystals in all of the buffers of the Hampton kit overnight
(approximate size: 0.1x0.1x0.1 mm), and the Se-Br-DNA also formed good quality of
crystals overnight in the same buffers, though the crystal sizes were smaller
(approximate 0.05x0.05x0.05 mm). However, both the Br-DNA and the native DNA did
not grow crystals in any buffers of the kit (24 buffers) over several months. While the
native DNA and the Br-DNA crystallize in the native conditions in a few weeks. (106) It is
also worth to mention that these two Se-derivatized DNAs can also crystallize in the
native conditions.
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Table 4.1: Summary of data collection and phasing statistics for Se-DNA (1Z7I).

Wavelength, Å
Resolution range, Å
(last shell)
Unique reflections
Completeness, %
Rmerge ,%
<I/σ(I)>
Redundancy
R-Cullis (Friedel)
Phasing power λ3/λι
(Friedel)
Figure of merit
(Friedel)
Overall figure of merit

Selenium K-edge
peak
inflection
remote
0.9790
0.9794
0.9400
50.0-1.4
50.0-1.4
50.0-1.4
(1.49-1.4)
(1.49-1.4) (1.49-1.4)
4478 (441) 4425 (420)
4396
(402)
97.6 (99.1) 96.3 (94.0)
95.2
(90.0)
6.9 (40.2)
7.2 (44.0) 7.3 (45.0)
14.0 (3.8)
13.9 (3.9) 13.2 (3.5)
13.0 (10.5) 11.5 (9.7) 10.5 (9.7)
0.513
0.371
- (0.428)
(0.330)
(0.279)
2.026
3.155
- (3.405)
(4.345)
(5.021)
0.426
0.502
- (0.380)
(0.508)
(0.539)
0.817
Rmerge=Σ|I-‹I›|/ΣI

Table 4.2: Data collection and phasing statistics for Se-Br-DNA (2DLJ).

Wavelength, Å
Resolution range, Å
(last shell)
Unique reflections
Completeness, %
Rmerge , %
I/σ(I)
Redundancy
R-Cullis (Friedel)
Phasing power
(Friedel)
Figure of merit
(Friedel)
Overall figure of merit

Peak
0.9790
50.0-1.80
(1.86-1.80)
2283 (222)
99.8 (100.0)
7.8 (36.7)
11.4 (3.1)
12.8 (12.8)
0.709 (0.455)
1.221 (3.223)

Selenium K-edge
inflection
0.9794
50.0-1.80
(1.86-1.80)
2284 (219)
99.8 (100.0)
7.2 (31.8)
12.2 (3.7)
12.9 (13.0)
0.469 (0.359)
2.365 (4.043)

0.321 (0.429)

0.425 (0.477)
0.731

Remote
0.9400
50.0-1.80
(1.86-1.80)
2288 (220)
99.9(100.0)
6.7 (32.9)
12.1 (3.7)
12.9 (13.0)
- (0.510)
- (2.826)

peak
0.9196
50.0-1.80
(1.86-1.80)
2290 (220)
99.8 (100.0)
7.9 (39.5)
11.4 (3.1)
12.9 (13.1)
0.686 (0.417)
1.205 (4.002)

Bromine K-edge
inflection
0.9199
50.0-1.80
(1.86-1.80)
2292 (220)
99.9 (100.0)
7.9 (41.0)
11.1 (2.6)
12.9 (13.0)
0.587 (0.407)
1.646 (4.053)

- (0.311)

0.324 (0.465)

0.385 (0.478)
0.761

remote
0.9400
50.0-1.80
(1.86-1.80)
2288 (220)
99.9(100.0)
7.8 (40.4)
11.1 (2.7)
12.9 (13.0)
- (0.482)
- (3.395)
- (0.356)

91

Table 4.3: Data collection and refinement statistics in Se-DNA, Se-Br-DNA and Br-DNA
structures.
Structure
(PDB ID)
Data collection
Space Group
Cell dimensions: a=b,
c (Å),
Resolution range, Å
(last shell)
Unique reflections
Completeness, %
Rmerge , %
I/σ(I)
Redundancy
Refinement
Resolution range, Å
(last shell)
Rwork , %
Rfree , %
Number of reflections
Number of atoms
Nucleic Acid (single)
Heavy Atoms and
Ion
Water
R.m.s. deviations
Bond length, Å
Bond angle,
Average B-factors, Å2
All atoms
Wilson plot
Overall anisotropic Bvalues
B11/B22/B33
Bulk solvent
correction
Solvent density, e/Å3
B-factors, Å2
Coordinates error (c.v.), 5Å
Esd. from Luzzatt
plot, Å
Esd. from SIGMAA,
Å

Se-DNA
(1Z7I)

Se-Br-DNA
(2DLJ)

Se-Br-DNA
(2GPX)

Br-DNA
(2H05)

P43212
42.076,
23.935
50.00 - 1.28
(1.36 - 1.28)
6325 (552)
95.3 (70.0)
8.0 (32.8)
14.8 (4.3)
12.4 (10.7)

P43212
42.369,
23.744
50.00 - 1.50
(1.55 - 1.50)
3777 (354)
99.7 (99.2)
5.1 (27.8)
14.4 (4.9)
12.3 (9.1)

P43212
42.252,
24.133
50.00 – 1.60
(1.66 – 1.60)
3161 (297)
99.7 (99.3)
8.4 (49.9)
13.1 (4.2)
12.4 (9.0)

P43212
42.048,
24.270
50.00 – 1.80
(1.86-1.80)
2248 (203)
99.4 (95.8)
4.5 (32.3)
12.1 (2.7)
12.1 (7.1)

20.81 - 1.28
(1.36 - 1.28)
17.7 (23.7)
20.0 (23.1)
5275 (552)

18.16 - 1.50
(1.59 - 1.50)
18.3 (18.9)
22.8 (22.7)
3597 (473)

18.90 – 1.60
(1.70 – 1.60)
18.7 (21.3)
23.8 (24.4)
2909 (289)

18.81 – 1.80
(1.91-1.80)
21.3 (27.3)
24.8 (41.3)
2036 (247)

161

160

160

1 Se

1 Se, 1 Br

1 Br

44

43

160
1 Se, 1 Br, 1
Ba2+
31

0.012
1.8

0.011
1.6

0.010
1.8

0.009
1.9

15.0
14.9

18.8
18.2

25.9
23.6

32.5
29.8

0.70/0.70/1.41

-0.29/0.29/0.58

0.31/0.31/0.62

2.20/2.20/4.41

0.30
22.2

0.32
34.5

0.34
40.05

0.32
41.04

0.15

0.19

0.22

0.23

0.10

0.05

0.12

0.20

33
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To further demonstrate this interesting observation, we have synthesized and
purified four other native DNAs (41,42, PDB ID: 395D & 1QPH) and their selenium
derivatives

(Se-DNAs):

5’-GdUSeACGTAC-3’,

5’-GTAC-GCGdUSeAC-3’,

5’-

CCGdUSeACGTACGG-3’, and 5'-GA-CCACGTGGdUSeC-3'. The Se derivatization was
incorporated into different regions of these DNA molecules, including the 5’, middle, and
3’ regions. These self-complementary DNA molecules were screened using the
Hampton kit. High quality single crystals (average size: 0.1x0.1x0.1 mm) of these SeDNA sequences were formed in three days under many different buffer conditions: 5’GdUSeACGTAC-3’ in buffer #9, #12, #13, #22 and #23, 5’-GTACGCGdUSeAC-3’ in buffer
#8, #10, #12, #17, #19 and #24, 5’-CCGdUSeACGTACGG-3’ in buffer #11, #12 and #21,
and 5'-GACCACGTGGdUSeC-3' in buffer #18, #22 and #23. The corresponding native
DNA sequences, however, did not crystallize over two weeks in any of these 24 buffers.
It seems that it is quite challenging to crystallize the native molecules. In summary,
these observations suggest that these Se-derivatized DNAs can crystallize in broader
buffer conditions and have better crystallizability than these native and Br-derivatized
DNAs.
Our observations indicate that the 2’-selenium derivatization may facilitate the
crystal growth, which is probably assisted by the better packing of the Se-derivatized
DNA. As the bulky 2’-Se modification may be able to lock the sugar pucker into the 2’exo conformation, the rigidity of the Se-derivatized DNAs may facilitate molecular
packing. Furthermore, the structure studies of the Se, Br modified DNAs, grown under
different buffer conditions, indicated that the different buffers may not change the crystal
packing and the space groups. The more results will be discussed in chapter 5.
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4.2.4 MAD & SAD phasing
As one Se atom should enable the phase determination for DNAs and RNAs with
up to 30 nucleotides, one selenium or one bromine atom in the octamer DNA is
sufficient for MAD or SAD phasing. As shown in Table 4.1, we have used the Se-DNA
data only up to 1.4 Å for MAD and SAD phasing. The overall figures of merit (FOM) of
the initial phases for both Se-DNA MAD and SAD data sets were 0.816 and 0.442,
respectively. This produced an excellent electron density map showing a single strand
of DNA after solvent flattening and density modification. The reference data were used
as the amplitudes of the structure factors and combined with the phase probabilities
from MAD/SAD, and the phases were extended from 1.4 Å to 1.28 Å for the refinement
of Se-DNA. The MAD data sets for the Se-Br-DNA were available to up to 1.8 Å
resolution. The data at the selenium K-edge and the bromine K-edge were processed
separately. As shown in Table 5, the overall FOMs of the initial phases were 0.731 and
0.761 respectively from the selenium and bromine K-edge data sets. Both produced
excellent electron density maps clearly showing the DNA strands. The experienced
phases were extended to 1.5 Å for the refinement of the Se-Br-DNA structures. Likewise,
the Br-DNA structure was determined.
These Se and/or Br modified DNA structures have the same tetragonal space
group P43212, as the native structure. These duplex models are generated by applying
the symmetry operator (y, x, -z) of P43212. Figure 4.3 shows the electron density maps
with the duplex models of the Se and Br derivatized DNA structures. The resulting
structures of the 2’-Se-DNA (1Z7I), the Se-Br-DNA (2DLJ), and the Br-DNA (2H05) were
refined at 1.28, 1.5, and 1.8 Å resolution, respectively. The second Se-Br-DNA structure
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(2GPX), containing a barium ion, was refined at 1.6 Å resolution; its electron density
map (identical to 2DLJ) is not shown. Figure 4.4 illustrates the details of the electron
density maps of the modified dUs in the structures. Figure 4.3A, 4.3B and 4.3C
represent the structures of the 2’-Se-dU in the Se-DNA, 5-Br-dU in the Se-Br-DNA and
5-Br-dU in the Br-DNA, respectively.

A.

B.

C.

Figure 4.3: Electron density maps and models of the derivatized DNA duplexes (stereo
view). Red and green balls represent Se and Br respectively. Contours are at the
1.2σ level. (A). the structure of the Se-DNA (GdUSeGTACAC) at 1.28 Å resolution (1Z7I).
(B). the structure of the Se-Br-DNA (GdUSeGdUBrACAC) at 1.5 Å resolution (2DLJ). (C).
the structure of the Br-DNA (GTGdUBrACAC) at 1.8 Å resolution (2H05).

A.

B.

C.

Figure 4.4: Electron density maps and models of the Se and Br modified nucleotides in
the derivatized DNAs. (Stereo view) Red and green balls represent Se and Br,
respectively. Contours are at the 1.2σ level.

(A). the structure of the 2’-Se-dU in
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d(GdUSeGTACAC) at 1.28Å resolution (1Z7I). (B). the structure of the 5-Br-dU in
d(GdUSeGdUBrACAC) at 1.50Å resolution (2DLJ). (C). the structure of the 5-Br-dU in
d(GTGdUBrACAC) at 1.80Å resolution (2H05).

4.2.5 Structures of Se and Br derivatized DNAs
As showed in figure 4.5, the Se-DNA structure (1Z7I, in blue, Figure 4.5A) is
superimposable over the native A-form DNA structure (1DNS, in pink), which has the
same tetragonal space group (P43212). The overall r.m.s.d. of the Se-DNA over the
native is low (0.328 Å) and mainly contributed by the first and the last bases, and the
main structure is considered as the same as the native, although the spermine molecule
bound to the native was not observed in the derivatized structure. The superimposed
local dUSe structure of the Se-DNA (1Z7I, in blue) over T2 of the native structure (1DNS,
in pink) is shown in Figure 4.4B. The derivatized local structure of the Se-DNA is also
superimposable over that of the second native (34, 1D78, in gray, Figure 4.5B), which
has a different space group (P6122). Therefore, the selenium modification causes no
local perturbations when it is compared with both native forms. In addition,
superimposing the dUSe in this Se-DNA structure (space group P43212, Figure 4.5C)
with the dUSe in the reported DNA structure (23, GCGTAdUSeA-CGC, 1MA8 in yellow,
space group P212121) indicates no difference, suggesting that the Se-derivatized local
structure is stable and independent from its sequence environment.
Figure 4.5D and 4.5E show the superimposed Br-DNA (2H05, in green) and SeBr-DNA (2DLJ in cyan) over the native (1DNS, in pink), respectively. We observed the
local perturbations in both Br-derivatized DNA structures, thought the global structures
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were very close to the native structure with the same crystal form (1DNS, 33). The
overall r.m.s.d. values of the Se-Br-DNA and the Br-DNA over the native are 0.713 Å
and 0.642 Å, respectively.

B.

C.
A.

D.

E.

Figure 4.5: Superimposed comparison of the native and the derivatized DNA structures.
(red and green balls represent Se and Br, respectivly). (A) the comparison of the SeDNA (GdUSeGTACAC, 1Z7I in blue) and the native (GTGTACAC, 1DNS in pink). (B) the
comparison of the Se-DNA dUse (1Z7I in blue) and the two native T2 (1DNS in pink and
1D78 in gray). (C) the comparison of the dUse of the Se-DNA (1Z7I in blue) and the
reported DNA (GCGTAdUSeACGC, 1MA8 in yellow). (D) the comparison of the Br-DNA
(GTGdUBrACAC, 2H05 in green) and the native (1DNS in pink). (E) the comparison of
the Se-Br-DNA (GdUSeGdUBrACAC, 2DLJ in cyan) and the native (1DNS in pink).

In addition, the comparison of the Br-DNA dUBr with the T4 of the native DNA
(1DNS) and the Se-DNA indicated that the Br incorporation could alter the hydration
pattern (Figure 4.6A and 4.6B) and the water networking (Figure 4.7) at the derivatized
site, though the sugar pucker of the dUBr was almost not changed from that of the native
(Figure 4.6A). The alterations at the dG3 site of the Br-DNA (Figure 4.6C), including the
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dG sugar pucker change and approximately 107 degree rotation about its C4’-C5’ bond,
were also observed. This rotation caused large local perturbations on the dG3, with its
C5’ and P deviations by 1.30 and 0.63 Å, respectively. The C2’ of the Br-DNA T2 is also
deviated by 0.60 Å (Figure 4.6D), which also created the flattened sugar pucker as the
dG3 (Figure 4.6C). Unsurprisingly, the same perturbations were also observed with the
Se-Br-derivatized DNA (2DLJ) while the perturbations were not observed with the Sederivatized DNA (1Z7I). These perturbations caused by the Br derivatization may
explain why some Br-derivatized DNAs have been difficult to crystallize even after
successful crystallization of their natives. Our observation may serve as a reminder in
the bromine derivatization.
A.

B.

C.

D.

Figure 4.6: The superimposed comparison of the native and Br-DNA local structures.
(green ball represents Br). The green and gray dash lines represent hydrogen and nonhydrogen bonds, respectively. (A) the comparison of the dUBr of the Br-DNA
(GTGdUBrACAC, 2H05 in green, and water molecules in blue balls) and the T4 of the
native DNA (GTGTACAC, 1DNS in pink). (B) the comparison of the dUBr of the Br-DNA
(2H05 in green, and its water molecules in blue balls) and the T4 of the Se-DNA
(GdUSeGTACAC, 1Z7I in blue, its water molecules in gray). (C) the comparison of the
dG3 of the Br-DNA (in green) and the native (1DNS in pink). (D) the comparison of the
T2 of the Br-DNA (in green) and the native (1DNS in pink).
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A.

B.

C.

D.
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Se
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Figure 4.7: The bromine hydration pattern and the local structures. Water molecules, Se,
and Br are in blue, red, and green balls, respectively. The green and gray dash lines
represent hydrogen and non-hydrogen bonds, respectively. (A) the TGT backbone
structure of the native DNA (GTGTACAC, 1D78). (B) the dUSeGT backbone structure of
the Se-DNA (GdUSeGTACAC, 1Z7I). (C) the dUSeGdUBr backbone structure of the SeBr-DNA structure (GdUSeGdUBrACAC, 2GPX). (D) the TGdUBr backbone structure of
the Br-DNA (GTGdUBrACAC, 2H05).

4.2.6 Local purterbation and hydration pattern comparison
The native d(GTGTACAC) structure in tetragonal space group (1DNS) did not
include any water molecules in the refined structure, while the other native structure in
hexagonal space group (1D78), determined at 1.4 Å resolution, has included 37 waters.
The TGT local structures of the tetragonal native DNA (GTGTACAC), the hexagonal
native, and the Se-DNA are identical (Figure 4.5A, 4.7A and 4.7B). Instead of comparing
with those of the tetragonal native structure due to the absence of the water molecules,
we compared the water networking and local backbone structure of the Se-DNA
structure with those of the hexagonal native structure. The water molecules were found

99

forming hydrogen bonds to the oxygen atoms of the 5’-phosphate groups of TGT in the
native and Se-derivatized structures (Figure 4.7A and 4.7B). In the hexagonal native
structure (1D78, Figure 4.7A), two water molecules (W1 and W3) formed hydrogen
bonds (the green dash lines) to the oxygen atoms of the T2 and dG3 5’-phosphate
groups. In the Se-DNA structure (1Z7I, Figure 4.7B), three water molecules (W1, W3
and W4) formed the hydrogen bonds to each other and to the oxygen atoms of the
dUSe, dG3 and T4 5’-phosphate groups, forming the same water networking as the
native. In the Se-Br-DNA structure (2GPX in Figure 4.7C), four water molecules (W1,
W2, W3 and W4) were found in the region, connecting with each other and the oxygen
atoms of the dUSe, dG3 and T4 5’-phosphate groups. These four water molecules
formed a different water networking from those of the native and Se-DNA structures.
Similar to the Se-Br-DNA structure (Figure 4.7C), the same water networking (W2, W3
and W4) was found in the Br-DNA (GTGdUBrACAC, 2H05, Figure 4.7D). Interestingly,
in both the Br-DNA and Se-Br-DNA structures, the W2 water insertion, which can
probably facilitate the 5’-phosphate perturbation and the C4’-C5’ bond rotation of the
dG3, was observed. This inserted water (W2) formed the hydrogen bonds with W1, the
dG3 5’-phosphate oxygen, and W3, which was pushed closer to the dUBr bromine atom
in both structures. In both the Br-DNA structure (Figure 4.7D) and the Se-Br-DNA
structure (Figure 4.7C), we observed that ordered W3 molecules are very close to the
bromine atom (3.02 Å and 2.95 Å, respectively), which suggests a hydrogen bond
formation. This hydrogen bond may weaken the Br-C5 bond, which probably is one
reason of the debromination reported previously.
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Our experimental results indicate that though it does not cause the change in the
sugar pucker of the dUBr, the Br derivatization placed in major groove caused
significant conformation changes of the sugar puckers in the dG3 and T2 and the large
changes of the hydration pattern and water molecule networking, which may lead to the
local perturbation. Unlike the bromine derivatization, the 2’-selenium derivatization is
placed in the minor groove, and the hydration alteration in the minor groove was not
observed, probably due to disorder of the water molecules near the 2’-position of T2.
No ordered water molecules near the 2’-positions in the Se-derivatized and native
structures have been observed. Probably, the hydration alteration caused by the 2’selenium modification is insignificant.

4.3 Conclusion of this chapter
To facilitate X-ray crystal structure studies of nucleic acids, we are in a process of
developing selenium derivatization strategies by synthesizing SeNA via atom-specific
replacement of oxygen with selenium and studying SeNA structures by comparing them
with the structure-known natives and the conventional bromine derivatization. By using
both MAD and SAD phasing, we have demonstrated the X-ray crystal structure
determination of the 2’-Se-derivtized DNA at high resolution. The Se-derivatized DNA
structure (1.28 Å resolution) is identical to the native structure with the same crystal
form (33, 2.0 Å resolution). Besides the demonstration of the formation of these Sederivatized crystals with high diffraction quality and in broader buffer conditions, we also
demonstrated that these Se-derivatizated DNAs crystallized faster than these native
and Br-derivatized DNAs. Furthermore, by comparing with the conventional bromine
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derivative, which retained the same global structure as the native, we found that the
bromine derivatization caused the local perturbations, such as the backbone rotation,
the water networking disruption, and the hydrate pattern alteration. Our experimental
results indicate that the selenium derivatization may assist the studies of the nucleic
acid X-ray crystal structures in two major ways: phasing and crystal growth with high
quality, which leads to structure determination with high resolution. These experimental
results suggest that the selenium derivatization can be an alternative to the
conventional bromine derivatization. This Se derivatization strategy via the atomspecific substitution will significantly facilitate X-ray crystal structure studies of nucleic
acids and their protein complexes.
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5. CRYSTALLIZATION FACILITATION OF DNA OLIGONCULEOTIDES BY 2’SELENIUM FUNCTIONALITY

5.1 Introduction
Since the discovery of dramatic facilitation of selenium function modification at 2’position of ribose to the growth of oligonucleotide crystal, the further effort has been
devoted to explore the mechanism of this phenomenom. In addition, it was amazing to
find that in certain DNA sequences with 2’-SeMe modification and certain concentrations,
the crystal growth could happen in a few minutes with a fixed shape of single or double
crystals, therefore, it is possible to real-time monitor the crystal growth by a normal
digital camera through microscopes, as well as the calculation of time dependent crystal
volumes, which could provide the direct information about the macromolecule packing
rate, although the nucleation process is still a mystery.
Inspired by this exciting result, in this section, we systematically incorporated a
series of functional group at 2’ position, such as –F, -OH, -OMe, -SMe, -H and -SeMe,
into a well studied oligonucleotide model sequence 5’-GU*GTACAC-3’, where the U is
the modified residue. By screening various combination, the same condition for single
crysal growth of all these modified DNA was selected. Then, under the same
concentration, their time-course crystal growth or the molecular packing was compared.
Besides this thermaldynamic study, the following NMR study of the modified
nucleosides and mechanical simulation calculation of the modified oligomers are still on
going by the writing of this dissertation. The results, together with our current studies,
will be summarized and published later.
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5.2 Results and discussion
5.2.1 Preparation of DNA samples containing various functionalities at 2’-position
The phosphoramidite building blocks containing 2’-SeMe and 2’-SMe were
synthesized through the nucleophilic ring-opening addition of 2,2’-anhydrouridine by
either SeMe or SMe group which are generated by the reduction of commercial
available reagent dimethyl diselenide and dimethyl disulfide, followed by the standard
procedure of making phosphoramidites, as showed in scheme 5.1. All the other building
blocks including 2’-OMe, F, OH and H phosphoramidites are purchased from
ChemGenes Inc. All the modified octermer were synthesized and purified by the
standard DNA synthesis procedures.
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Scheme 5.1: Synthesis of oligonucleotides containing 2’-SeMe or 2’-SMe.
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5.2.2 Time-course crystals growth measurement of 2’-Se-DNAs
The 2’-SeMe modified model was applied to screen the best crystallization
conditions in terms of buffers, temperatures, concentrations of sample and precipitant,
more importantly, crystal shape repeatability. Finally, the number seven of the Hampton
nucleic acid mini-screen buffer was found to be the best condition. (see appendix A)
(buffer consist of: 10% v / v MPD, 40 mM Na Cacodylate pH 6.0, 12 mM Spermine tetraHCl, 80 mM Sodium Chloride and 20 mM Magnesium Chloride). By setting the
concentration of sample and precipitant to 0.25 mM and 35% MPD respectively, the
time course growth of single crystal was achieved. The shape of crystal was shown in
figure 5.1. All the lengthes and angles was measured with calibrated high resolution
digital camera Olympus-3.3MPX. Based on a real model we built, a volume calculation
of this crystal was figured out.

V= 0.7581*c*d*(a+b)/2 + c*(b+c)*[f2-(c2+(b-e)2)/4]1/2/3
+ a*(c+g) *[h2-(a2+(c-g)2)/4]1/2/3
Figure 5.1: Crystal shape, parameters and volume calculation of 2’-SeMe-8mer.
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With this information in hand, a time-course volume increasement was then
recorded and calculated during the crytal growing. Since it has been known by our
crystallography study that one unit cell contains two molecules of DNA duplex, and the
unit cell volume is also known, so, although it’s not very accurate in terms of the
absolute number, we are still able to calculate the rough number of DNA duplex
molecules in a fixed shape of crystal. With this guidance, a time coursed molecule
packing curve for this 2’-SeMe-8mer DNA crystal was obtained, as showed in figure 5.2.

Figure 5.2: Time-course molecule packing curve for the 2’-SeMe-8mer DNA. The
picutures on the curve represents the according real size of the time.
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5.2.3 Comparison of crystal growth of DNAs containing various functionalities
Then, a comparison of this crystal growth facilitation effect among these 2’modifications was carried out. Fortunitely, the single crystals with the same shapes
could be obtained in the same concentration and crystal growing conditions as selenium
derivatization, except the 2’-F, which need much higher concentrations to be crystallized.
As example, the molecule packing curves of 2’-SMe and 2’-OMe were placed together
with a long time-course (up to 100 hours), as showed in figure 5.3. The 2’-OH and 2’-H
growth is too slow in this time scale comparing the aboved three samples, therefore is
hard to compare here. For each sample, the crystal growing rate and quality under the
24 screen conditions were further compared in table 5.1.

Figure 5.3: Time-course molecule packing comparison of DNA-8mer containing 2’-SeMe,
2’-SMe and 2’-OMe. (Represented by red, blue and pink curves respectively).
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Table 5.1: Crystal growth comparison for DNA-8mer with various modifications.

DNA

H

Working buffers

0

Appear time

Max-size

(ave)

time (ave)

0

None

None

None

N/A in 4

2/96

7, 14, 16

Two weeks
Month

(3 plate)

Best ones

One crystal rate

17 (3,5,67,8,9,10,
F

11,13,14,15,16,
17,18,19,21,23)
11

3/120
OH

(4,5,6,7,9,10,11,

5,7,10,23

7 days

7 days
(5 plate)

15,22,23,24)
13
(4,6,7,8,10,11,

6,7,10,11

12,14,16,18,19,

16

OMe

1/120
7 days

200 h
(5 plate)

22,23)
15 (2,3,4,5,7,8,9,
2/144
SMe

10,11,13,15,18,

7,10, 13, 19

3 days

70 h
(6 plate)

19,21,23 )
5,6,7,9,11
10/120
SeMe

All the 24

13,18,20,

8 min

22 h
(5 plate)

22,24
* Conditions: 0.25mM DNA, 35% MPD, r.t.
* Explanation: Working buffers mean the buffers from Hampton Mini-Screen kid which
could grow the crystal successfully; Best ones means the buffers which can grow less
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than five crystals; The appear time was averaged by certain numbers of experiment in
the same condition (0.25 mM).

The results in the aboved table clearly showed that comparing the native one, all
these 2’ groups showed a certain function of facilitating crystal growth of this 8mer DNA.
While comparing the other groups, this function is much stronger, in all the aspects,
including the buffer conditioin diversity, number of best crystallization conditions, the first
crystal appear time, the maximum-size reach time and the one crystal possibilities.
It’s also interesting to point out that the crystal shapes of these DNA samples
could be very diverse with different buffer conditions, concentrations and temperatures.
The figure 5.4 summerized the most oftenly appeared crystal shapes during this work.

Figure 5.4: The diversity of DNA crystal shapes in this work.
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5.3 Conclusion of this chapter
In this work, it was found that the modifications at the 2’ position of
deoxyribouridine could facilitate the crystal growth of a DNA-8mer model 5’GU*GUACAC-3’, and comparing other groups such -SMe, -OMe, -OH, and -F,
methylseleno group has much stronger effort, which could make crystals grow in less
than ten minutes. By optimizing the crystal growing conditions, we were able to obtain
the single crystal with a fixed shape for each modified DNA sample. A crystal volume
calculation was figured out based on the measurement of crystal parameters, which was
further applied to the quantitative calculation of time-course molecule packing patterns
with the support of our previous crystallography results.
As far as we know, this is the first dynamic study of macromolecular crystal packing,
although the mechanism is still not clear. We assume that this selenium modification at
2’ position of the ribose could lock the sugar pucker into 2’-exo form in a right extent
which provides a perfect scafford for the next molecular packing, while the other
modifications generates more dynamic equilibrium for the ribose between the 2’-exo
and 2’-endo form. Although the nucleation process is hard and impossible to monitor
with current conditions, the fact that this 2’-SeMe-8mer DNA crystal appears in an
amazingly short time indicates that the original molecules should have a relatively rigid
shape and low entropy value, which makes the starting packing very accurate, fast and
highly reproducible. When a certain size is reached, the surface of the crystals can
serve as a good template for the self-assembly of more freely wandering molecules into
the organized model. Further researches such as NMR and mechanic modeling studies
are needed to explore the detailed mechanism of this crystal facilitation.
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6. SYNTHESIS OF BASE MODIFIED 4-SELENIUM-THYMIDINE AND 4-SELENIUMURIDINE FOR STRUCTURE STUDIES OF DNA AND RNA OLIGONUCLEOTIDES

6.1

Introduction
Besides the structural application of SeNA strategy, we are also seeking their

potential functional studies for both DNA and RNA. This chapter presents our work
about introducing selenium function into the nucleobase, including 4-position of
thymidine and uridine.
Nucleic acids participate in many important biological functions in living systems,
including the genetic information storage, the gene expression, and catalysis. (1) (2)
The T-A and C-G base-pairing and stacking allow the formation of the stable DNA
duplex for genetic information storage, transcription and replication. (107) (3) The
replacement of oxygen on the nucleobases with sulfur(108) (109) has provided more
insights on the DNA duplex stability, recognition and replication at the atomic level.
(110) (75) The 2-thio thymidine causes the slight stabilization of the T-A pare and DNA
duplex, while the 4-thio thymidine causes the slight destabilization of them. (73) The
recent studies on these sulfur modifications have revealed the enhanced base-pare
selectivity, and the replication efficiency and fidelity, especially with the 2-thio thymidine
probably due to discouraging the undesired T-G wobble base-pairing by the larger sulfur
atom at 2-position of the thymine.
As selenium (atomic radius, 1.16 Å), another element member of Family VIA in the
Periodic Table, is much larger than oxygen (0.73 Å), the replacement of O with Se on
the nucleobases of nucleic acids will most likely provide more advantages over the
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natives and reveal more insights on the base-pairing selectivity, the duplex stability and
recognition, and the replication efficiency and fidelity. Combining the function of
anormalous dispersion center, we believe that this nucleobase Se-derivatization can
provide unique opportunities over the Se-derivatized nucleic acids (SeNA) with Se on
other positions for the structure study. In addition, specific pyrimidines in natural tRNAs
have been derivatized by Se on the nucleobases, and the Se function has been barely
understood though it was suggested that the Se substitution might involved in the tRNA
anticodon. (77) Furthermore, the discoveries on the functional importance of small RNAs
and specialized RNA domains in many biological processes have increased
dramatically over the past decade, so, the further investigation of phenomena such as
RNA interference and RNA-protein interactions for gene regulation requires advanced
research on RNA base pair recognition and stability based on hydrogen bonding,
stacking interaction and size-shape impacts, which is also accompanied by a growing
demand for X-ray structure analysis of RNAs. Despite the synthesis of the Secontaining nucleobases and nucleosides over decades ago, (76) (111) synthesis of the
nucleic acids containing the Se-nucleobases remained a challenge.

6.2 4-Se-thymidine containing DNA
6.2.1 Synthesis of 4-Se-thymidine and its phorsphoramidite
As showed in figure 6.1, to replace the 4-oxygen with selenium, we activated the
partially protected thymidine derivative (1) at the 4-position via the formation of triazolide
2 in two reactions (87% yield). We also developed di(2-cyanoethyl) diselenide reagent
for the Se introduction. (112) After reducing the diselenide reagent to the corresponding
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selenol with NaBH4, the protected Se functionality was introduced to the 4-position of 2
by displacing the 4-triazolyl activating group, achieving the simultaneous Se
incorporation and protection for the Se-T intermediate (3). Due to the undesired removal
of the 2-cyanoethyl group on Se while removing the 3’-TMS group by the fluoride or
base treatment, we developed a mild condition to remove the 3’-TMS group by using
10% triethylamine in methano (81% yield). Alternatively, the 3’-TMS group could also
firstly be removed by the fluoride treatment, followed by the Se incorporation (85% yield
in two reactions). Finally, Se-thymidine derivative 3 was converted to the corresponding
phosphoramidite 4 in 92% yield. The detailed experiment and characterization for each
compound were listed in the following.
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Scheme 6.1: Synthesis of 4-Se-thymidine phosphoramidite (4) and oligonucleotides
containing 4-Se-T (5). (a)

TMS-Im and CH3CN; (b) triazole-POCl3-Et3N; (c)

(NCCH2CH2Se)2/NaBH4, EtOH; (d) 10% Et3N in MeOH; (e) 2-cyanoethyl N,Ndiisopropylchlorophosphor-amidite and N,N-diisopropylethylamine in CH2Cl2; (f) the
solid phase synthesis.
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4-(1,2,4-triazol-1-yl)-5’-O-(4,4’-dimethoxytriphenylmethyl)-3’-O-trimethylsilylthymidine(2).
Phosphorus oxychloride (0.92 mL, 10 mmol) was added to a solution of 1,2,4-triazole
(2.77 g, 40 mmol) in dry acetonitrile (32 mL) under argon, and the reaction was stirred
for 45 min at room temperature. Dry triethylamine (11.2 mL, 79 mmol) was then injected
into the reaction and the reaction was stirred for another 45 min. Without exposing to air,
the suspension was filtered directly into a round bottle flask (100 mL) containing
compound 1 (1.82 g, 3.35 mmol) reacted with 1-(trimethylsilyl)imidazole (0.98 ml, 6.67
mmol) in dry acetonitrile (15 mL) under argon. The reaction mixture was allowed to run
for 1 hr at room temperature. The formation of N4-triazolide 2 was revealed by a
fluorescent spot on TLC (5% MeOH in CH2Cl2, product Rf = 0.25). After the reaction was
complete, the reaction mixture was poured into water (150 mL), and extracted with
ethylacetate (3x 80 mL). The combined organic layer was washed with saturated NaCl
(100 mL) and dried over MgSO4 before evaporation. After loading the crude product on
a silica gel column equilibrated with hexanes/CH2Cl2 (1:1), the column was eluted with
hexanes/CH2Cl2 (1:1), pure CH2Cl2, and then with a methanol/CH2Cl2 gradient (0, 0.5%
and 1% methanol in CH2Cl2). After solvent evaporation and dry on high vacuum, the
pure compound (2) was obtained as a white foam product (1.94 g, 87% yield). 1H-NMR
(300 MHz, CDCl3) δ: 0.61 [s, 9H, (CH3)3Si], 1.98 (s, 3H, CH3), 2.26-2.35 and 2.63-2.71
(2x m, 2H, H-2’), 3.30-3.60 (2x dd, J = 2.7, 11.1 Hz, 2H, H-5’), 3.79 (s, 6H, 2xCH3O),
4.07-4.10 (m, 1H, H-3’), 4.46-4.52 (q, J = 4.8 Hz, 1H, H-4’), 6.30 (t, J = 6.3 Hz, 1H, H-1’),
6.84 (dd, J = 1.5, 9.0 Hz, 4H, aromatic), 7.22-7.42 (m, 9H, aromatic), 8.09 (s, 1H, H-6),
8.42 (s, 1H, H-Im), 9.29 (s, 1H, H-Im).
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C-NMR (100 MHz, CDCl3) δ: -0.06 (CH3-Si),

16.54 (CH3), 42.20 (C-2’), 55.26 (OCH3), 62.12 (C-5’), 70.58 (C-3’), 86.88, 135.31,
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135.33, 144.23, 158.16 (Ar-C), 87.16 (C-4’), 87.65 (C-1’), 105.71 (C-5), 113.29, 113.31,
127.14, 128.02, 128.13, 130.06, 130.07 (Ar-CH), 146.70 (C-6), 153.36 (CH-Im), 153.95
(C-2), 158.79 (C-4). HRMS (ESI-TOF): molecular formula, C36H41N5O6Si; [M+Na]+:
690.2724 (calc. 690.2718).
4-(2-cyanoethyl)seleno-5’-O-(4,4’-dimethoxytriphenylmethyl) thymidine (3).
The NaBH4 suspension (250 mg NaBH4 in 5 mL of EtOH) was injected into a flask
containing di(2-cyanoethyl) diselenide [(NCCH2CH2Se)2, 0.45 mL, d= 1.8 g/mL, 3.0
mmol] and ethanol (8 mL) on an ice bath and under argon. After injection of the NaBH4
suspension for 15 minutes, the ice bath was removed. The yellow color of the diselenide
disappeared in approximately 15 min, giving an almost colorless solution of sodium
selenide (NCCH2CH2SeNa). The solution of 2 (1.34 g, 2 mmol) in THF (4 mL) was
injected to the solution of sodium selenide. After the selenium incorporation was
completed in 15 min. (monitored on TLC, 5% MeOH in CH2Cl2, product Rf = 0.58), water
(100 mL) was added to the reaction flask. The solution was adjusted to pH 7-8 using
CH3COOH (10%), and was then extracted with ethyl acetate (3 x 100 mL). The organic
phases were combined, washed with NaCl (sat., 100 mL), dried over MgSO4 (s) for 30
min., and evaporated to minimum volume under reduced pressure. Deprotecting
solution (5 mL, 10% triethylamine in methanol) was added to the crude product, and the
reaction was stirred for 4 hours to completely remove the 3’-TMS group (monitored on
TLC, 5% MeOH in CH2Cl2, product Rf = 0.46). The deprotecting solution was
evaporated under reduced pressure. The crude product was then dissolved in
methylene chloride (5 mL) and purified on a silica gel column equilibrated with
hexanes/methylene chloride (1:1). The column was eluded with a gradient of methylene
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chloride (CH2Cl2, 0.5%, 1%, and 2% MeOH in CH2Cl2, 500 mL each). After solvent
evaporation and dry on high vacuum, the pure compound (3) was obtained as a white
foamy product (1.07 g, 81% yield). 1H-NMR (400 MHz, CDCl3) δ: 1.62 (s, 3H, CH3),
2.27-2.35 and 2.71-2.77 (2x m, 2H, H-2’), 3.00 (dd, J = 6.5 and 6.7 Hz, 2H, CH2-CN),
3.32 (br, 1H, OH), 3.37-3.41 (m+t, J = 6.7 Hz, 3H, 1H-5’, CH2-Se), 3.52 (dd, J5’-5’ = 10.6
Hz, J5’-4’ = 3.0 Hz, 1H, 1H-5’), 3.81 (s, 6H, 2x OCH3), 4.17-4.22 (m, 1H, H-3’), 4.57-4.62
(m, 1H, H-4’), 6.34 (t, J1’-2’ = 6.3 Hz, 1H, H-1’), 6.85 (dd, J = 8.8 Hz, 4H, aromatic), 7.237.42 (m, 9H, aromatic), 7.91 (s, 1H, H-6).
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C-NMR (100 MHz, CDCl3) δ: 14.30 (CH3),

18.73 (CH2-CN), 20.53 (CH2-CH2-CN), 42.17 (C-2’), 55.29 (OCH3), 63.18 (C-5’), 71.71
(C-3’), 86.90, 135.37, 135.41, 144.36, 158.73 (Ar-C), 86.73 (C-4’), 87.01 (C-1’), 113.31,
127.17, 128.03, 128.10, 130.07 (Ar-CH), 114.38 (C-5), 119.00 (CN), 137.56 (C-6),
153.35 (C-2), 177.20 (C-4). HRMS (MALDI-TOF): molecular formula, C34H35N3O6Se;
[M+Na]+: 684.1583 (calc. 684.1583).
Alternative approach: Et3N•3HF (7.5 mL, 1 M in THF, 7.5 mmol) was added to the
solution of 2 (4.98 g, 7.47 mmol) in THF (10 mL). The reaction was completed after
stirring under argon for 15 minutes (monitored by TLC). The solvent of the reaction was
removed by rotary evaporation and the crude intermediate was then dried on high
vacuum. The NaBH4 suspension (933 mg NaBH4 in 10 mL of EtOH) was injected into a
flask containing di(2-cyanoethyl) diselenide [(NCCH2CH2Se)2, 1.66 mL, d= 1.8 g/mL,
11.2 mmol, 3 eq.] and ethanol (10 mL) on an ice bath and under argon. After adding the
NaBH4 suspension and stirring it for 15 minutes, the ice bath was removed. The brownyellow color of the diselenide disappeared in approximately 15 min, giving an almost
colorless solution of sodium selenide (NCCH2CH2SeNa). The sodium selenide solution
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was then injected into the flask containing the crude intermediate under argon. After the
selenium incorporation reaction was completed in 45~60 minutes (monitored on TLC,
5% MeOH in CH2Cl2, product Rf = 0.58), CH2Cl2 (100 mL) was added to the reaction
flask, followed by addition of NaCl solution (100 mL, saturated) and addition of
CH3COOH (5%) to adjust the pH to 7-8. After removing the organic phase, the aqueous
phase was extracted again with CH2Cl2 (2 x 100 mL). The organic phases were
combined, washed with NaCl (sat., 50 mL), dried over MgSO4 (s) for 25 min., and
evaporated to minimum volume under reduced pressure. The crude product was
dissolved in CH2Cl2 (5 mL) and purified on a silica gel column equilibrated with CH2Cl2
and eluded with a gradient (CH2Cl2, 0.5%, 1.0%, 2.0% MeOH in CH2Cl2, 400 mL each).
After solvent evaporation and dry on high vacuum, the pure compound (3) was obtained
as a white foamy product (4.20 g, 85% yield).
4-(2-cyanoethyl)seleno-5’-O-(4,4’-dimethoxytriphenylmethyl)-thymidine3’-O-(2-cyanoethyl) diisopropylamino phosphoramidite (4).
To the flask (25 mL) containing 3 (453 mg, 0.68 mmol) under argon, dry methylene
chloride (2.5 mL), N,N-diisopropylethylamine (0.17 mL, 1.03 mmol, 1.5 eq.), and 2cyanoethyl N,N-diisopropyl-chlorophosphoramidite (195 mg, 0.83 mmol, 1.2 eq.) were
added sequentially. The reaction mixture was stirred at -10 °C in an ice-salt bath under
argon for 10 minutes, followed by removal of the bath. The reaction was completed in
45 minutes at room temperature (indicated by TLC, 5% MeOH in CH2Cl2, product Rf =
0.63 and 0.68), generating a mixture of two diastereisomers. The reaction was then
quenched with NaHCO3 (2 mL, sat.), stirred for 5 min, and the product was then
extracted with CH2Cl2 (3 x 5 mL). The combined organic layer was washed with NaCl
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(10 mL, sat.) and dried over MgSO4 (s) for 20 min, followed by filtration. The solvent
was then evaporated under reduced pressure and the crude product was re-dissolved in
CH2Cl2 (2 mL). This solution was added drop-wise to petroleum ether (100 mL) under
vigorous stirring, generating a white precipitate. The petroleum ether solution was
decanted. The crude product was re-dissolved again in CH2Cl2 (2 mL) and then loaded
into an Al2O3 column (neutral) that was equilibrated with CH2Cl2/Hexanes (1:1). The
column was eluded with a gradient of methylene chloride and ethyl acetate [CH2Cl2 to
CH2Cl2/EtOAc (7:3)]. After solvent evaporation and dry over high vacuum, the pure 4
(538 mg) was obtained as a white foamy product (92% yield). 1H-NMR (400 MHz,
CDCl3, two sets of signals from a mixture of two diastereomers) δ: 0.85-1.20 (m, 24H,
8x CH3-ipr), 1.55 and 1.57 (2x s, 6H, 2x CH3), 2.30-2.38 and 2.70-2.82 (2x m, 4H, 2x H2’), 2.34 and 2.64 (2x t, J = 6.4 Hz, 4H, 2x O-CH2-CH2-CN), 3.00-3.04 (m, 4H, 2x SeCH2-CH2-CN), 3.32-3.44 (m, 6H, 2x H-5’, 2x Se-CH2), 3.52-3.64 (m, 8H, 4x CH-ipr, 2x
O-CH2-CH2-CN), 3.73-3.84 (m, 2H, 2x H-5’), 3.82 and 3.83 (2x s, 12H, 4x OCH3), 4.184.24 (m, 2H, 2x H-3’), 4.63-4.72 (m, 2H, 2x H-4’), 6.28 and 6.32 (2x t, J1’-2’ = 6.3 Hz, 2H,
2x H-1’), 6.83-3.88 (m, 8H, aromatic), 7.27-7.43 (m, 18H, aromatic), 7.82 and 7.94 (2x s,
2H, 2x H-6).

13

C-NMR (100 MHz, CDCl3, two sets of signals from a mixture of two

diastereomers) δ: 14.18 (CH3), 18.78 (Se-CH2-CH2-CN), 20.15 and 20.23 (O-CH2-CH2CN), 20.43 (Se-CH2-CH2-CN), 24.48, 24.52, 24.55, 24.59, 24.67 (CH3-ipr), 40.85, 40.89
and 41.17, 41.19 (C-2’), 43.17, 43.25, 43.29, 43.38 (CH-ipr), 55.27 and 55.31 (OCH3),
58.15 and 58.34 (O-CH2-CH2-CN), 62.30 and 62.65 (C-5’), 72.31 and 72.87 (C-3’),
85.68 and 85.86 (C-4’), 86.74 and 86.76 (C-1’), 86.87, 135.28, 135.31, 144.25, 158.77
(Ar-C), 113.27, 127.18, 127.23, 128.00, 128.18, 128.26, 130.13, 130.19, 130.21 (Ar-CH),
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114.04 and 114.08 (C-5), 117.38 and 117.53 (O-CH2-CH2-CN), 119.03 (Se-CH2-CH2CN), 137.41 and 137.44 (C-6), 153.10 (C-2), 176.98 (C-4). HRMS (MALDI-TOF):
molecular formula, C43H52N5O7PSe; [M+H]+: 862.2836 (calc. 862.2842).

6.2.2 Preparation of DNA oligonucleotides containing 4-Se-T
The 4-Se-T phosphoramidite was examined on solid-phase nucleotide synthesis.
As expected, it is compatible with the coupling reaction, acetylation, I2 oxidation, and
trichloroacetic acid treatment to remove the 5’-DMTr group, without causing any
deselenization. Unfortunately, the concentrated ammonia treatment, which is commonly
used for deprotecting the nucleobases and the 2-cyanoethyl groups from the backbone,
will cause the deselenization probably due to the good electrophile of the positioin 4 in
the thymidine base under high pH values caused by the selenium functionality. To
prevent this deselenization, we found the deprotecting condition by using 0.05 M of
potassium carbonate solution in methanol, which could remove the 2-cyanothyl group
on Se in two hours. The oligonucleotides synthesized using the phosphoramidites
containing the ultramild nucleobase deprotection groups can also be fully deprotected
for eight hours or overnight with the same potassium carbonate solution. Then the
solution was neutralized with 1M HCl and ready to be purified. The synthesized SeDNAs were purified and analyzed by HPLC and MS (Figure 6.1 and Table 6.1). A typical
crude Se-DNA HPLC profile, which is almost identical to that of the corresponding
native, as well as the according MALDI-TOF mass spectrum is shown in Figure 6.2.
Less than 2% of short oligonucleotides were formed in this Se-decamer synthesis,
indicating the high yield of the Se-thymidine coupling (99%).
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Table 6.1: MS analysis of the DNAs Containing 4-Se-T.

6.2.3 Study of 4-Se-T DNA with yellow color
More excitingly about this work, we have discovered for the first time the yellow
colored 4-Se-thymidine with special UV-absorption at 369 nm (Figure 6.3) by just
altering a single atom on native thymidine (colorless). This visualization of DNA is of a
lot of interest and importance to many biochemical, biological and medical applications,
(113) (114) such as gene expression analysis, human disease-and-pathogen detection
and even the crystal screening of nucleic acid-protein complex. This function of DNA
visualization is usually achieved by intercalated dye molecules (115) (116) and specific
DNA probes tagged with fluorescent moieties. (117) (118) However, these intercalated
dye molecules and tethered fluorescent moieties are often bulky, which can cause
perturbation of DNA duplex structures. So, this atom-specific selenium modification
could have potential to be applied as a novel DNA probes for visualization without
obvious structure perturbation.
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Figure 6.1: LC-MS analysis of SeNAs. (A): 5’-SeTT-3’; Molecular Formular:
C20H17N4O12PSe; [M-H]-: 609.0 (calcd: 609.1). (B): 5’-DMTr-SeTSeTT-3’; Molecular
Formular: C51H58N6O19P2Se2; [M-H]-: 1279.0 (calcd: 1279.1)
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A.

B.

Figure 6.2: HPLC and MS analysis of purified 5’-GCG(SeT)ATACGC-3’. (A) HPLC
analysis: the sample was analyzed on a Zorbax SB-C18 column (4.6 x 250), eluted
(1ml/min) with a linear gradient from buffer A (20mM triethylammonium acetate, pH 7.1)
to 100% buffer B (50% acetonitrile, 20 mM triethylammonium acetate, pH 7.1) in 30 min.
Its retention time is 11.52 min. (B). MALDI-MS analysis: Molecular Formular:
C97H123N38O57P9Se; [M+H]+: 3091.6 (calcd: 3092.0).

A.

B.

Figure 6.3: UV spectra and color of natural thymidine and 4-Se-thymidine TTP. (A): UV
spectrum of thymidine (red, λmax= 267 nm) and UV spectrum of 4-Se-thymidine (gray,
λmax= 369 nm); (B): thymidine (on left, colorless) and 4-Se-thymidine (on right, yellow).
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6.2.4 Thermal stability and denaturalization study
Besides that, the thermal stability and thermal denaturalization studies of this
selenium modification containing DNA was carried out. Figure 6.4 indicated that the
selenium functionality of the research model is stable at 60 oC over three hours with less
than 5% was decomposed. Considering that the stability in air is required in most
crystallization experiments, we have also monitored the stability of the Se-derivatized
DNA for a week in dark. The results showed in figure 6.5 indicated that the Se-DNA is
quite stable for long time.
Based on the previous results, the UV-melting temperatures were measured for
the duplex system of 5’-ATGGSeTGCTC-3’ and 5’-GAGCACCAT-3’. Figure 6.6 is the
original Tm curves which repeated for four times. It clearly showed that the derivatized
Tm of Se-DNA (38.6 oC) is very close to that of the corresponding native duplex (39.2
o

C), suggesting no significant perturbation caused by the this modification on thymine.

6.2.5 Crystallization and structure determination of 4-Se-T- DNA
After confirming the structure isomorphism by Tm study, we have also
successfully crystallized the 4-Se-T-containing DNA (5’-G-dUSe-G-SeT-A-C-A-C-3’, selfcomplementary), where the dUSe (2’-Se-dU) was used to facilitate the crystal growth
based on our previous results. Though the Se functionality is relatively stable in air, 10
mM DTT was still used in the crystallization buffers to prevent the oxidative
deselenization of 4-Se-thymidine. The Se-DNA crystallized in three days in buffer # 8,
#17, and #21 of the Hampton kit). The structure of the Se-DNA crystal, grown under
buffer #17, was determined at 1.50 Å resolution via Se MAD phasing.
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Figure 6.4: UV thermostability study of the SeNA DNA-9-mer (5’-ATGT-SeT-TCTC-3’).
Smaple heated at 60 oC for 3 hours in buffer (5 mM, NaH2PO4-Na2HPO4, pH 7.5). A. UV
analysis over 3 hr. B. HPLC analysis: a) 0 hr, monitored at 260 nm by HPLC; b) 0 hr;
monitored at 368 nm by HPLC; c) 1 hr, monitored at 368 nm by HPLC; d) 2 hr,
monitored at 368 nm by HPLC; e) 3 hr, monitored at 368 nm by HPLC.
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Figure 6.5: Stability of the SeNA DNA-9-mer (5’-ATGT-SeT-TCTC-3’) in air. Samples
were stored in buffer (5 mM, NaH2PO4-Na2HPO4, pH 7.5). a) 0 day, monitored at 260
nm by HPLC; b) 0 days; monitored at 368 nm by HPLC; c) 3 days, monitored at 368 nm
by HPLC; d) 7 days, monitored at 368 nm by HPLC.

A.

B.

Figure 6.6: UV melting curves of native and Se-DNAs. (A) The native DNA duplex: 5’ATGGTGCTC-3’ & 5’-GAGCACCAT-3’ (Tm= 39.2 ºC). (B) The Se-DNA duplex: 5’ATGG-SeT-GCTC-3’ & 5’-GAGCACCAT-3’ (Tm= 38.6 ºC).
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The data collection, phasing and refinement statistics of the determined Se-DNA
structure (2NSK) are listed here in the Table 6.2. The positions of the selenium were
identified by CNS heavy atoms search function (crystallography & NMR structure).
Following the refinement of the selenium positions, the experimental phases were
calculated and extended using the SAD or MAD (single- or multiple- wavelength
anomalous dispersion) procedures in CNS. The initial phased maps were then improved
by the solvent flattening and density modification procedure. The model of single strand
of DNA was manually built into the electron density map using program O, and then the
following refinement was carried out. The refinement protocol includes simulated
annealing, positional refinement, restrained B-factor refinement, and bulk solvent
correction. The stereo-chemical topology and geometrical restrain parameters of
DNA/RNA, as well as the water, ions parameters from CNS default files have been
applied for the normal DNA residues. The topologies and parameters for Se-modified
dU (UMS) and dT (T4S) were built based on the parameters of selenium and carbon
bonds and angles, then applied in the refinement. After several cycles of refinement and
the model rebuilding, a number of highly ordered waters were picked up and added to
the structure before the final runs of refinement. Finally, the occupancies of selenium
were adjusted. A Cross-validation with a 5-10% test set was monitored during each
refinement. The σA-weighted maps of the (2m|Fo| - D|Fc|) and the difference (m|Fo| D|Fc|) density maps were used in model building. The final R value is blow 20% (19.5%)
and the R free is 21.2%. The helical parameters of 4-Se-T DNA (2NSK) and the
comparison with the native DNA structure (1DNS) are compiled using CURVES version
5.3 and listed in Table 6.3.
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Table 6.2: X-ray data collection, phasing, refinement and model statistics for the Se DNA
(5’-G-dUSe-G-SeT-A-C-A-C-3’, 2NSK).
Data collection and phasing
Wavelength, Å
Resolution range, Å
(last shell)
Unique reflections
Completeness, %
Rmerge ,%
<I/σ(I)>
Redundancy
R-Cullis (Friedel)
Phasing power (Friedel)
Figure of merit (Friedel)
Overall figure of merit

peak
inflection
remote
0.9795
0.9798
0.9400
40.0-1.5
40.0-1.5
40.0-1.5
(1.55-1.5) (1.55-1.5) (1.55-1.5)
3736
3741
3743
(357)
(352)
(354)
99.1
99.2
99.2
(100.0)
(100.0)
(100.0)
8.8 (27.6) 6.3 (26.8) 6.3 (27.9)
15.3 (6.8) 14.9 (6.3) 14.6 (5.9)
13.0
13.1
13.2
(13.6)
(13.6)
(13.7)
0.485
0.371
(0.428)
(0.306)
(0.279)
2.31
4.37
(4.79)
(4.98)
(6.24)
0.473
0.578
(0.438)
(0.548)
(0.584)
0.882

Refinement and model
Space group
Unit Cell
Resolution range, Å (last shell)
Number of reflections
Rwork , %
Rfree , %
Nucleic Acid (single strand)
Heavy atom
Water
Bond length R.M.S.D, Å
Bond angle R.M.S.D
Average B-factors, Å2
All atoms
Wilson plot
Overall anisotropic B-values
B11/B22/B33
Solvent density, e/Å3
B-factors of solvent, Å2
Esd. from Luzzatt plot, Å
Esd. from SIGMAA, Å

reference
1.100
40.0-1.5
(1.55-1.5)
3718
(352)
98.3
(100.0)
4.8 (27.2)
14.7 (5.6)
12.7
(12.2)

P 43 21 2
a=b= 42.31 Å, c= 23.84 Å
15.82 - 1.50 (1.59 - 1.50)
3531 (492)
19.5 (19.5)
21.2 (19.9)
160
2 (Se)
36
0.011
1.8
24.0
17.4
-1.51/-1.51/3.02
0.34
47.6
0.16
0.08
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Table 6.3: Comparison of helical parameters of 4-Se-T DNA (2NSK) and native (1DNS).

32.4
2.7
1.4
12.7
-4.3
C2’-exo

Native
DNA
(1DNS)
32.6
2.9
0.7
11.7
-4.3
C2’-exo

9.5
1.5

9.7
1.4

19.3

19.2

Se-DNA
(2NSK)
Mean Twist (o)
Mean Rise (Å)
Roll (o)
Inclination (o)
X-displacement (Å)
Sugar pucker
Minor groove
Mean width (Å)
Mean depth (Å)
Mean helical
diameter (Å)

The final solved 4-Se-T DNA structure was superimposable over the native
structure (2.0 Å resolution) with the same tetragonal space group P43212, as showed in
Figure 6.7A, which indicates that the oxygen replacement by selenium at this position
does not cause the significant structure perturbation. Interestingly, the large Se atom is
observed to be accommodated by a slight shift (Fig. 6.7B), revealing the flexibility of the
DNA duplex structure. Furthermore, the atomic distance (3.02 Å) between the thymine
N3 and the adenine N1 indicates a hydrogen bond formation (Fig. 6.7C). In addition,
considering that the Se atomic radius is 0.43 Å larger than that of O, and that the
distance between T4 exo-O4 and A5 exo-N6 in the native structure is 2.87 Å, the
distance (3.35 Å) between the exo-Se4 and exo-N6 indicates a Se-mediated longer
hydrogen bond formation. The observation of the longer Se-hydrogen bond (usual
hydrogen bond length: 2.8-3.2 Å) in the crystal structure is consistent with the 4-SeDNA UV-melting study which has a little bit decreased Tm.
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A.

B.

C.

Figure 6.7: The global and local structures of the 4-Se-T DNA [(5’-G-dUSe-G-SeT-ACAC3’)2]. (A) The duplex structure of the modified DNA (2NSK, in cyan) is superimposed
over the native (1DNS, in pink). (B) The comparison of the modified (in green) and
native (in cyan) local T4 structures. (C) The Se-base pair of T4-A5 with the experimental
electron density.

6.3 4-Se-uridine containing RNA
6.3.1 Synthesis of 4-Se-uridine and the phorsphoramidite
Following the above stated work, the selenium replacing oxygen at the thymidine
4-position have provided an additional useful methodology for DNA base pair and
duplex stability studies besides the sulfur modification on the nucleobases. It was also
clearly revealed by crystallography studies that DNA is flexible enough to accommodate
a large atom and the selenium atom can also mediate the hydrogen bond formation with
adenosine while not causing obvious structure perturbation. Furthermore, it was found
in our 4-Se-thymidine work that this atom-specific mutagenesis could generate fairly
stable yellow colored DNAs with a special UV-absorption, which could have great
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potentials to visualize nucleic acids molecule. Therefore, to further explore this novel
strategy, it’s very necessary and interesting to explore the selenium modified RNA
version in the nucleobase for RNA and RNA-protein complex structural and functional
studies. It’s being more urgent to develop this kind of novel tool in nowadays since the
small RNA has been widely investigated as RNA interference and gene regulators. (119)
Here, we also would like to report the first synthesis of the 4-Se-uridine phosphoramidite,
its incorporation into oligonucleotides, thermostability and the ongoing crystal structure
studies of the RNAs containing 4-Se-uridine modification.
As showed in scheme 6.2, our synthesis started from the partially protected 2’TBDMS-5’-trityl-uridine 1 considering the following compatibility of RNA solid phase
synthesis. Considering the presence of bulky TBDMS group at the 2’ positioin, we
simplified here the synthesis route by using a relatively more chemoselective TIBS
(2,4,6-Triisopropylbenzenesulfonyl) group to activate position 4, in stead of the previous
trizaole group, thus avoiding the protection and deprotection steps for the 3’-hydroxyl
group. Without purifying this activated intermediate, the selenium functionality could be
introduced directly by the substitution of TIBS group at position 4 with sodium 2cyanoethylselenide in good yield, which was generated by the reduction of di-(2cyanoethyl) diselenide with NaBH4 in ethanol. This selenium functionality has been
proved to be well compatible with solid phase synthesis and can be removed by week
base treatment. Finally, the Se-uridine derivative 2 was converted to the corresponding
phosphoramidite 3 in a satisfied yield, although the reaction took much longer time
comparing the thymidine due to the TBDMS group. The experimental detail and
characterization of these two compounds are listed as following.
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Scheme 6.2: Concise Synthesis of 4-Se-Uridine Phosphoramidite (3) and 4-Se-U-RNAs.
Reagents and conditions: (a) TIBSCl, DMAP, CH2Cl2, r.t; (b) (NCCH2CH2Se)2/NaBH4,
EtOH,

r.t;

(c)

2-cyanoethyl

N,N-diisopropylchlorophosphoramidite

and

N,N-

diisopropylethylamine in CH2Cl2, 0 °C then r.t; (d) the solid phase synthesis. TIBSCl:
2,4,6-(Triisopropylbenzene)sulfonyl chloride.

4-(2-cyanoethyl)seleno-5’-O-(4,4’-dimethoxytriphenylmethyl) thymidine (2).
To a dry dichloromethane solution of the starting material compound 1 and 4,4’dimethylamino-pyridine

(DMAP)

under

argon,

was

dropwisely

added

the

dichloromethane solution of 2,4,6-Trisopropyl-Benzenessulfonyl chloride, followed by
several drops of triethyl amine. The system was stirred for one hour before this reaction
is finished (monitor by TLC, 5% methanol in dichloromethane). At the same time, the
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NaBH4 suspension (250 mg NaBH4 in 5 mL of EtOH) was injected into a flask containing
di(2-cyanoethyl) diselenide [(NCCH2CH2Se)2, 0.45 mL, d= 1.8 g/mL, 3.0 mmol] and
ethanol (8 mL) on an ice bath and under argon. The yellow color of the diselenide
disappeared in approximately 15 min, giving an almost colorless solution of sodium
selenide (NCCH2CH2SeNa). Then, the solution of compound 1 (1.34 g, 2 mmol) was
slowly injected into this solution. After the selenium incorporation was completed in 45
min, (monitored on TLC, 5% MeOH in CH2Cl2, product Rf = 0.68), water (100 mL) was
added to the reaction flask. The solution was adjusted to pH 7-8 using CH3COOH (10%),
and was then extracted with ethyl acetate (3 x 100 mL). The organic phases were
combined, washed with NaCl (sat., 100 mL), dried over MgSO4 (s) for 30 min., and
evaporated to minimum volume under reduced pressure. The crude product was then
dissolved in methylene chloride (5 mL) and purified on a silica gel column equilibrated
with hexanes/methylene chloride (1:1). The column was eluded with a gradient of
methylene chloride (CH2Cl2, 0.5%, 1%, and 2% MeOH in CH2Cl2, 500 mL each). After
solvent evaporation and dry on high vacuum, the pure compound (2) was obtained as a
slightly yellow foamy product (1.07 g, 81% yield). 1H-NMR (400 MHz, CDCl3) δ: 0.21 (s,
3H, CH3), 0.38 (s, 3H, CH3), 0.95 (s, 6H, 2x CH3), 2.31-2.37 (m, 1H, H-2’), 3.00 (dd, J =
6.5 and 6.7 Hz, 2H, CH2-Se), 3.37-3.41 (m, 2H, CH2-CN), 3.50-3.52 (m, 2H, 1H-5’), 3.81
(s, 6H, 2x OCH3), 4.17-4.22 (m, 1H, H-3’), 4.31 (s, 1H, 3’-OH), 4.40-4.50 (m, 1H, H-4’),
5.78 (s, 1H, H-1’), 5.90 (d, 1H, J=6.8 Hz, H-5), 6.8-6.90 (m, 4H, aromatic), 7.20-7.46 (m,
9H, aromatic), 8.31 (d, 1H, J=6.8 Hz, H-6).
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C-NMR (100 MHz, CDCl3) δ: -4.30, -4.40

(CH3), 18.09 (CH2-CN), 19.04 (CH2-CH2-CN), 20.45 ((CH3)2C(t-Bu)), 25.87 (CH3), 55.30
(OCH3), 68.67 (C-3’), 76.42 (C-2’), 83.14 (C-4’), 91.03 (C-1’), 106.0 (C-5), 118.8 (CN),
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113.3, 127.1, 128.0, 128.2, 130.1, 135.0, 135.3, 144.2, 158.73 (Ar-C), 140.4 (C-6),
153.3 (C-2), 175.0 (C-4). HRMS (MALDI-TOF): molecular formula, C39H46N3O7PSeSi;
[M+H]+: 776.2267 (calc. 776.2270).
4-(2-cyanoethyl)seleno-5’-O-(4,4’-dimethoxytriphenylmethyl)-thymidine3’-O-(2-cyanoethyl) diisopropylamino phosphoramidite (3).
To the flask (25 mL) containing 2 (453 mg, 0.68 mmol) under argon, dry methylene
chloride (2.5 mL), N,N-diisopropylethylamine (0.17 mL, 1.03 mmol, 1.5 eq.), and 2cyanoethyl N,N-diisopropyl-chlorophosphoramidite (195 mg, 0.83 mmol, 1.2 eq.) were
added sequentially. The reaction mixture was stirred at -10 °C in an ice-salt bath under
argon for 10 minutes, followed by removal of the bath. The reaction was completed in
45 minutes at room temperature (indicated by TLC, 5% MeOH in CH2Cl2, product Rf =
0.63 and 0.68), generating a mixture of two diastereisomers. The reaction was then
quenched with NaHCO3 (2 mL, sat.), stirred for 5 min, and the product was then
extracted with CH2Cl2 (3 x 5 mL). The combined organic layer was washed with NaCl
(10 mL, sat.) and dried over MgSO4 (s) for 20 min, followed by filtration. The solvent
was then evaporated under reduced pressure and the crude product was re-dissolved in
CH2Cl2 (2 mL). This solution was added drop-wise to petroleum ether (100 mL) under
vigorous stirring, generating a white precipitate. The petroleum ether solution was
decanted. The crude product was re-dissolved again in CH2Cl2 (2 mL) and then loaded
into an Al2O3 column (neutral) that was equilibrated with CH2Cl2/Hexanes (1:1). The
column was eluded with a gradient of methylene chloride and ethyl acetate [CH2Cl2 to
CH2Cl2/EtOAc (7:3)]. After solvent evaporation and dry over high vacuum, the pure 3
(538 mg) was obtained as a white foamy product (92% yield). 1H-NMR (400 MHz,
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CDCl3, two sets of signals from a mixture of two diastereomers) δ: 0.2-0.4 (m,12H, 4 x
CH3), 0.85-1.20 (m, 36H, 8x CH3-ipr and 4x Si(CH3)), 2.30-2.38 and 2.70-2.82 (2x m,
4H, 2x H-2’), 2.34 and 2.64 (2x t, J = 6.4 Hz, 4H, 2x O-CH2-CH2-CN), 3.00-3.04 (m, 4H,
2x Se-CH2-CH2-CN), 3.32-3.44 (m, 6H, 2x H-5’, 2x Se-CH2), 3.52-3.64 (m, 8H, 4x CHipr, 2x O-CH2-CH2-CN), 3.73-3.84 (m, 2H, 2x H-5’), 3.82 and 3.83 (2x s, 12H, 4x OCH3),
4.12-4.35 (m, 2H, 2x H-3’), 4.43-4.48 (m, 2H, 2x H-4’), 5.70-5.90 (m, 4H, 2x H-5 and 2x
H-1’), 6.83-6.88 (m, 8H, aromatic), 7.27-7.43 (m, 18H, aromatic), 8.30 and 8.39 (2x s,
2H, 2x H-6). HRMS (MALDI-TOF): molecular formula, C48H64N5O8PSeSi; [M+H]+:
978.3512 (calc. 978.3505.).

6.3.2 Preparation of RNA oligonucleotides containing 4-Se-U
Then this phosphoramidite was examined on the RNA solid-phase synthesis,
which usually is less facile and need more coupling time than DNA synthesis due to the
additional sterically protected 2’-hydroxyl group. In this work, the ultramild CE
phosphoramidites protected with widely used (tert-butyl)-dimethylsilyl (TBDMS) group
were selected due to the instability of selenium functionality under strong base cleavage,
as well as 5-benzylmercapto-1H-tetrazole as the activating reagent. As expected, this
modified residue is compatible with the long coupling reaction (12 min), I2 oxidation and
trichloroacetic acid treatment to remove 5’-DMTr group, without causing deselenization.
When the oligonucleotides contain many guanosine residues, phenoxyacetic anhydride
(Pac2O), instead of acetic anhydride is used in the capping step to avoid the G
acetylation, which is difficult to remove under mild K2CO3 condition. All the RNA
oligonucleotides were synthesized as DMTr-on form. After synthesis, they were cleaved

134

and partially deprotected by 0.05 M K2CO3 solution in methanol for 8h. The solution was
neutralized with 1M HCl and evaporated to dryness, then all the 2’-TBDMS groups were
removed by 1M TBAF solution in THF for overnight. After desalting using SephadexG25, the pure RNA oligoes (MALDI-MS listed in Table 6.4) were obtained by RP-HPLC
purification, followed by the detritylation and precipitation. A typical MS analysis is
shown in Figure 6.8. Similar as 4-Se-Thymidine, these base modified RNAs also
present yellow color with the same UV absorption at 368 nm.

Table 6.4: MALDI-MS analysis of RNAs containg 4-Se-U.

Entry

Selenium oligonucleotides

Measured (calcd) m/z

1

5’-GU(4-Se)GUACAC-3’

[M+H]+: 2573.3

2

5’-GUGU(4-Se)ACAC-3’

[M+H]+: 2573.3

3

5’-CGCGAAU(4-Se)UCGCG-3’
C114H143N46O81P11Se: FW 3873.3

[M+H]+: 3873.3
(3874.3)

4

5’-CGCGAAUU(4-Se)CGCG-3’
C114H143N46O81P11Se: FW 3873.3

[M+H]+: 3873.3
(3874.3)

5

5’-UU(4-Se)AUAUAUAUAUAA-3’
C133H162N49O95P13Se: FW 4448.6

[M+H]+: 4449.7
(4449.6)

6

5’-AAU(4-Se)AU(2’-Se)AUAUAUAUU-3’
C134H164N49O94P13Se2: FW
4525.6
(4-Se)
AUUGCGGUACC-3’
5’-GGU
C133H165N52O97P13Se: FW 4525.7

[M+H]+: 4526.4
(4526.6)

7

[M+H]+: 4526.4
(4526.7)
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Figure 6.8: MALDI-TOF mass spectrum of 4-Se-U-RNA and its UV-spectrum. 5’-rGG
U(4-Se)AUUGCGGUACC-3’, C133H165N52O97P13Se, [M+H]+: 4526.4 (Calcul. 4526.7).

6.3.3 Thermal denaturalization study
Again, the thermal denaturalization study was also carried out using a RNA
14mer as model. Similar as 4-Se-T-DNA, comparing the native counterpart, there is no
obvious difference was observed for the 4-Se-U containing RNA, as showed in figure
6.9, which indicates no obvious structure perturbation.
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A: 5’-rUUAUAUAUAUAUAA-3’
Tm=38.0 ±0.6 ºC

B: 5’-rUUAU(4-Se)AUAUAUAUAA-3’
Tm=37.3 ±0.6 ºC

Figure 6.9: Tm studis of Se-U 14mer RNA comparing with native RNA.

6.3.4 Crystallization and structure studies
After the preliminary confirming of the structural isomorphism by Tm study with
several RNA models, we have also successfully crystallized two RNA sequences
containing this modified 4-Se-U residue (5’-rGUGUSeACAC-3’ and 5’-rUUAU(4Se)AUAUAUAUAA-3’) through nucleic acids mini-screen conditions and Natrix buffer
(also from Hampton Res.) within a week. Although the crystal qualities is not as perfect
as the our previous ones (indicated by the rough surfaces of the RNA crystals
comparing the shining and flatter ones), we still collected several data sets from
beamline X-12B of brookhaven national laboratory with acceptable resolution (from 2.5
to 2.9 Å), the typical crystal pictures were showed in figure 6.10. Although the structure
determination work hasn’t been done till the writing of this dissertation, the obvious
yellow color of these types of crystal gives a signal that it can be potentially used as a
probe of detecting RNA-protein complex.
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(A)

(B)

(C)
Figure 6.10: Crystals photos of 4-Se-U containing RNAs (A, B) and the X-ray exposure of
crystal (C).

6.4 Conclusion of this chapter
In summary, we have synthesized the 4-Se thymidine and 4-Se uridine
phosphoramidite, and incorporated them into DNA and RNA oligonucleotides with

138

quantitative yields. The Se substitution on the nucleobase is relatively stable under the
elevated temperature. By the UV-melting and crystal structure studies, we have further
demonstrated that the O substitution with Se on the nucleobase does not cause the
significant duplex structure perturbation (the RNA case is still to be confirmed). The
crystal structure study also reveals the accommodation of the large Se atom on the
thymine by the DNA duplex and the formation of the Se-mediated hydrogen bond within
the T-A base pair. This work will stimulate the studies on the Se substitution on other
nucleobases and positions, opening a new avenue for further exploring the base-paring
selectivity governed by the hydrogen bond and base shape, the duplex structure and
flexibility, the DNA replication efficiency and fidelity, and the polymerase recognition of
the modified nucleobases, as well as the RNA structural and functional research.
Moreover, the Se derivatization on the nucleobases will largely facilitate X-ray crystal
screen and structure determination of protein-nucleic acids complexes.
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7.

SYNTHESIS OF 2’-TELLURIUM MODIFIED URIDINE AND THYMIDINE FOR
NUCLEIC ACID STRUCTURE AND FUNCTION STUDIES

7.1 Introduction
The increasing application of selenium as anormalous scattering center in both
protein and nucleic acids X-ray crytallogarphy studies have also gained our attention to
its downstair neighbour of element periodic table: Tellurium.
As a chalcogen element, tellurium follows sulfur and selenium in elemental group
VI of the periodic table. Tellurium has a larger covalent radius (1.35 Å), compared with
selenium (1.17 Å), sulfur (1.02 Å) and oxygen (0.73 Å) (their van der Waals radius is
2.06, 1.90, 1.80 and 1.52 Å respectively). Probably due to its matallic property and
weak covalent bonds with carbon and hydrogen, so far, no tellurium functionality has
been discovered in any natural biological molecules. Usually, it’s used in alloys with
other metals to improve the strength and durability, and to decrease the corrosive action
of acids; tellurium is also a p-type semiconductor that shows a greater conductivity in
certain directions which depends on atomic alignment, so, it has a wider application in
electronic and optical industry. (120)
In 1989, tellurium was successfully incorporated into proteins through Te-resistant
fungi grown in the presence of tellurite on a sulfur-free medium. Later, the Temethionine derivatization for protein structure determination was investigated and
developed as a similar exploration of Se-Met strategy. In principle, the electronic and
atomic properties of tellurium are ideal to generate clear signals in the isomorphous and
anomalous difference Patterson maps using just the common in-house X-ray diffraction
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facility (Cu, Kα wavelength: 1.54 Å). Therefore, a synchrotron facility is not necessary to
collect X-ray diffraction data of the Te-derivatized protein crystals. This Te-derivatization
strategy is a promising alternative to the conventional multiple isomorphous
replacements (MIR) by the soaking procedures. With the guidance of this direction,
Boles and co-workers reported in 1994 the expression of telluromethionine (TeMet)
dihydrofolate reductase, and the Te-incorporation technique was further optimized to
efficiently introduce TeMet into several proteins. Furthermore, the Te-protein stability
under the X-ray exposure and the isomorphism of Te-proteins were also confirmed. At
the same time, more and more tellurium chemistry has also been developed.
However, the facile oxidation of telluromethionine was also found to present a
serious drawback for the further use of this methionine analogue for bioexpression of
heavy atom variants of proteins, since oxidized forms were difficult to refold from
inclusion bodies or to crystallize. In particular, surface-located and, in a more
pronounced manner, solvent-exposed Tem residues were found to oxidize readily and
thus to generate electron densities of difficult assignment and local non-isomorphism.
Nonetheless, telluromethionine represents a heavy atom Met analogue well suited for
isomorphous replacements in proteins. Although tellurium has a lower electronegativity
and larger coordination-sphere radius than sulfur and selenium and the C–Te bonds are
larger than Se–C and S–C (2.4 Å comparing with 1.95 and 1.82 Å), the plasticity of
proteins still could allow for accommodation of the tellurium atoms without significantly
affecting the native structures. In terms of structure stability in solution, it was found that
the per-telluromethionine-variant of annexin V was less stable than the related wild-type
protein and the selenomethionine-variant.
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Comparing the unstability of TeMet in protein, it’s possible to make the tellurium
centers more stable in nucleic acids, and our success in selenium-derivatization of
nucleic acids also naturally encourages us to take advantage of tellurium and develop
tellurium-derivatized nucleic acids (TeNA) for structure and function studies. We
initiated our projects aiming at overcoming the tellurium stability issues and their
compatibility with nucleic acid solid phase synthesis. As the proof of principle, this
chapter will report, the first synthesis of 2’-Te derivatized uridine, thymidine, their
according phosphoramidites and oligonucleotides containing tellurium functionalities
(Figure 7.1).

+

H3N

H
C

COO-

CH2

5' end
O

B

O

CH2
X

O

CH3

3'end

1a: X=S: Methionine
1b: X=Se: Se-Met
1c: X=Te: Te-Met

X

2a: X=Se: 2'-Se-DNA or RNA
2b: X=Te: 2'-Te-DNA or RNA

Figure 7.1: Selenium and tellurium derivatized methionine and oligonucleotide.

7.2 Novel tellurium induced addition-elimination for anti-HIV drug d4T synthesis
Our previous studies of the nucleic acids derivatized with selenium at 2’-position of
uridine and thymidine have revealed that the 2’-Se-modification does not cause
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significant perturbation of DNA and RNA structures. Thus, the 2’ position became our
starting point to synthesize Te-functionalized DNA. As showed in Scheme 7.1, the 5’DMTr-2,2’-anhydrouridine was chosen as the starting materials which were synthesized
previously. Similar as selenium work, the tellurium functionalities were designed to be
introduced by a SN2 reaction of methyl telluride ion, which was generated through the
reduction of dimethyl ditelluride by sodium borohydride. But to our surprise, instead of
the target compound, there was only the base elimination product 6 formed. Then, the
acetylation step was carried out to protect the 3’-hydroxyl group (compound 7), as a
result, 5’-DMTr-d4U (8) was the major product in dimethyl ditelluride experiment, which
could be further detritylated to d4U, an analog of anti-HIV drug.

O
N
DMTr

O

O

N

O

MeTeTeMe
NaBH4

DMTr

O
O

92%

OH

OH

6

3a
AcOAc Et3N

O

O

N
DMTr

O

O
O

HN
N

MeTeTeMe
NaBH4
90%

DMTr

O

O

N

O

OAc
7

8

Scheme 7.1: Elimination reactions resulted from the presence of MeTeTeMe and NaBH4.
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Moreover, it was also found that catalytic amount (10%) of dimethyl ditelluride was
enough to finish this elimination conversion, without which there was only hydrolyzed
products observed. However, the amount of NaBH4 seemed very important to the
reaction, in absence of NaBH4, there was no reaction happened, which meant that the
effective part of the tellurium reagent was the reduced tellurium ion form; on the other
hand, the more it was used, the more hydrolyzed compounds formed, thus the lower the
yields were, probably due to the resulted strong basic solution. Finally, the same
amount of sodium borohydride as dimethyl ditelluride (usually 0.5 equiv) was found a
good condition to obtain both acceptable reaction rates and yields.
Inspired by that, several attempts were carried out to check the universe of this
strategy. A general synthetic route was described in scheme 7.2, starting from uridine
(11a) and ribothymidine (11b), which were cyclized to the according 2,2’anhydronucleosides before the different protecting groups (including benzyl, trityl, acetyl
and their combinations) were introduced into 3’ and 5’ positions to generate compounds
13a-f. The further treatment of dimethyl ditelluride and NaBH4 in the mixed solution of
THF with ethanol at 50 °C for 3-5 hours could generated the according 5’-protected
intermediate 9a-d in moderate to good yields (69-89%) (Table 7.1), which gave the final
compounds d4U and d4T by the following deprotection steps. Since the 2’,3’dideoxynucleosides (ddNs) and 2’,3’-didehydro-2’,3’-dideoxynucleosides (d4Ns) are
FDA-approved anti-HIV drugs, our accidently discovered novel telluride-mediated high
yield elimination reaction has potential to simplify the conventional synthesis of these
compound and further reduce the cost of AIDS treatment and will also facilitate
development of novel d4N and ddN analogs.
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Scheme 7.2: The novel synthetic route of d4U and d4T with different derivatives. (i)
diphenolcarbonate, DMF, 100 °C; 12a: 85%. 12b: 83%. (ii) 13a, 13b: Dimethoxytrityl
chloride, acetic anhydride, Py, r.t. 87%. 13c: acetic anhydride, py, r.t. 89%. 13d: benzoyl
chloride, py, 75%. (iii) dimethyl ditelluride, NaBH4, THF:EtOH=7:1, 50 °C; 9a: 87%. 9b:
90%. 9c: 83%. 9d: 79%. (iv) Dowex 50 W for 9a, 9b, or NH4OH, CH3OH for 9c and 9d,
90-92%.

Table 7.1: Synthesis of d4U and d4T derivatives.
R2
R
Products Yield (%)
Substrates R1
13a
H DMTr
Ac
9a
90
13b
CH3 DMTr
Ac
9b
85
13c
H
Ac
Ac
9c
80
13d
H
Bz
Bz
9d
69
13e
H DMTr DMTr
None
None
13f
H DMTr MOM
None
None
13g
H DMTr
H
10
92
* DMTr: dimethoxytrityl; MOM: methoxymethyl.
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7.3 Preparation of 2’-Te functionalized nucleosides and DNAs
7.3.1 Synthesis of 2’-Te -U, T and the phosphoramidites
As stated above, due to the early synthetic challenges caused by the 1’,2’ and
2’,3’ elimination using dimethylditelluride, we decided turn our attention to pursue the
Te-incorporation with diphenylditelluride first (Scheme 7.3), the electron withdrawing
ability of which could also make the tellurium center more stable, preventing being
oxidized. It turned out that the diphenylditelluride reagent is much easier to be reduced
with sodium borohydride in dry THF at room temperature. The ring opening reaction
underwent well at 50 °C with a a satisfied yield, indicating that the tellurium nucleophile
center is still electron-rich enough to attack the 2’-position from the α face. The
generated key intermediates 4a and 4b were successfully converted to the
corresponding phosphoramidites 5a and 5b in high yields by following the standard
protocol.
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Scheme 7.3: Synthesis of 2’-TePh-5’-DMTr-uridine (5a), thymidine phosphoramidite.

146

At the same time, considering that the possible potential structure perturbation of
the duplex structures caused by the bulky phenyl group at the minor groove, we still
made more efforts targeting the dimethylditelluride after the success of phenyl one. As
stated above, since it is difficult to reduce dimethylditelluride efficiently with certain
amount of sodium borohydride even at an elevated temperature, which probably is due
to the relatively higher instability of methyl telluride moity, a stronger reducing reagent
LiAlH4 was applied in this work (Scheme 7.4). However, only trace amount of the
desired compound (9) was observed initially, while the base elimination compound was
still the major by-product. In order to minimize its formation and enhance the
methyltelluride reactivity, we decided to run the telluride incorporation at a lower
temperature (0 °C) in presence of crown ether (12-crown-4) to chelate lithium ions.
Fortunately but not sufficiently, we were able to obtain the desired product in 47% yield,
while the 1’,2’-eliminated product was still formed as the major by-product, we also
played with the various temperature, concentration, solvents and the reaction time, but
no further optimized conditions were successful identified so far. The characteristic
chemical shift of the Te-methyl group was observed at -21.2 ppm in

13

C-NMR spectrum,

which indicated the real incorporation of the methyl telluride group. Moreover, the
tellurium isotope distributions in the HR-MS spectra also provided the supplemental
proof of the TeMe existance. The isolated key intermediates 9a and 9b were then
successfully converted to the corresponding phosphoramidites 10a and 10b in high
yields by following the standard protocol and they were found to be stable to the basic
conditions and not to disturb the reactivity of the 3’-hydroxyl group. All the detailed
experimental information and compound identification are listed as following.
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Scheme 7.4: Synthesis of 2’-TeMe-5’-DMTr-uridine (10a), thymidine phosphoramidites
(10b) and the 2’-TeMe functionalized DNAs.

2’-deoxy-2’-phenyltellanyl-5’-O-(4,4’-dimethoxytrityl)-uridine

(4a)

and

2’-deoxy-2’-

phenyltellanyl-5’-O-(4,4’-dimethoxytrityl)-5-methyluridine (4b):
To a stirred suspension of NaBH4 (6.2 mg, 0.15 mmol) in anhydrous THF (5 mL), under
argon at 0 °C, the THF solution of diphenylditelluride (0.2 g, 0.5 mmol in 5 mL) was
added, followed by several drops of dry ethanol until bubble formed and the solution
turned colorless. To this solution the starting material 3a and 3b (0.285 g and 0.292g
separately, 0.5 mmol, dissolved in 5 mL of THF) was added and the reaction was slowly
warmed up to room temperature and then into 50 ºC for three hours, which monitored
by TLC. The solvent was then evaporated. The residue was dissolved in CH2Cl2 (20 mL)
and washed with water (3 x 20 mL). The CH2Cl2 solution was dried (MgSO4),
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concentrated and the crude product was purified by silica gel column chromatography
with 0-3% methanol in CH2Cl2 to give compound 4a and 4b as slight yellow solid (4a:
310 mg, 80% yield, 4b: 292mg, 78% yield). 4a: 1H NMR (400 MHz, CDCl3, 25 ºC):
δ=3.45-3.46 (m, 2H), 3.82 (s, 3H), 3.92-3.95 (m, 1H), 4.24 (m, 1H), 4.54-4.57 (m, 1H),
5.12 (d, J = 8 Hz, 1H), 6.63 (d, J = 9.2 Hz, 1H), 6.81-6.86 (m, 4H), 7.19-7.37 (m, 12H),
7.45 (d, J = 8 Hz, 1H), 7.82 (m, 2H);

13

C NMR (100 MHz, CDCl3, 25 ºC): δ=36.9, 55.3,

63.9, 85.5, 87.2, 91.6, 102.5, 109.6, 113.3, 127.2, 127.8, 128.1, 128.1, 128.7, 129.5,
130.1, 135.2, 140.2, 144.2, 150.2, 158.7, 162.7; HRMS: m/z : calcd for C36H34N2O7TeNa:
759.1326, found: 759.1316 [M+Na]+. 4b: 1H NMR (400 MHz, CDCl3, 25 ºC): δ=1.21 (s,
3H), 3.35-3.52 (m, 2H), 3.81 (s, 6H), 3.98-4.01 (m, 1H), 4.22 (m, 1H), 4.55 (m, 1H), 6.69
(d, J = 10 Hz, 1H), 6.81-6.84 (m, 4H), 7.16-7.35 (m, 15H), 7.83 (m, 2H), 8.17 (b, 1H);
13

C NMR (100 MHz, CDCl3, 25 ºC): δ=11.5, 36.8, 55.3, 63.9, 85.2, 87.2, 91.0, 109.5,

111.3, 113.3, 127.2, 128.0, 128.1, 128.6, 129.6, 130.1, 135.0,135.2, 140.3, 144.2, 150.4,
158.8, 163.1; HRMS: m/z : calcd for C37H36N2O7TeNa: 773.1477, found: 773.1475
[M+Na]+.
2’-phenyltellanyl-5’-O-(4,4’-dimethoxytriphenylmethyl)-uridine

3’-O-(2-cyanoeth

yl)

diisopropylamino phosphoramidite (5a) and 2’-phenyltellanyl-5’-O-(4,4’-dimethoxytri
phenylmethyl)-5-methyluridine 3’-O-(2-cyanoethyl) diisopropylamino phosphoramidite:
To the flask (25 mL) containing 4a or 4b (500 mg and 510 mg seperately, 0.68 mmol)
under argon, dry methylene chloride (2.5 mL), N,N-diisopropylethylamine (0.17 mL, 1.03
mmol, 1.5 eq.), and 2-cyanoethyl N,N-diisopropyl-chlorophosphoramidite (195 mg, 0.83
mmol, 1.2 eq.) were added sequentially. The reaction mixture was stirred at -10 °C in an
ice-salt bath under argon for 10 minutes, followed by removal of the bath. The reaction
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was completed in 45 minutes at room temperature (indicated by TLC, 5% MeOH in
CH2Cl2), generating a mixture of two diastereisomers. The reaction was then quenched
with NaHCO3 (2 mL, sat.), stirred for 5 min, and the product was then extracted with
CH2Cl2 (3 x 5 mL). The combined organic layer was washed with NaCl (10 mL, sat.) and
dried over MgSO4 (s) for 20 min, followed by filtration. The solvent was then evaporated
under reduced pressure and the crude product was re-dissolved in CH2Cl2 (2 mL). This
solution was added drop-wise to petroleum ether (200 mL) under vigorous stirring,
generating a white precipitate. The petroleum ether solution was decanted carefully. The
crude product was re-dissolved again in CH2Cl2 (2 mL) and then loaded into an Al2O3
column (neutral) that was equilibrated with CH2Cl2/Hexanes (1:1). The column was
eluded with a gradient of CH2Cl2 to CH2Cl2/EtOAc (7:3). After solvent evaporation and
dry over high vacuum, the pure 5a and 5b (570 mg) were obtained as a white foamy
products (88-90% yield). 5a: 1H NMR (400 MHz, CDCl3, 25 ºC): δ=1.13-1.35 (m, 24H),
2.37 and 2.68 (2x t, J=6.4Hz, 4H), 3.38-3.69 (m, 12H), 3.83 (s, 12H), 3.90-4.03 (m, 2H),
4.32 and 4.38 (2x m, 2H), 4.67-4.82 (m, 2H), 4.95 and 5.00 (2x d, J=8 Hz, 2H), 6.73 and
6.75 (2x d, J=5.8 Hz, 2H) , 6.83-6.86 (m, 8H), 7.16-7.37 (m, 26H), 7.76 (br, 2H), 7.817.85 (m, 4H);

13

C NMR (100 MHz, CDCl3, 25 ºC): δ=20.13, 20.20, 20.44, 20.51, 24.50,

24.61, 24.69, 25.23, 33.85, 34.43, 43.36, 43.40, 43.49, 43.52 , 55.29, 57.68, 57.87,
59.04, 59.23, 63.58, 63.73, 74.91 and 75.09, 84.97, 87.29, 89.38, 111.69, 113.46,
117.29, 126.99, 127.81, 128.54, 130.21, 130.42, 135.22, 135.40, 135.44, 144.10,
150.37, 158.85, 163.34;

31

P NMR (160 MHz, CDCl3, 25 ºC): δ=148.6, 149.2; HRMS:

m/z : calcd for C45H52N4O8PTe: 937.2579, found: 937.2578 [M+H]+. 5b: 1H NMR (400
MHz, CDCl3, 25 ºC): δ=1.10-1.42 (m, 24H), 2.34 and 2.66 (2x t, J=6.4Hz, 4H), 3.35-3.69
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(m, 12H), 3.83 (s, 12H), 3.92-4.05 (m, 2H), 4.31 and 4.37 (2x m, 2H), 4.65-4.82 (m, 2H),
6.71 and 6.74 (2x d, J=5.8 Hz, 2H) , 6.84-6.86 (m, 8H), 7.16-7.37 (m, 26H), 7.77 (br,
2H), 7.80-7.84 (m, 4H);

13

C NMR (100 MHz, CDCl3, 25 ºC): δ=11.69, 20.12, 20.22,

20.43, 20.53, 24.49, 24.60, 24.67, 25.24, 33.85, 34.43, 43.37, 43.40, 43.49, 43.53 ,
55.27, 57.67, 57.88, 59.05, 59.25, 63.57, 63.74, 74.92 and 75.09, 84.97, 87.27, 89.38,
111.68, 113.45, 117.28, 126.98, 127.81, 128.54, 130.20, 130.39, 135.24, 135.38, 135.42,
144.11, 150.35, 158.87, 163.36; 31P NMR (160 MHz, CDCl3, 25 ºC): δ=148.4, 149.3;
HRMS: m/z : calcd for C46H53N4O8PTeNa: 973.2561, found: 973.2560 [M+Na]+.
(R)-5-(4,4’-dimethoxytrityloxymethyl)-2,3-dihydrofuran-4-ol (6):
To a stirred suspension of NaBH4 (12 mg, 0.3 mmol) in dry THF (5 mL), under argon,
dimethyl ditelluride (0.05 mL, 0.3 mmol) was added, followed by several drops of dry
ethanol until bubble formed. The suspension was heated to 50 °C, followed by the
addition of THF solution of starting material 3a (320 mg, 0.6 mmol). The mixture was
heated for three hours at this temperature under argon. The solvent was then
evaporated and the residue was dissolved in CH2Cl2 (20 mL) and washed with water (3
x 20 mL). The CH2Cl2 layer was dried MgSO4, concentrated and the residue was
purified by silica gel column chromatography with pure CH2Cl2 to give compound 6 as
white solid (230 mg, 92% yield). 1H NMR (400 MHz, CDCl3, 25 ºC): δ=3.18-3.22 (m, 2H),
3.81 (s, 3H), 4.44-4.49 (m, 1H), 4.79-4.81 (m, 1H), 5.20-5.21 (m, 1H), 6.62-6.63 (m, 1H),
6.84-6.86 (m, 4H), 7.23-7.46 (m, 9H,), 7.85 (d, J = 7.6 Hz, 1H);

13

C NMR (100 MHz,

CDCl3, 25 ºC):δ=55.2, 63.7, 76.2, 86.0, 88.3, 103.3, 113.1, 126.8, 127.8, 128.1, 130.1,
136.0, 144.8, 150.3, 158.5; HRMS: m/z : calcd for C26H25O5: 417.1702, found: 417.1708
[M-H]-.
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2,2’-Anhydro-1-[2’-deoxy-3’-acetyl-5’-O-(4,4-dimethoxytrityl)-β-D-arabino

furanosyl]-

uracil (7):
To a solution of 3a (320 mg, 0.6 mmol) in THF, acetic anhydride (0.19 mL, 2 mmol) was
added, followed by several drops of triethylamine. The mixture was stirred at 50 degree
for further 45 minutes (monitored by TLC, 5% MeOH in CH2Cl2) before quenched by
methanol (4 mL). The solvent were removed under reduced pressure and the residue
was re-dissolved in CH2Cl2 (40 mL). The suspension was washed with sodium
bicarbonate (sat., 2 x 15 mL) and sat. brine (2 x 15 mL). The organic layer was dried
over MgSO4 (s), concentrated under reduced pressure, and the resulting residue was
subjected to silica gel chromatography (0-5% MeOH in CH2Cl2) to give 7 (291 mg, 85 %
yield) as white solids. 7: 1H NMR (400 MHz, CDCl3, 25 ºC): δ=2.14 (s, 3H), 2.99-3.06 (m,
2H), 3.81 (s, 6H), 4.45 (m, 1H), 5.30-5.32 (m, 1H), 5.40 (m, 1H), 5.86 (d, J = 7.6 Hz, 1H),
6.27 (d, J = 5.6 Hz, 1H), 6.80-6.83 (m, 4H), 7.21-7.35 (m, 10H);

13

C NMR (100 MHz,

CDCl3, 25 ºC): δ=20.7, 55.3, 62.6, 77.0, 85.8, 86.3, 86.6, 90.4, 110.2, 113.3, 127.1,
128.0, 129.8, 135.2, 144.1, 158.6, 134.5, 159.1, 169.4, 171.2; HRMS: m/z : calcd for
C32H31N2O8: 571.2080, found 571.2080 [M+H]+.
5’-O-(4,4-dimethoxytrityl)-2’,3’-didehydro-2’,3’-dideoxyuridine (8):
To a stirred suspension of NaBH4 (12 mg, 0.3 mmol) in anhydrous THF (5 mL), under
argon, dimethyl ditelluride (0.05 mL, 0.3 mmol) was added, followed by several drops of
dry ethanol until bubbles were formed. The suspension was heated to 50 °C, and the
THF solution of the starting material 7, (170 mg, 3 mmol) was added. The reaction
completed in 3 hours, which monitored by TLC. Then the solvents were evaporated and
the residue was dissolved in CH2Cl2 and washed with water. The organic solution was
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dried over MgSO4 and concentrated. The crude product was purified by silica gel
column chromatography with 0-3% methanol in CH2Cl2 to give 90% yields of 8. 1H NMR
(400 MHz, CDCl3, 25 ºC): δ= 3.47-3.48 (m, 2H), 3.82 (s, 3H), 4.97-4.98 (m, 1H), 5.06 (d,
1H, J = 7.6 Hz), 5.89-5.91 (m, 1H), 6.35-6.37 (m, 1H), 6.84-6.86 (m, 4H), 7.05 (d, J =
2.0 Hz, 1H), 7.27-7.38 (m, 9H), 7.85 (d, J = 7.6 Hz, 1H);

13

C NMR (100 MHz, CDCl3, 25

ºC): δ=55.4, 64.2, 86.1, 86.9, 89.6, 102.2, 113.2, 127.1, 127.8, 127.4, 129.1, 130.20,
150.6, 127.1, 134.6, 141.4, 150.6, 158.6, 163.2; HRMS: m/z : calcd for C30H27N2O6:
511.1869, found 511.1868 [M-H]-.
2’-deoxy-2’-methyltellanyl-5’-O-(4,4’-dimethoxytrityl)-uridine

(9a)

and

2’-deoxy-2’-

methyltellanyl-5’-O-(4,4’-dimethoxytrityl)-5-methyluridine (9b):
To a THF solution of dimethyl ditelluride (CH3TeTeCH3, 0.2 ml, 1.1 mmol, in 10 mL of
THF) located in an ice bath under argon, was added 1M THF solution of LiAlH4 (0.55
mmol) in 5 min. After the solution turned to slightly yellow, 12-crown-4 (0.6 mmol, 0.1
mL) was added and the mixture was stirred at 0 °C for further 20 min before the starting
material 3a and 3b (0.57g and 0.58 g respectively in THF, 1.0 mmol) was added
dropwisely. The reaction was monitored by TLC (5% CH3OH in CH2Cl2) and it was
found that the yield reached maximum in 4-5 hours before it dropped again by the
generation of compound 6. The reaction was quenched by adding 10 mL of saturated
sodium chloride, followed by adding 10 mL of CH2Cl2, the organic solvent was further
washed, dried over anhydrous MgSO4 and removed under reduced pressure. The
residue was then purified by a silica gel column (equilibrated with CH2Cl2) eluted with a
methanol/methylene chloride gradient (CH3OH in CH2Cl2, 0-3%) to afford the pure
foamy product 9a and 9b in 40%-47% yield. 9a: 1H NMR (400 MHz, CDCl3, 25 ºC):
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δ=2.0 (s, 3H), 2.5 (s, 1H), 3.52 (dd, J1=2.8 Hz, J2=7.2Hz, 2H), 3.69 (t, J= 4 Hz, 1H),
3.82 (s, 6H), 4.21-4.23 (m, 1H), 4.31-4.36 (m, 1H), 5.40 (d, J=8.4 Hz, 1H), 6.33 (d, J=
8.4Hz, 1H) , 6.86-6.88 (m, 4H), 7.26-7.39 (m, 9H), 7.77 (d, J=8.4 Hz, 1H), 8.38 (br, 1H);
13

C NMR (100 MHz, CDCl3, 25 ºC): δ=-21.2, 33.35, 55.29, 63.37, 73.75, 84.51, 87.29,

89.90, 102.73, 113.35, 127.28, 128.07, 130.08, 135.12, 139.77, 144.20, 150.23, 158.79,
162.64; HRMS: m/z : calcd for C31H31N2O7Te: 673.1194, found: 673.1204 [M-H]-. 9b: 1H
NMR (400 MHz, CDCl3, 25 ºC): δ=1.43 (s, 3H), 1.99 (s, 3H), 3.47 (dd, J1=1.6 Hz, J2=
9.6Hz, 2H), 3.70-3.74 (m, 1H), 3.82 (s, 6H), 4.24-4.25 (m, 1H), 4.36-4.37 (m, 1H), 6.37
(d, J=9.2 Hz, 1H), 6.85-6.87 (m, 4H), 7.26-7.40 (m, 9H), 7.60 (s, 1H), 8.03 (br, 1H);

13

C

NMR (100 MHz, CDCl3, 25 ºC): δ=-20.8, 11.71, 33.11, 55.29, 63.86, 74.62, 84.64, 87.19,
89.90, 111.75, 113.32, 127.29, 128.09, 129.14, 135.20, 135.16, 144.21, 150.48, 158.82,
163.41; HRMS: m/z : calcd for C32H33N2O7Te: 687.1350, found: 687.1354 [M-H]-.
2’-methyltellanyl-5’-O-(4,4’-dimethoxytriphenylmethyl)-uridine

3’-O-(2-cyanoethyl)

diisopropylamino phosphoramidite (10a) and 2’-methyltellanyl-5’-O-(4,4’-dimethoxy
triphenylmethyl)-5-methyluridine-3’-O-(2-cyanoethyl) diisopropylamino phosphoramidite:
To the flask (25 mL) containing 9a or 9b (230 mg and 234 mg seperately, 0.34 mmol)
under argon, dry methylene chloride (2.5 mL), N,N-diisopropylethylamine (0.1 mL, 0.51
mmol, 1.5 eq.), and 2-cyanoethyl N,N-diisopropyl-chlorophosphoramidite (120 mg, 0.51
mmol, 1.5 eq.) were added sequentially. The reaction mixture was stirred at -10 °C in an
ice-salt bath under argon for 10 minutes, followed by removal of the bath. The reaction
was completed in 45 minutes at room temperature (indicated by TLC, 5% MeOH in
CH2Cl2), generating a mixture of two diastereisomers. The reaction was then quenched
with NaHCO3 (2 mL, sat.), stirred for 5 min, and the product was then extracted with
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CH2Cl2 (3 x 5 mL). The combined organic layer was washed with NaCl (10 mL, sat.) and
dried over MgSO4 (s) for 20 min, followed by filtration. The solvent was then evaporated
under reduced pressure and the crude product was re-dissolved in CH2Cl2 (2 mL). This
solution was added drop-wise to petroleum ether (200 mL) under vigorous stirring,
generating white precipitate. The petroleum ether solution was decanted. The crude
product was re-dissolved again in CH2Cl2 (2 mL) and then loaded into an Al2O3 column
(neutral) that was equilibrated with CH2Cl2/Hexanes (1:1). The column was eluded with
a gradient of methylene chloride and ethyl acetate [CH2Cl2 to CH2Cl2/EtOAc (7:3)]. After
solvent evaporation and dry over high vacuum, the white 10a and 10b was obtained as
a white foamy product (88-90% yield). 10a: 1H NMR (400 MHz, CDCl3, 25 ºC): δ=0.851.38 (m, 24H), 1.98 and 1.99 (2x s, 6H), 2.41 and 2.67 (2x t, J=7.6Hz, 4H), 3.42-3.69 (m,
12H), 3.83 (s, 12H), 3.89-4.05 (m, 4H), 4.22 and 4.30 (2x m, 2H), 4.57-4.77 (m, 2H),
6.43 and 6.55 (2x d, J=8.6 Hz, 2H) , 6.80-6.92 (m, 8H), 7.16-7.45 (m, 18), 7.78 and 7.79
(s, 2H);

13

C NMR (CDCl3, 25 ºC): δ=-21.32, 19.16, 19.66, 20.88, 24.81, 24.44, 43.30,

43.46, 46.34, 47.53, 51.47 and 51.85, 55.62, 57.03, 58.39, 62.52, 73.36, 73.67, 84.57,
87.35, 88.12, 103.39, 113.42, 117.28, 127.21, 127.94, 128.36, 130.19, 130.25, 135.17,
135.38, 139.53, 144.20, 150.42, 158.80, 163.19.

31

P NMR (160 MHz, CDCl3, 25 ºC):

δ=148.5, 149.2; ESI-TOF: m/z calcd for C40H48N4O8PTe: 873.2272, found 873.2264.
10b: 1H NMR (400 MHz, CDCl3, 25 ºC): δ= 0.89-1.42 (m, 24H), 1.40 (2x s, 6H), 2.10 (2x
s, 6H), 2.42 and 2.69 (2x t, J =7.8 Hz, 4H), 3.48 -3.72 (m, 12H), 3.82 (s, 12H), 3.904.05 (m, 2H), 4.22 and 4.31 (2x m, 2H), 4.58-4.72 (m, 2H), 6.42 (d, J =8.6 Hz, 2H),
6.79-6.92 (m, 8H), 7.20-7.45 (m, 18H), 7.62 (2x s, 2H), 8.25 (br, 2H); 13C NMR (100
MHz, CDCl3, 25 ºC): δ=-21.32, 4.58, 4.72, 20.13, 20.16, 20.48, 20.55, 22.52, 24.39,
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24.47, 24.59, 24.68, 24.76,24.83, 43.21, 43.32, 43.34, 43.41, 46.35, 46.42, 47.37, 47.42,
50.36, 55.32, 63.29, 63.33, 74.90, 75.09, 84.99, 87.28, 89.36, 111.70, 113.44, 117.29,
126.99, 127.83, 128.55, 130.20, 130.41, 135.23, 135.41, 135.44, 144.11, 150.38,
158.86, 163.35. 31P NMR (160 MHz, CDCl3, 25 ºC): δ=148.6, 149.5; ESI-TOF: m/z calcd
for C41H52N4O8PTe: 889.2585, found 889.2587.

7.3.2 Incorporation of Te-functionality into oligonucleotides
Both 2’-TeMe and 2’-TePh modified phosphoramidites were incorporated into
oligonucleotides by solid-phase synthesis in over 95% coupling yield, using 5(benzylmercapto)-1H-tetrazole (5-BMT) as the activator. We found that the bulky 2’-Temoieties didn’t significantly affect the coupling reaction, and these 2’-Te-modified
phosphoramidites could achieve almost quantitative coupling even with a standard 25
seconds of coupling time. The Te-oligonucleotides were synthesized via the DMTr-on
mode using ultra-mild phosphoramidites and cleaved with K2CO3 at room temperature
for 8 hours. To reduce the partially oxidized Te-DNAs, a diborane treatment was
performed right after the deprotection step. As an example, the HPLC analysis profile of
a crude 2’-TePh-T DNA with DMTr-on is showed in Figure 7.2, from which we
determined the Te-coupling yield as over 95%. After the HPLC purification with DMTr-on,
the DMTr group was removed by treatment with 3% trichloroacetic acid, and the
oligonucleotides were purified again by HPLC, followed by MALDI-TOF MS analysis to
confirm the integrety of these Te-DNAs (Table 7.2 and Figure 7.3). To our pleasant
surprise, both methyltelluride and phenyltelluride functionalities are stable during the
deprotection and purification.
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Figure 7.2: HPLC analysis of the Te-DNA: 5’-DMTr-G(2’-TePh-U)GTACAC-3’. This
analysis was performed on a Zorbax SB-C18 column (4.6 x 250 mm) with a linear
gradient from buffer A (20 mM TEAAc: triethylammonium acetate, pH 7.1) to 100%
buffer B (50% acetonitrile in 20 mM TEAAc) in 20 min.; the retention time of the fulllength Te-DNA is 20.7 min.

Table 7.2: MALDI-TOF analysis of 2’-Te modified oligonucleotides.

DNA sequences

Formula

MS (M-H) (Calcd.)

GU(2’-TeMe)GTACAC

C78H99N30O46P7Te

2536.1 (2536.2)

ATGGU(2’-TeMe)GCTC

C88H112N32O54P8Te

2856.3 (2856.4)

GU(2’-TePh)GTACAC

C83H101N30O46P7Te

2599.4 (2599.3)

ATGGU(2’-TePh)GCTC

C93H114N32O54P8Te

2919.0 (2918.5)

GCGU(2’-TePh)ATACGC

C102H125N38O58P9Te

3218.0 (3216.7)

GT(2’-TePh)GTACAC

C84H103N30O46P7Te

2611.8 (2612.3)

ATGGT(2’-TePh)GCTC

C94H116N32O54P8Te

2933.3 (2932.5)

CTdU(2’-TePh)CTTGTCCG C111H140N32O69P10Te

3464.5 (3465.4)

CTdU(2’-TeMe)CTTGTCCG C106H138N32O69P10Te

3400.5 (3401.8)
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Figure 7.3: MALDI-TOF mass of Te-oligonucleotide 5’-GU(2’-TePh)GTACAC-3’. The
peak at m/z with M+16 showed the possible oxidation of tellurium atom.

It’s noteworthy that approximately 5% of the Te-DNAs are oxidized to the
telluoxides after the solid-phase synthesis. Fortunately, the telluoxides can be reduced
back to the tellurides. The detailed investigation of the purified Te-DNAs by HPLC
analysis has revealed that the telluride DNA can be oxidized to the telluoxide DNA by
the I2 condition, and the telluoxide can be reduced back to the telluride by B2H6
(Scheme 7.5 and Figure 7.4). This provides a useful approach to recover the oxidized
telluride, and allows further investigation of the redox property of tellurium functionalities.
Interestingly, under heating at 50 °C, we have observed a site-specific cleavage of the
2’-TePh-DNA at the modification site in the presence of either B2H6 or I2 (Figure 7.5).
This result is also consistent with our previous observation of the 2’,3’ elimination of the
Te-nucleosides. This site-specific fragmentation provides a good model for DNA
damage study. Furthermore, in a 2’-TeMe modified 9mer DNA [5’-ATGG(2’-TeMeU)GCTC-3’], the base elimination was also observed (Figure 7.6). This Te-DNA
research can facilitate investigation of the DNA cleavage and nucleobase damage.
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Scheme 7.5: Redox and fragmentation of DNA oligonucleotides containing 2’-Te
functionalities.
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Figure 7.4: Redox behavior of 2’-TePh-8mer GU(2’-TePh)GTACAC with B2H6/I2 system.
Red: original profile; blue: I2 treatment; black: co-injection; purple: re-treated with B2H6.
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Full length 8mer

Fragmented 6mer

Full length 8mer

Figure 7.5: Thermo-cleavage of 2’-TePh modified DNA 8mer 5’-GU(2’-TePh)GTACAC-3’.
Above: the original MALDI-TOF spectrum, molecular weight is 2600 (M+H)+; Bottom:
MALDI-TOF spectrum of fragmentated DNA, after heating with either I2 or B2H6 at 50
degree, the fragmentated 6mer represents 5’-p-GTACAC-3’, Fw=1856.

160

5'-ATGG

5'-ATGG(2'-TeMe-U)GCTC-3'

O

O

BH3 and 50 °C
3h

O
GCGC-3'
MW= 2856.3

MW= 2602.6

Debased Peak
Original Peak

Figure 7.6: MALDI-TOF analysis of the reductive base elimination of the 2’-TeMe
modified sequence 5’-ATGG(2’-TeMe-U)GCTC-3’.

7.4 Thermal denaturization studies of 2’-Te containing DNAs
Due to the size of Te atom, we anticipate that the incorporation of the Tefunctionalities at the 2’ position perturbs the DNA duplexes. In addition, we expect that
the 2’-Te-Ph moiety causes more perturbation than the 2’-Te-Me. Thus, we have
investigated

the

Te-modified

duplex

stability

by

measuring

their

UV-melting

temperatures. In the case of a self-complementary duplex [5’-G(2’-TeX-U)GTACAC-3’]2,
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where the double Te-modifications are introduced to a short DNA duplex, the melting
temperature dropped dramatically (Figure 7.7). In the case of the 2’-TePh, the Tm
decreased by 15 ºC while the 2’-TeMe by 10 ºC from the native duplex. It suggests that
short duplex of the self-complimentary DNA can not accommodate these two bulky
modifications well.
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Figure 7.7: Thermaldenaturation curves of 2’-TeX modified self-complementary
sequence 5’- GU(2’-TePh)GTACAC -3’ (X=Me or Ph). The samples (1 mM duplex) were
heated from 6 to 70 ºC with a rate of 0.5 ºC/min. The red, blue and purple curves
represent the native, 2’-TeMe and 2’-TePh duplex respectively. The averaged (four times
experiments) Tm are: 39.4ºC(purple), 28.6ºC(Blue), 23.4ºC(Pink) respectively.
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When introducing the Te-functionalities to a non-self-complementary duplex [5’C(2’-TeX-U)TCTTGTCCG-3’ and 5’-CGGACAAGA-AG-3’], it was observed that the
melting temperatures of the native, 2’-TeMe and 2’-TePh duplexes were 44.0, 40.7 and
36.8 ºC, respectively. It is noteworthy that when the TeMe moiety is introduced close to
a terminal position, the Te-modification is relatively well accommodated (Figure 7.8).
Since the termini are usually dynamic and spacious, our result suggests that the
dynamics and space allow a better accommodation. Therefore, the perturbation is most
likely a local event, and this bulky Te-modification may be useful in investigating the
formation of DNA or RNA loop, bulge, and other local conformations.
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Figure

7.8:

Normalized

thermaldenaturation

curves

of

11mer

pair

5’-CU(2’-

TeX)TCTTGTCCG-3’&3’-CGGACAAGAAG-5’. The samples (1 mM duplex) were heated
from 6 to 75 ºC with a rate of 0.5 ºC/min. The red, blue and green curves represent the
native, 2’-TeMe and 2’-TePh duplex respectively. The averaged (four times experiments)
Tm are: 44.0 ± 0.1 ºC, 40.7 ± 0.1 ºC and 36.8 ± 0.2 ºC respectively.
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7.5 Conclusion of this chapter
In summary, we have synthesized for the first time the Te-derivatized nucleoside
phosphoramidites and incorporated the Te-functionalities into oligonucleotides with a
high coupling yield. Several 2’-Te-modified oligonucleotides were synthesized and
characterized by HPLC and MS. We have demonstrated that both of the 2’-TeMe and
2’-TePh functionalities are compatible with the solid-phase synthesis, deprotection and
purification. In addition, we revealed the redox property of the Te-functionalities and the
interchange of the telluride and telluoxide DNAs by a redox reaction. We also found that
the 2’-Te-modified DNA can be reductively or oxidatively cleaved, and the DNA
nucleobase can be eliminated via the 1’,2’ elimination. This system may be useful in
studying the DNA cleavage and nucleobase damage. Furthermore, in our UV-melting
study of the 2’-Te-modified DNA duplexes, as expected, we observed the Tm decrease
of the Te-DNA duplexes. And probably that’s also the reason why we haven’t succeeded
to obtain the crystal for this derivatization using the self-complementary sequence
model. But since the Tm decrease is dependent on the size and location of the Temodifications, this derivatization strategy is useful in probing DNA and RNA local
conformations and topological structures. Moreover, this Te-derivatization of nucleic
acids has great potentials in nucleic acid X-ray crystallography as well as in structural
and functional analysis of nucleic acid-protein large complexes with electron microscope.
In the end, a novel tellurium mediated elimination reaction was discovered by accident
during this process, which could provide another new application of tellurium reagents in
medicinal research area.
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8.

SYNTHESIS OF 5-TELLURIUM MODIFIED URIDINE FOR NUCLEIC ACID
STRUCTURE AND FUNCTION STUDIES

8.1 Introduction
To further take the potential advantage of tellurium functionality as promising
alternative to the usual soaking procedure of heavy-atoms incorporation for classic
multiple isomorphous replacement (MIR) while avoiding the use of synchrotron light
source which is not always convenient and available, we continue our TeNA (tellurium
modififed nucleic acids) project by exploring the Te-derivatization at different positions.
As stated in the previous chapter, although the 2’-tellurium (either phenyl or methyl)
functionalities could cause some structure perturbations in some oligonucleotide
duplexes especially self-complementary ones, probably due to the large size of tellurium
center, the compatibility of tellurium chemistry with solid phase synthesis is well proved,
as well as the stability of tellurium functions. In addition, although we could not get the
crystal for this 2’-Te modified DNAs, the stability and structural isomorphorism of TeMetproteins have been confirmed as far comparing the native proteins. So, we thought it’s
still very necessary to get the more detailed structure information about the effect of
tellurium functionality to nucleic acid structures.
Considering that the space limitation of the 2’-position which located in the minor
groove of DNA, we would like to carried out the trial to the 5-position of the deoxyuridine
base which located in the major groove instead. Hopefully, the derivatization of this
position will cause much less structure perturbations. This chapter will present the
related work, as well as our structure studies.
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8.2 Preparation of 5-TePh functionalized nucleosides and DNAs
8.2.1 Synthesis of 5-TePh-uridine and the phosphoramidites
The synthesis of 5-TePh-uridine phosphoramidite is showed in scheme 8.1,
starting from the silylation of commercially available 5-Iodo-2-deoxyuridine derivative 1
in a quantitative yield. After purification, the treatment of this intermediate with NaH/nBuLi followed by adding diphenylditelluride (PhTe)2 gave an inseparable mixture of the
desired 5-PhTe derivative (major) and the corresponding 6-PhTe derivatives, along with
the reduction byproduct 2’-TBDMS-5’-DMTr-deoxyuridine. After several failure trials
such as re-crystallization and slow column chromatography to separate the isomers, we
switched the starting compound to the 3’,5’-di-O-silyl derivatives, but unfortuniterly, this
5-isomer was still difficult to be isolated from the corresponding 6-regio-isomer. Finally,
the concentrations of the reactant were adjusted, based on the 3’-O-silyl-5’-DMTr
derivative (Scheme 8.1). As a result, it was found that when the concentration of
reactant was increased to as high as 0.15 M or 0.18 M of THF solution and the reaction
was performed at the lower temperature, the 6-TePh isomeric compound could indeed
be completely eliminated, which produced a mixture of 5-TePh derivative and the
corresponding reductive byproduct deoxyuridine. This mixture could then be separated
by careful column purification in acceptable yield. With this key intermediate in hand, the
deprotection of compound 2 with TBAF/THF was carried out, as a result, the precursor 3
was generated quantitatively, which is ready to be transferred into the phosphoramidite
for solid phase synthesis. The final phosphoramidite compounds were obtained and
purified by following the standard procedures.
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Scheme 8.1: Synthesis of 5-TePh derivatized 2’-deoxyuridine phosphoramidite.
(a) TBDMSCl, Pyridine. (b) NaH, nBuLi, PhTeTePh, THF. (c) Et3N•3HF, THF. (d) 2Cyanoethyl N, N-diisopropyl-chlorophosphoramidite and N,N-diisopropyl ethylamine,
CH2Cl2.

8.2.2 Incorporation of 5-Te-functionality into oligonucleotides
Considering that the tellurium center could be a good electrophile, ultra-mild
phosphoramidite reagents was used to avoid the ammonium treatment. As expected,
this Te-phosphoramidite is well compatible with solid phase synthesis conditions and
thus has been incorporated into several designed DNA sequences. After K2CO3 (0.05 M
in MeOH) cleavage and deprotection, the crude DNA solution was checked by analytical
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RP-HPLC. From the percentage of full length DNA in figure 9.1, the real coupling yield
could be claimed as over 98%. The samples were then purified in a preparative RPHPLC system as trityl-on form. After treated with 3% trichloroacidic acid for two minutes,
the solution was neutralized with triethylamine and extracted with petroleum ether,
ready for the second purification as trityl-off form.
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Figure 8.1: HPLC analysis of 5-TePh-9mer: 5'-ATGGdU(5-TePh)GCTC-3'. Buffer A: 20
mM of TEAAC, Buffer B: 50% ACN in buffer A. Gradient: 5%~ 50% B in 10min, up to
100% B in 15 min, keep 100% B until 25min, then go back to 0% in 30 min. The full
length sample retention time is 15.25 min.

All the tellurium modified DNA oligonucleotides were characterized by MALDITOF. From an example showed in figure 8.2, we can tell that the tellurium function is
also fairy stable with the oxidation environment including iodine treatments and air
exposure during synthesis and purification, except a tiny amount of oxidized form was
observed in the mass spectrum. As demonstration, several tellurium modified DNA
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oligoes were listed in table 8.1. It’s also worthy to mention that the thermal stability test
was also carried out by heating this DNA 9mer at 80 degree for 8 hr, and from the mass
spectrum, we didn’t see any fragmentation or decomposition.

Figure 8.2: MALDI-TOF mass spectrum of 5-TePh-9mer: 5'-ATGGdU(5-TePh)GCTC-3'.
C93H114N32O54P8Te, calculated: 2919.5, observed: 2919.3

Table 8.1: MALDI-TOF analysis of 5-TedU containing DNA oligonucleotides.
DNA sequences

Formula

MS (Calcd.)

ATGGdU(5-TePh)GCTC

C93H114N32O54P8Te

2919.3 (2920.4)a

CTCCCAdU(5-TePh)CC

C89H113N27O53P8Te

2984.4 (2785.4)a

CTdU(5-TePh)CTTGTCCG

C111H140N32O69P10Te

3464.5 (3465.4)a

GCGdU(5-TePh)ATACGC

C102H125N38O58P9Te

GTGdU(5-TePh)ACAC
GdU(2'-SeMe)GdU(5-TePh)ACAC

3218.0 (3216.7)b

C83H101N30O46P7Te
2599.4 (2600.3)a
C83H101N30O46P7SeTe 2679.2 (2678.3)b

a: negative charged (M-H); b: positive charged (M+H).
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8.3 Thermal denaturalization study
After confirming the thermal stability of Te-DNA oligoes, we have further conducted
the duplex thermodenaturaization studies. As original thought, the bulky phenoyltelluride
group shouldn’t affect the duplex global structures since it’s located in the much wider
major groove. Our experimental data also confirmed this assumption, which showed in
figure 8.3 as an example in a DNA 9mer duplex model. There was no obvious Tm
decrease observed, instead, a little bit increase was observed, probably due to the
enhancement of base stacking between the Te-dU and the neighbours. Similarly, the
other two DNA models were also applied, which showed the consistent results.
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Figure 8.3: Normalized thermaldenaturization

curves of DNA 9mer duplex: 5’-

ATGGU*GCTC-3’&5’-GAGCACCAT-3’. Red desh curve represents native pair, Tm=39.8
± 0.3 °C; while blue line represents the Te-pair, Tm=40.3 ± 0.2 °C.
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8.4 Crystallization and data collection of tellurium derivatized DNA
To further confirm that this 5-TePh modification didn’t cause obvious structure
perturbations, we have also tried to get the crystal structures for them. Initially, none of
the sequence crystallized for a long time although more than 100 buffer conditions were
applied to screen. Later on, this problem was solved by using our 2’-Se modification
strategy we discovered previously, which could greatly facilitate the crystal growth. This
both Se-Te-modified DNA (5'-GU2’-SeMeGU5-TePhACAC-3') was designed, synthesized and
purified. Before setting crystallization, the sample was annealed by heating at 70 degree
for 3 min and cooling down to room temperature slowly. As a result, all the 24 conditions
of the Hampton Mini-Screening kit were working well to generate high quality of crystals
with reasonable sizes and shapes within two days (Figure 8.4A and 8.4B as an
example). By diffraction screening, buffer #7 of the kit (10% v/v MPD, 40 mM sodium
cacodylate pH 6.0, 12 mM spermine tetra-HCI, 80 mM potassium chloride and 20 mM
magnessium chloride) was identified to give the highest resolution. Besides this, several
good data sets were also collected for further refine purpose. The data collection and
refine parameters are listed in table 8.2 and 8.3.

Figure 8.4 (A): Photos of Se-Te derivatized DNA octomer crystals.
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Figure 8.4 (B): Photos of Se-Te derivatized DNA octomer crystals.

Table 8.2: X-ray data collection: The data collected at selenium K-edge.
Data Collection

λ = 0.9795 Å

Resolution range, Å (last shell)

18.89-1.50 (1.55-1.50)

Unique reflections

3659

Completeness, %

94.4

Rmerge ,%

7.5 (42.7)

<I/σ(I)>

14.9 (2.4)

Redundancy

8.63 (5.30)

Reduced ChiSquared

0.93 (0.42)

Rmerge=Σ|I-‹I›|/ΣI
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Table 8.3: Refinement statistics in Se-Te-8mer.

Refinement
Resolution range, Å (last shell)

25-1.50 (1.55 - 1.5)

Number of reflections

6859 (424)

Rwork , %

19.3

Rfree , %

21.5

Nucleic Acid (single)
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Heavy atom

2 (Se, Te)

Water

28

Bond length R.M.S.D, Å

0.010

Bond angle R. M.S.D,

1.73

Average B-factors, Å2
All atoms

22.3

Wilson plot

19.6

Overall anisotropic B-values
B11/B22/B33

0.6/0.6/-1.2

Solvent density correction, e/Å3

0.44

Solvent B-factors, Å2

59.6

Coordinates error (c.-v.), 5Å
Esd. from Luzzatt plot, Å

0.17

Esd. from SIGMAA, Å

0.15
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8.5 X-ray crystallography of the first Te-containing DNA
This Se-Te-8mer DNA structure have the same tetragonal space group P43212 as
the native one (33). Figure 8.5 showed the electron density maps of the Te-dU residue,
as well as the base pair between this residue and the A5, which indicates that this
modification doesn’t affect the duplex base pair. To our surprise, there was no phenyl
group present in this structure, which was also consistent with the other sets of highquality data we have collected. In addition, although the density map of tellurium atom is
very obvious (much bigger than oxygen), the Te occupancy was only about 40%. Since
our thermal stability study has showed there was no decomposition happened during
the annealing heating, we therefore tested its X-ray stability, as a result (figure 8.6), our
MALDI-TOF spectrum showed that both phenyl and phenyl telluride groups could
partially fell off during the exposition. We also reduced the exposure time to as short as
5s, but the same results were obtained. Although low occupancy it was, we thought the
tellurium signal should be still strong enough for the structure determination purpose.
Furthermore, the absence of phenyl group could also have the positive affect to reduce
the potential structure perturbation due to the big group accommodation. We also
observed there was a reserved water molecule attached closely with tellurium center,
which might be another factor to facilitate the elimination of phenyl group during the high
energy x-ray exposure. In terms of structure perturbation, when this Se-Te-DNA
structure was superimposed over the native one (Figure 8.7a), the main global structure
was considered the same, although a small content of backbone torsion was observed,
probably because the accommodation of much bigger tellurium atom could slightly
affect the base packing, as well as the hydration pattern. The overall r.m.s.d value is
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0.407 Å, which was mainly contributed by this slight shift and the last base. The
superimposed local Te-dU residue over native counterparts was also shown in figure
8.7b, which could indicate the reason of the backbone shift.

2.82

2.86

Figure 8.5: Electron density maps of Te-residue TTE and the base pair of T4-A5 in
derivatized DNA. Contours are at 2.0σ level, the red ball represents the Te atom.

Figure 8.6: MALDI-TOF mass of Se-Te-DNA 8mer: GU(2'-SeMe)GdU(5-TePh)ACAC
after irradiating with X-ray (positive mode). C83H101N30O46P7SeTe, exact mass is
2678.16. MS 2601.2 represents removal of phenyl group [M-77], while 2475.3
represents removal of TePh group.
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Figure 8.7: Superimposed comparison of the native and tellurium derivatized DNA
structures. (1DNS and 3FA1). The red and green balls mean Te and Se respectively). (A)
Global comparison; (B) Local comparison of Te-residue TTE and native T4.
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8.6 Conclusion of this chapter
In summary, we have successfully developed a novel tellurium modification
strategy in our process of developing new heavy atom derivatization methodologies for
nucleic

acids

structure

determination

besides

selenium.

The

5-TePh-uridine

phosphoramidite was synthesized and incorporated into several DNA oligonuelctotides
through solid phase synthesizer in high yields.

Our thermaldenaturation studies

indicated that this tellurium modification on the nuclei-base doesn’t affect the DNA
duplex stabilities. The x-ray crystallography structure of a Te-DNA was determined to
further demonstrate the presence of tellurium atom and the structure isomorphism of
this modification comparing with native one. Following the considerable interests in the
bioincorporation of tellurium methionine analogs into proteins, our site specifically
chemical incorporation of tellurium functionality into nucleic acids is expected to offer
similar advantages, which using tellurium to provide clear signal in both isomorphous
and anomalous difference Patterson maps at the commonly used CuKα wavelengths,
thus avoiding the synchrotron light source requirement. In addition, since tellurium is
much more metallic comparing O, S, and Se, this method could also have potential to
be applied in microscopy detection such as AFM or cryo-EM. Furthermore, our Te-DNA
could also provide a model for the research of tellurium toxicity in macromolecule
system.
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APPENDIX:

•

Nucleic Acids Mini Screen (NAM)

Application and Features:
Crystallization screen for nucleic acid fragments; Can be used to screen a matrix

of pH, polyamine and ions; Uses MPD as the primary precipitant.
•

Description:
The Nucleic Acid Mini Screen is an efficient screen formulated to assist in the

determination of preliminary crystallization conditions of nucleic acid fragments. The
formulation is based upon the publication “A Highly Efficient 24 Condition Matrix for the
Crystallization of Nucleic Acid Fragments” where the preliminary crystallization
conditions of 35 nucleic acids were determined utilizing this formulation. Samples
include DNA-Drug complexes, C-Tetrad and G-Quartet Motifs, RNA oligomers, and
others. By using 1 to 4 mM oligonucleotide stock concentration, the screen requires less
than 100 µl of sample. The screen is typically performed at 4°C although room
temperature incubations can also be performed. To evaluate the effect of equilibration
kinetics as well as initial and final sample concentrations, the screens are typically
performed using the hanging or sitting drop vapor diffusion method with two drops on a
slide (1 µl + 2 µl and 2 µl + 2 µl), side by side. The 24 well format of the mini screen
provides for a fast setup and uses small amounts of sample. This makes it possible to
cost-effectively screen many sequences as well as variations of a particular sequence.
The composition of the Nucleic Acid Mini Screen allows one to apply the formulation to
other nucleic acids such as deoxy- and ribozymes, pseudoknots, and tRNAs.
Each Nucleic Acid Mini Screen kit contains 24 unique reagents, 1.0 milliliter each plus a
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250 milliliter volume of dehydrant (35% v/v MPD). All solutions are formulated using
ultra-pure water and are sterile filtered. The detailed compositions are listed as table A1.

Figure A1: Picture of Nucleic Acid Mini Screen from Hampton Research.

Table A1: Crystal buffer conditions of NAM.
40 mM
Entrya

Sodium

Monovalent Ion

Divalent Ion or others

Cacodylate
1

pH 5.5

None

20 mM MgCl2

2

pH 5.5

80 mM NaCl

20 mM MgCl2

3

pH 5.5

12 mM NaCl, 80 mM KCl

None

4

pH 5.5

40 mM LiCl

20 mM MgCl2

5

pH 6.0

80 mM KCl

20 mM MgCl2

6

pH 6.0

80 mM KCl

None

7

pH 6.0

80 mM NaCl

20 mM MgCl2

8

pH 6.0

80 mM NaCl

None
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9

pH 6.0

80 mM NaCl, 12 mM KCl

20 mM MgCl2

10

pH 6.0

12 mM NaCl, 80 mM KCl

None

11

pH 6.0

80 mM NaCl

20 mM BaCl2

12

pH 6.0

80 mM KCl

20 mM BaCl2

13

pH 6.0

none

80 mM SrCl2

14

pH 7.0

80 mM KCl

20 mM MgCl2

15

pH 7.0

80 mM KCl

None

16

pH 7.0

80 mM NaCl

20 mM MgCl2

17

pH 7.0

80 mM NaCl

None

18

pH 7.0

80 mM NaCl, 12 mM KCl

20 mM MgCl2

19

pH 7.0

12 mM NaCl, 80 mM KCl

None

20

pH 7.0

80 mM NaCl

20 mM BaCl2

21

pH 7.0

80 mM KCl

20 mM BaCl2

22

pH 7.0

40 mM LiCl

80 mM SrCl2
20 mM MgCl2

23

pH 7.0

40 mM LiCl

24

pH 7.0

None

80 mM SrCl2
80 mM SrCl2
20 mM MgCl2

a: #1-4 buffers contain 10% (v/v) MPD, and 20 mM cobalt hexamine chloride
[Co(NH3)6Cl3]. #5-24 buffers contain 10% (v/v) MPD, and 12 mM Spermine tetra-HCl.
Entry numbers are the same as the Hampton kit number (Nucleic Acid Mini Screen
Kit, http://www.hamptonresearch.com/).
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